Implementing the Exercise is Medicine™ Solution:  A Process Evaluation Conducted in a University-Based Healthcare System by Birchfield, Natasha R (Author) et al.
Implementing the Exercise is Medicine™ Solution:  
A Process Evaluation Conducted in a University-Based Healthcare System  
by 
Natasha R. Birchfield 
 
 
 
 
 
A Dissertation Presented in Partial Fulfillment  
of the Requirements for the Degree  
Doctor of Philosophy  
 
 
 
 
 
 
 
 
 
 
Approved November 2019 by the 
Graduate Supervisory Committee:  
 
Cheryl Der Ananian, Chair 
Aaron Krasnow 
Bradley Doebbeling 
Marc Adams 
Pamela Swan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ARIZONA STATE UNIVERSITY  
December 2019  
  i 
ABSTRACT  
   
Background: Exercise is Medicine (EIM) is a health promotion strategy for 
addressing physical inactivity in healthcare. However, it is unknown how to successfully 
implement the processes.  
Purpose: The purpose of this study was to understand how implementing EIM 
influenced provider behaviors in a university-based healthcare system, using a process 
evaluation. 
Methods: A multiple baseline, time series design was used. Providers were 
allocated to three groups. Group 1 (n=11) was exposed to an electronic medical record 
(EMR) systems change, EIM-related resources, and EIM training session. Group 2 (n=5) 
received the EMR change and resources but no training. Group 3 (n=6) was only exposed 
to the systems change. The study was conducted across three phases. Outcomes included 
asking about patient physical activity (PA) as a vital sign (PAVS), prescribing PA (ExRx), 
and providing PA resources or referrals. Patient surveys and EMR data were examined. 
Time series analysis, chi-square, and logistic regression were used. 
 Results: Patient survey data revealed the systems change increased patient 
reports of being asked about PA, χ2(4) = 95.47, p < .001 for all groups. There was a 
significant effect of training and resource dissemination on patients receiving PA advice, 
χ2(4) = 36.25, p < .001. Patients receiving PA advice was greater during phase 2 (OR = 
4.7, 95% CI = 2.0-11.0) and phase 3 (OR = 2.9, 95% CI = 1.2-7.4). Increases were also 
observed in EMR data for PAVS, χ2(2) = 29.27, p <. 001 during implementation for all 
groups. Increases in PA advice χ2(2) = 140.90, p < .001 occurred among trained 
providers only. No statistically significant change was observed for ExRx, PA resources 
or PA referrals. However, visual analysis showed an upwards trend among trained 
providers. 
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 Conclusions: An EMR systems change is effective for increasing the collection of 
the PAVS. Training and resources may influence provider behavior but training alone 
increased provider documentation. The low levels of documented outcomes for PA 
advice, ExRx, resources, or referrals may be due to the limitations of the EMR system. 
This approach was effective for examining the EIM Solution and scaled-up, longer trials 
may yield more robust results. 
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CHAPTER 1 
INTRODUCTION 
The United States is facing an imminent health care crisis due to the burden 
associated with cardiovascular diseases (CVDs) and type 2 diabetes. Current estimates 
show that 12% of U.S. adults have CVDs and 12% have type 2 diabetes (Centers for 
Disease Control and Prevention, 2017; Clarke, Ward, Norris, & Schiller, 2017). In 
addition, more than one third (34%) of the population is reported to have prediabetes, a 
major risk factor for developing type 2 diabetes (Centers for Disease Control and 
Prevention, 2017). Direct medical costs associated with CVDs and diabetes are 
approximately $555 billion annually (American Diabetes Association, 2018; American 
Heart Association, 2017) and an additional $44 billion for prediabetes (Khan, Tsipas, & 
Wozniak, 2017).  Although the vast majority of chronic diseases are observed in middle-
aged (ages 45-64 years) and older adults (ages 65+ years) populations, the prevalence of 
type 2 diabetes has increased by 83% in younger adults (age 18-44) since 1996 (Centers 
for Disease Control and Prevention, 2017). While age is the predominant risk factor 
associated with the development of chronic diseases, decades of epidemiological 
research support the notion that physical activity (PA) plays a distinct role in CVD and 
type 2 diabetes prevention (Archer & Blair, 2011; Burr, Rowan, Jamnik, & Riddell, 2010; 
Colberg et al., 2010; Reddigan, Ardern, Riddell, & Kuk, 2011). Moreover, reducing risk 
through PA is recognized as a cost-effective primary prevention strategy for improving 
disease outcomes (Abu-Omar et al., 2017). Due to frequency of contact with at-risk 
populations, primary care professionals have been called upon to address PA behaviors 
(Orrow, Kinmonth, Sanderson, & Sutton, 2012; Sallis et al., 2015; US Preventive Services 
Task Force et al., 2017). In addition, due to the overwhelming evidence supporting PA 
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for disease prevention, targeting PA behaviors in the health care setting must be 
considered for early intervention. 
Improving PA behaviors has been a public health priority for over two decades 
due to the burden associated with inactivity (Physical Activity Guidelines Advisory 
Committee, 2018; US Department of Health and Human Services, 1996, 2008). Physical 
inactivity has been identified as the cause of 6.7% of CVDs and 8.3% of type 2 diabetes in 
the U.S. (Lee et al., 2012). Inactivity is also estimated to contribute to $117 billion in 
excess healthcare costs with inactive adults incurring 27% higher costs than their active 
counterparts (Carlson, Fulton, Pratt, Yang, & Adams, 2015). Although PA trends have 
increased in recent years, a substantial proportion of the population are still not meeting 
national PA guidelines. The most recent estimates indicate that 45% of American adults 
(ages 18+ years) do not meet the minimal PA guidelines for health (>150 min/week of 
moderate-intensity aerobic PA) and 76% are not meeting the combined 
recommendations for aerobic and muscle strengthening (≥ 2 days targeting major 
muscle groups) activities (Schiller, Clarke, & Norris, 2018). Significant decreases in PA 
occur with age but unlike other health risk behaviors such as smoking, trajectories for 
inactivity begin in early childhood, continue across the lifespan, and are unlikely to 
reverse (Corder et al., 2017; Katzmarzyk, Lee, Martin, & Blair, 2017; Varma et al., 2017). 
In addition, the sharpest declines in PA are most likely to occur before the age of 20 
(Varma et al., 2017). Early onset and longer exposure to physical inactivity may be 
disproportionally contributing to the rise in other health-related risks. 
Factors such as obesity and dysfunctional cardiometabolic profiles are highly 
influential in chronic disease pathways. Obesity trends have drastically changed in the 
U.S. over the past several decades and rates are the highest ever documented. According 
to the most recent 2015-2016 National Health and Nutrition Survey (NHANES), 40% of 
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adults (ages 20+) and 19% of children (ages 2-19) are considered obese; an increase of 
30% and 33% respectively since the year 2000 (Warren, Beck, & Rayburn, 2018). 
Furthermore, it appears that young adulthood is a particularly vulnerable period for 
weight gain. Obesity in young adults (ages 20-39 years) is 30% compared to 17% in 
adolescents (ages 12-19 years); a 70% increase in prevalence rates between the two age 
groups (Dietz, 2017). Obesity is also associated with the rising trends observed in 
increased systolic blood pressure, insulin resistance, and inflammation in young adult 
populations (Murthy et al., 2016; Reis et al., 2013). However, research suggests that 
much of the health risk associated with obesity can be attenuated by increasing PA and 
physical fitness even in the absence of weight loss (Barry et al., 2014; Reddigan et al., 
2011).  
Chronic stress is another health risk factor that has been strongly implicated in 
the development of conditions such as CVD and type 2 diabetes and is related to 
maladaptive inflammatory responses (Lopez-Candales, Hernández Burgos, Hernandez-
Suarez, & Harris, 2017; Slavich, 2015; Welty, Alfaddagh, & Elajami, 2016). Stress gives 
rise to pro-inflammatory chemical mediators (i.e. neurotransmitters and hormones) that 
trigger the “fight or flight” response, a biological mechanism that is critical for human 
survival. Following acute stress the body is able to return to homeostasis but prolonged 
activation has been found to suppress immune function and promote inflammatory 
states that are linked to multiple chronic disease pathophysiologies (Cohen et al., 2012; 
Liu, Wang, & Jiang, 2017). Exercise has been recognized as an independent factor that 
mitigates dysregulated inflammatory responses. Interleukin-6, an anti-inflammatory 
protein released during exercise, reduces levels of TNF-alpha, a protein that triggers 
inflammatory responses involved in insulin resistance and atherosclerosis, and inhibits 
the signaling of interleukin-1 beta, a protein that disrupts insulin production in 
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pancreatic beta cells (Pedersen, 2017). Moreover, chronic inflammation is also linked to 
visceral fat accumulation which is exacerbated by physical inactivity and enhances 
inflammatory responses; increasing cardiometabolic dysfunction. However, exercise has 
also been shown to increase interleukin-15, a protein which decreases lipid deposition 
and white adipose tissue (Quinn, Straitbodey, Anderson, Argiles, & Havel, 2005). Due to 
the evidence linking physical inactivity to multiple chronic diseases, prescribing PA and 
exercise should be the first line of defense used in clinical care.  
Studies that have examined PA counseling from a process evaluation perspective 
are primarily focused on environments outside of the U.S. (e.g. United Kingdom, 
Scandinavia, Canada ) where referral schemes and allied health professionals are heavily 
relied upon for delivery (Morgan et al., 2016; Orrow et al., 2012; Samdal et al., 2019; 
Tulloch, Fortier, & Hogg, 2006). However, this may not translate to U.S. healthcare 
systems where such relationships rarely exist. The latest estimates indicate that only 34% 
of U.S. adults have reported being counseled by a healthcare provider about PA 
behaviors, despite perceived importance being high among clinicians (Shuval et al., 
2017). While the benefits of PA for health cannot be refuted, ineffectiveness of PA 
counseling may be attributed to factors which influence implementation and may not be 
well understood. There may a greater need to investigate the processes, programs, 
organizational cultures, resources, and provider support to determine why adoption 
remains low (Huijg et al., 2015).  
In 2007, Exercise is Medicine™ (EIM) was introduced, jointly by the American 
Medical Association and the American College of Sports Medicine, as a clinical solution 
for addressing physical inactivity in clinical environments (Haskell et al., 2007). The 
EIM processes include: 1) assessing PA as a vital sign (PAVS), 2) providing brief PA 
counseling, 3) delivering exercise prescriptions (ExRX) to inactive or insufficiently active 
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patients, and 4) providing self-directed resources or referrals to PA programs. While 
EIM solution has been successfully adopted as a standard of care by organizations such 
as Kaiser Permanente and Intermountain Healthcare, two large non-profit healthcare 
organizations in the Western U.S. (Sallis et al., 2015), widespread implementation is 
lacking. Furthermore, there is a dearth of research investigating the implementation 
processes of EIM. Not having a clear understanding of what leads to or prevents 
successful adoption may dissuade healthcare organizations from considering the 
program. Moreover, investigating PA promotion in the healthcare environment is often 
focused on patient-related outcome evaluations (i.e. efficacy or effectiveness trials) with 
little attention given to the processes involved (Bauer, Damschroder, Hagedorn, Smith, 
& Kilbourne, 2015). While this is certainly important to recognize, what drives provider 
practices and organizational behaviors cannot be overlooked and must be better 
understood. 
With respect to EIM, there have been publications focused on calls to action 
(Crump, Sundquist, Sundquist, & Winkleby, 2019; Sallis, 2015) and commentary on 
strategies for using EIM (Cowan, 2016; Heath, Kolade, & Haynes, 2015; Sallis et al., 
2015). Published research studies have investigated the validation of the PAVS (Coleman 
et al., 2012), effectiveness of adding the PAVS to the EMR (Grant, Schmittdiel, 
Neugebauer, Uratsu, & Sternfeld, 2014), acceptability of program protocols (Heath et al., 
2015), and effectiveness of training workshops for increasing provider adoption (Fowles, 
O’Brien, Solmundson, Oh, & Shields, 2018). However, there is a major gap in research 
related to how the entire EIM Solution can be successfully implemented. If the EIM 
Solution is to be considered a standard of care, this must be addressed.  
Complex interventions that aim to improve health outcomes often target multiple 
factors that occur at individual, interpersonal, and organizational levels; and are often 
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delivered in systems which respond in unpredictable ways (G. Moore et al., 2014). An 
intervention deemed unsuccessful may be the result of issues such as poor design, 
incomplete implementation, or insufficient reach within the organization. Examining the 
processes and how they affect the organization is essential for understanding what may 
have occurred that prevented successful implementation. A process evaluation aims to 
answer such questions and must be considered before evaluating efficacy and 
effectiveness with respect to patient outcomes (Saunders, Evans, & Joshi, 2005). 
Ignoring the evaluation process can be a detriment when trying to understand why an 
intervention was or was not successful in changing patient behavior. Implementation 
must include an evaluation plan which aims to (a) understand a program and how it is 
intended to work, (b) defines the purpose for the evaluation, ands (c) considers and 
contextualizes the influence of program characteristics (Saunders et al., 2005).   
Process evaluations aim to capture three themes involved with intervention 
delivery: (a) implementation, (b) causal mechanisms, and (c) contextual factors (G. F. 
Moore et al., 2015). In 2010, the Medical Research Council’s (MRC’s) Population Health 
Science Research Network developed a framework (Figure 1) to use for understanding 
this complex interplay. Examining implementation components, such as delivery, 
training, and acceptability, leads to a better of understanding of factors that optimize or 
impede the facilitation and reach of the intervention (G. Moore et al., 2014). Evaluating 
fidelity (i.e. was the intervention delivered as intended), dose (i.e. what quantity of the 
intervention was implemented), adaptation (i.e. how was the intervention tailored to the 
local environment), and reach (i.e. what proportion of the intended audience received 
the intervention) allows inferences to be made about what is influencing the mechanisms 
of impact (G. F. Moore et al., 2015). Exploring interactions with the intervention, 
potential mediators, and factors leading to unexpected outcomes can provide greater 
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insight into the effectiveness of the intervention (G. F. Moore et al., 2015). 
Contextualizing these elements allows for a better understanding of the complexity of the 
interactions and aids to inform future or scaled-up iterations. 
  The purpose of this study was to conduct a process evaluation of the 
implementation of EIM in a university-based healthcare system. The rationale for the 
study was based on the need to establish an understanding of how the systematic 
processes proposed in EIM influence provider behaviors. This is vital to explore before 
considering scaled-up trials or examining the effectiveness of the intervention on patient 
behaviors. The focus on a university-based health system is a uniquely different than 
typical healthcare environments due to the age and perceived health of the patient 
population. However, this may be far-reaching in the realm of preventive health. Nearly 
70% of high-school graduates are enrolled in colleges or universities (National Center for 
Education Statistics, 2018) and overlooking the role these providers play may be a 
missed opportunity for understanding PA promotion in young adult populations. The 
specific aims of this study were to: 
1. Determine the overall number, proportion, and representativeness of patients 
who were (a) screened for physical inactivity, (b) counseled by providers (c) 
received an exercise prescription, and (d) provided with self-directed PA 
resources or a referral to an internal partner. 
2. Determine the number, proportion, and representativeness of providers who (a) 
conduct brief PA counseling, (b) deliver exercise prescriptions, and (c) provide 
self-directed PA resources or referral to patients, using the EIM solution, for each 
provider group. 
3. Compare the change in proportions of patients who were (a) screened for 
inactivity, (b) counseled by providers, (c) received exercise prescriptions, and (d) 
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provided with self-directed PA resources or a referral, from pre-implementation 
to implementation. 
H01: There will be no change in the proportions of patients screened, counseled, 
prescribed exercise, and provided with PA resources or referral between pre-
implementation and implementation. 
Ha1: The proportion of patients being screened, counseled, prescribed exercise 
and provided with PA resources or a referral will be greater during 
implementation compared to pre-implementation.  
4. Compare changes in the proportion of patients who were (a) screened for 
inactivity, (b) counseled by providers, (c) received exercise prescriptions, and (d) 
provided with self-directed resources or a referral, by provider group. 
H02: There will be no difference in the proportions of patients screened, 
counseled, prescribed exercise, and provided PA resources or referral, between 
provider groups. 
Ha2: The proportion of patients screened, counseled, prescribed exercise, and 
provided with PA resources or a referral during implementation will be greater 
among EIM trained providers compared to untrained providers.  
5. Qualitatively describe providers’ perceptions of using the EIM Solution as a 
health promotion strategy to address inactivity and satisfaction with the 
implementation processes. 
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CHAPTER 2 
REVIEW OF LITERATURE 
 
Physical Activity Promotion in Healthcare 
Physical activity counseling in the healthcare setting has been extensively 
researched and is accepted as a comprehensive and effective health promotion strategy 
for providers to use when addressing inactivity (Ainsworth & Youmans, 2002; Orrow et 
al., 2012; Pavey et al., 2011; Tulloch et al., 2006; Vuori, Lavie, & Blair, 2013). Due to the 
recognized importance of the role of PA in maintaining health-related outcomes, the U.S. 
Preventive Services Task Force first established guidelines in 1989 recommending that 
healthcare providers incorporate regular PA counseling into their practices (S. S. Harris, 
1989). Additionally, current guidelines outline the need to investigate the effectiveness of 
PA counseling for improving and preventing adverse health outcomes (US Preventive 
Services Task Force et al., 2017).  
 A myriad of primary care-based physical activity referral schemes, a model in 
which a PCP identifies and refers inactive patients to a third-party PA service, have been 
developed over the past 25+ years (Pavey et al., 2011). In 1990 the PA referral scheme 
began to emerge in primary care practices across the United Kingdom (U.K.) and has 
grown rapidly. There are currently more than 600 referral schemes in operation for 
addressing physical inactivity operating in the U.K. Pavey and colleagues (2011) 
conducted a meta-analysis of six RCTs with 3,900 patients to assess the impact of 
provider referral on PA. Providers were invited to refer inactive patients, at their 
discretion, who had had at least one cardiovascular risk factor (i.e. high blood-pressure, 
dyslipidemia, overweight) but no medical diagnosis of CVDs. Referrals were to a third-
party fitness professional or organization who conducted sessions twice per week for 30-
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60 minutes, for a total duration of 10-12 weeks. After 6-12 months of follow-up there was 
a 16% increase (RR= 1.16, 95% CI 1.03-1.30) in the proportion of patients who reported 
achieving 90-150 minutes of moderate intensity PA per week compared to patients 
receiving usual care (i.e. no PA referral). These findings indicate that a provider-based 
referral can improve PA behaviors. While this analysis speaks to the effectiveness of the 
referral scheme, there is no clear description of the processes used by providers to 
deliver the referral, what discretionary factors influenced the referral process, and no 
information about how many patients qualified and opted-out in relation to the number 
of patients who opted-in in any of the research trials. It is difficult to truly determine the 
effectiveness without considering this information.  
 Another systematic review and meta-analysis conducted on the effectiveness of 
physical activity promotion in primary care, examined 15 RCTs with 8,745 patient 
participants from primary care practices in the U.K., New Zealand, the U.S., Switzerland, 
the Netherlands, Australia, and Canada (Orrow et al., 2012). Providers included primary 
care doctors or nurses, physiotherapists, health promotion specialists, or PA specialists 
who provided PA counseling, referrals, and/or self-directed resources. Patients were 
invited to participate based on PA status. Seven of the studies used a “no intervention” 
comparison group and eight used comparator interventions consisting of additive 
components (e.g. varying levels of follow-up conducted in person, by phone, or by mail). 
Fourteen studies included self-reported PA and one study reported objectively measured 
PA. Pooled analysis, using dichotomous variables (i.e. ≤ 150 min/week or > 150 
min/week) of self-reported PA showed a significant increase (OR = 1.42, 95% CI 1.17-
1.73) after 12 months of follow-up. In addition, it was estimated that 12 sedentary adults 
had to receive a PA intervention, for one additional person to report meeting PA 
guidelines after 12-months. The authors compared this to smoking cessation advice 
  11 
delivered in primary care, where the best estimates indicate between 50-120 patients 
must receive advice for one person to report cessation. Sub-analyses showed comparator 
interventions with more intensive follow-up reported similar increases in the percentage 
of participants meeting PA guidelines (8-47%) as interventions with minimal follow-up 
(11-47%). Both were greater than the range reported for those allocated to no 
intervention groups (-2% - + 19%). These findings indicate that PA promotion in primary 
care are more effective at eliciting change than other behaviors that are commonly 
addressed in primary care such as smoking. Furthermore, the findings show that 
including additive levels of follow-up may not be necessary for getting patients to achieve 
the minimal PA guidelines for health. As with the previous study, there is little to no 
information provided about the processes involved. Although a better description of the 
type of providers who were involved in delivering the interventions was provided, there 
was no information provided on the overall numbers of eligible patients, those who 
opted-out, and what influenced the providers’ discretionary decisions for inviting 
patients to participate.  
 Despite decades of emphasizing the need for PA promotion, PA position 
statements, policies, and guidelines, physical inactivity remains a significant public 
health concern. Although many studies have been conducted on the efficacy of physical 
activity promotion in primary care, there is a lack of studies evaluating the processes that 
providers and organizations must adopt in order to successfully implement long-term 
programs. Furthermore, the strategies employed in the aforementioned studies often 
involve a team-based approach, relying on affiliated professionals for program delivery 
While RCTs are the gold standard for research, the strict criterion for inclusion and 
adherence to specific protocols may not be representative of a real-world clinical setting. 
Even though the EIM Solution provides a framework for standardizing the approach to 
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evaluating and addressing physical inactivity, there are no standard protocols for 
documentation, and reporting beyond the PAVS. Because primary care providers have a 
greater chance for interacting with the population, the impact of PA counseling may be 
far reaching, and these limitations must be addressed. 
 
The Exercise is Medicine Solution 
Historically, exercise has been viewed as a medicine for many ancient and 
modern ailments and diseases. The fathers of western medicine, Hippocrates and Galen, 
were among the first to be widely recognized for their philosophical ideology that 
exercise was a necessary component for maintaining health. Hippocrates was the first 
physician on record to provide an exercise prescription for walking to a patient suffering 
from consumption (Tipton, 2014). Likewise, Galen was known to prescribe exercise for 
arthritis, depression, epilepsy, gout, and tuberculosis (Tipton, 2014). In the mid-16th 
century, the Spanish physician Christobal Mendez published the Book of Bodily 
Exercise, which made the case that “exercise…deserves lofty praise as a blessed medicine 
that must be kept in high esteem” (Berryman, 2010). The idea that exercise is a medicine 
continued to dominate medical ideology throughout the 18th century by British physician 
Francis Fuller, Scottish physician William Buchan, and French physician Clement Tissot; 
all of whom recognized and the benefits for health (Berryman, 2010). In the 19th century, 
physical exercise as a means for preserving health became a standard for physicians 
training in major universities (i.e. Harvard, John’s Hopkins, Yale, and the University of 
Pennsylvania and prescribing exercise to preserve health was a common practice 
(Berryman, 2010). However, by the early 1900’s a dynamic shift away from prevention 
began to emerge as cures for infectious diseases took precedence and physical education 
evolved into sport-related curriculum.  
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In the mid-1900’s a new era for exercise science emerged as the early 
epidemiological findings of Morris and Paffenbarger began to reshape the ideology and 
science of PA, exercise, and the relationship to health and disease. The American College 
of Sports Medicine was founded in 1954 by epidemiologists, physiologists, and 
cardiologists to promote the pursuit of evidence-based research related to PA and health. 
In 2007, Exercise is Medicine™ (EIM) was introduced, jointly by the American Medical 
Association and the American College of Sports Medicine, as a clinical solution for 
addressing physical inactivity in clinical care settings. It has been suggested that the EIM 
Solution should become a standard of care for addressing physical inactivity, which 
ought to occur at every patient visit. The following procedures have been developed to 
make the EIM Solution a viable process to follow: (1) assess physical activity as a vital 
sign, (2) provide brief physical activity counseling, (3) deliver exercise prescriptions 
(ExRX) to inactive patients, and (4) provide self-directed resources or referrals to PA 
programs. While the EIM solution has been successfully adopted as a standard of care by 
health systems such as Kaiser Permanente and Intermountain Healthcare, two large 
non-profit healthcare organizations in the U.S. (Sallis et al., 2015), widespread 
implementation is lacking. Furthermore, there is a dearth of research investigating the 
implementation process itself. Not having a clear understanding of what leads to or 
prevents successful implementation likely dissuades many organizations from adopting 
the EIM Solution.  
The EIM initiative was endorsed by the American Academy of Family Physicians 
(AAFP) in 2008 with the rationale that 84% of individuals consult a family physician and 
providing brief counseling leading to modest changes in PA could significantly influence 
population health (Meriwether, Lee, Lafleur, & Wiseman, 2008). The recommendations 
included by the AAFP are to incorporate tailored counseling, shared decision making, 
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written prescriptions, printed support materials, and patient follow-up to increase 
successful PA counseling encounters. However, counseling behaviors among health care 
providers has remained relatively low and unchanged (~40%) since the mid 1980’s 
(VanWormer, Pronk, & Kroeninger, 2009). In addition, it is likely that the reported 
percentages are not truly representative due low response rates and response biases (e.g. 
physically active providers are more likely to participate; loose operational definitions for 
PA counseling) which may be limiting what is known about provider-based PA 
counseling. Furthermore, a lack of standardization with reporting or documenting 
patient-provider PA encounters may also introduce recall bias. With more healthcare 
systems adopting electronic medical record systems, introducing charting options to 
capture these metrics would provide invaluable insights into these practices.  
The physical activity vital sign. The National Physical Activity Alliance 
released the first National Physical Activity Plan (NAPP) in 2010, a collaborative effort 
informed by the private and public sectors, to create initiatives, policies, and programs 
focused on increasing PA in the U.S. (U.S. National Physical Activity Plan, 2016). The 
NAPP was updated in 2016 and is the most comprehensive program aiming to improve 
health, prevent disease, and enhance quality of life by creating a culture that supports 
active lifestyles. As with the EIM solution, the NAPP guidelines aim to make PA a clinical 
vital sign and recorded in the EMR so that it is regularly monitored, just as other vital 
statistics (e.g. blood pressure, body weight, BMI). The PAVS is two questions related to 
the number of days and minutes per day patients spend participating in moderate-
intensity PA. The product of the two numbers is recorded as the PAVS in the patient’s 
electronic health record. Although the vital statistic is subjectively reported, it has been 
validated as a good measure for monitoring PA behaviors. A study evaluating the validity 
of the PAVS among patients in primary care (n = 298) compared the PAVS to the 
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Modifiable Activity Questionnaire (MAQ), which is strongly correlated to objective PA 
measurements (i.e. accelerometry), and showed a strong correlation (r = 0.71, p < .001) 
for moderate intensity PA (Ball, Joy, Gren, & Shaw, 2016). The impact of recording the 
PAVS in the EMR has shown that a systematic process for collecting this information as 
a vital statistic is associated with small but significant increases in PA-related progress 
notes (OR = 1.12, 95% CI 1.11-1.13, p < 0.001) and documented PA referrals (OR = 1.14, 
95% CI 1.11-1.18, p < 0.001) compared to visits without the PAVS (Grant et al., 2014). 
 
Process Evaluations in Healthcare 
Health promotion interventions aimed at alleviating public health issues (i.e. 
smoking, obesity, PA) often use interventions which have multiple interacting 
components. In the healthcare environment this can be a complex issue when 
interpreting a program’s success with respect to implementation. Outcomes targeting 
multiple factors that occur at individual, interpersonal, and organizational levels are 
often delivered in systems which respond in unpredictable ways (G. Moore et al., 2014). 
An intervention deemed unsuccessful may be the result of issues such as poor design, 
incomplete implementation, or insufficient reach within the organization. In 2010, the 
Medical Research Council’s (MRC’s) Population Health Science Research Network 
provided a framework (Figure 1) to use when conducting process evaluations related to 
implementation. The framework includes the examination of the delivery, training, and 
acceptability of an intervention; provides a level of understanding that considers factors 
which optimize or impede the facilitation and reach of the intervention; evaluates fidelity 
(i.e. was the intervention delivered as intended), dose (i.e. what quantity of the 
intervention was implemented), adaptation (i.e. how was the intervention tailored to the 
local environment), and reach (i.e. what proportion of the intended audience received 
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the intervention); and allows inferences to be made about what is influencing the 
mechanisms impacting implementation (G. F. Moore et al., 2015). Exploring interactions 
with the intervention, potential mediators, and factors leading to unexpected outcomes 
can provide greater insight into the effectiveness of the intervention (G. F. Moore et al., 
2015). Contextualizing these elements allows for a better understanding of the 
complexity of the interactions.  
Prior to the MRC updating this evaluation framework, the need for process 
evaluations was recognized as a way to understand how a health promotion program was 
implemented, before assessing effectiveness outcomes (Saunders et al., 2005). Saunders 
and colleagues (2005) also recognized that ignoring the evaluation process could be a 
detriment when trying to understand why an intervention was or was not successful and 
lead to wasted resources when evaluating effectiveness. Without a comprehensive plan to 
measure the processes, the success of an intervention, or lack thereof, cannot be 
explained with confidence. Furthermore, the complexity of program characteristics, 
program delivery, and organizational characteristics must be contextualized to 
understand each factor and the influence they yield. Otherwise, these may be overlooked 
and attributed to the intervention being unsuccessful. For this reason, an emphasis to 
include an evaluation plan which aims to (a) understand a program and how it is 
intended to work, (b) defines the purpose for the evaluation, and (c) considers and 
contextualizes the influence of program characteristics is essential when examining 
program implementation (Saunders et al., 2005). 
Building on the MRCs framework, a set of criteria was established to help 
navigate the complexities of process evaluation in healthcare, irrespective of study design 
(Möhler, Bartoszek, Köpke, & Meyer, 2012). These criteria included assessment items to 
consider for: (1) development, (2) feasibility and piloting, and (3) introduction of the 
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intervention and evaluation when implemented in the target environment. The 
development phase should include a description of the intervention’s theoretical 
considerations, explanation of the intervention’s components, rationale for the 
intervention’s selection, components of the intervention that are used to enhance the 
effects of the intervention, the essential function of these components, and consideration 
of contextual factors that were used during the implementation process. The feasibility 
and piloting should inform on the acceptability and scope of the intervention’s delivery. 
Introduction and evaluation should include descriptions of the control or comparator 
group(s), location(s) of delivery, and materials used; description of the evaluation of the 
implementation process, deviations from protocols, and facilitators and barriers that 
influenced the implementation, descriptions of unexpected deviations from protocols 
during implementation, and the cost or resources necessary for implementation. All 
these criteria should be evaluated before longer term or scaled-up effectiveness trials are 
considered.  
 
Cost of Cardiovascular Disease, Type 2 Diabetes, and Physical Inactivity 
It is currently estimated that 11.5% of U.S. adults have CVDs and 12% have type 2 
diabetes (Centers for Disease Control and Prevention, 2017; Clarke et al., 2017). 
Additionally, 34% of the population is reported to have prediabetes, a major risk factor 
for developing type 2 diabetes (Centers for Disease Control and Prevention, 2017). 
Despite major medical advancements in treating CVDs, it has been the leading cause of 
death in the U.S. for more than 90 years (Dalen, Alpert, Goldberg, & Weinstein, 2014). 
Over the past 30 years, incidence and prevalence of type 2 diabetes has dramatically 
increased, is a primary risk factor for CVDs, and is among the leading causes of 
morbidity and mortality (Jaacks, Siegel, Gujral, & Narayan, 2016). Furthermore, the cost 
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of treating these chronic diseases has risen dramatically and is a significant burden on 
the health care system. Direct medical costs associated with CVDs are currently $317 
billion annually and are estimated to increase to $749 billion by the year 2035  
(American Heart Association, 2017). Likewise, direct medical costs associated with 
treating diabetes are $238 billion (American Diabetes Association, 2018) with an 
additional $44 billion for prediabetes (Khan et al., 2017). The combined direct medical 
costs for diabetes and prediabetes are projected to reach $472 billion by 2030 (Rowley, 
Bezold, Arikan, Byrne, & Krohe, 2017). Although most chronic illnesses are observed in 
middle-age (ages 45-64 years) and elderly (ages 65+ years) populations, trends for 
illnesses such as type 2 diabetes are increasing in younger populations at alarming rates.  
According to the Centers for Disease Control and Prevention (2017), prevalence 
of diabetes among U.S. adults (ages 18+ years) has increased by 55% since 1996. In 
addition, the International Diabetes Federation estimates prevalence rates will increase 
by an additional 58% by the year 2030 (Rowley et al., 2017). Furthermore, one in three 
Americans is currently living with prediabetes, a primary risk factor for developing type 
2 diabetes (Centers for Disease Control and Prevention, 2017). Among adults with 
diabetes, 47% of are middle aged and 49% are older adults; a strong indication that age is 
a predominant risk factor (Centers for Disease Control and Prevention, 2017). However, 
prevalence among young adults (age 18-44) has increased by 83% since 1996 (Centers 
for Disease Control and Prevention, 2017). Not only is the increase in prevalence and 
earlier onset an issue when addressing the health issues associated with diabetes, 
individuals with diabetes are twice as likely to experience complications from CVDs 
compared to non-diabetic populations (The DECODE Study Group & on behalf of the 
European Diabetes Epidemiology Group, 2004; The Emerging Risk Factors 
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Collaboration, 2010). Due to the rising prevalence and associated medical care 
associated with these illnesses, there is an imminent health care crisis looming.  
It is clear the trends for CVDs and type 2 diabetes are increasing at alarming rate, 
to better understand the impact of physical inactivity, a recent analysis was conducted to 
calculate population attributable fractions (PAFs) (Lee et al., 2012). PAFs estimate the 
proportion of cases that would not occur if a risk factor was absent. To determine the 
impact of physical inactivity on CVDs, type 2 diabetes, breast cancer, colon cancer, and 
mortality, data were obtained from ten large cohort studies or were provided by the 
World Health Organization representing 122 countries across the globe. Relative risk 
scores were calculated, and computer simulated techniques were employed to determine 
the PAFs associated with physical inactivity for each country and region included. 
Physical inactivity was defined as not meeting global PA guidelines (i.e. < 150 min/week 
of moderate intensity PA). PAFs reported for the U.S. were 6.7 (95% CI 2.5-11.1) for 
CVDs, 8.3 (95% CI 4.2-12.9) for type 2 diabetes, 12.4 (95% CI 5.8-19.2) for breast cancer, 
12.0 (95% CI 6.7-17.4) for of colon cancer, and 10.8 (95% CI 8.6-13.1) for all-cause 
mortality. These findings indicate that 6.7% of CVD, 8.3% of type 2 diabetes, 12.4% of 
breast cancer, 12% of colon cancer, and 10.8% of all-cause mortality could be prevented 
through physical activity.  
Not only are disease and mortality rates impacted by physical inactivity, 
healthcare costs are also greater for inactive individuals. A recent study using data from 
51,165 adults age 21 years or older, participating in both the National Health Interview 
Survey and the Medical Expenditure Panel Survey, was conducted to investigate the 
relationship between PA and healthcare expenditures (Carlson et al., 2015). The level of 
PA was determined using the current guidelines and participants were classified as active 
(i.e. ≥ 150 min/week of moderate intensity PA), insufficiently active (i.e. some PA but not 
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meeting guidelines), or inactive (i.e. < 10-minutes of moderate intensity PA per week). 
Healthcare expenditures were determined by summing the cost of inpatient, outpatient, 
emergency room, office-based, dental, vision, and home-health services in addition to 
prescription drug costs. Covariates were included for age, sex, race/ethnicity, marital 
status, census region, metropolitan statistical area, poverty level, health insurance status, 
education, smoking, BMI, and year each survey was completed. Econometric statistical 
modeling was performed, using generalized linear models, to compare mean and percent 
differences in health care expenditures between active, insufficiently active, and inactive 
participants. Two models were created, with and without BMI. Without BMI, after 
adjusting for the other covariates, health care expenditures were $1437 (95% CI 985-
1889) greater per capita for inactive compared to active or 29.9% (95% CI 19.3-40.4) 
higher. Expenditures for insufficiently active participants were $713 (95% CI $361 - 
$1064) greater per capita or 15.4% (95% CI 7.4% - 23.3%) higher compared to active. 
Combined, this resulted in $131 billion (95% CI $95 billion -$172 billion) or a 12.5% 
(95% CI 8.8-16.1) increase in aggregated health care costs compared to active 
participants. When BMI was entered, per capita costs slightly decreased but remained 
higher for inactive at $1313 (95% CI $848 - $1778) and insufficiently active at $576 (95% 
CI $224 - $927) per capita compared to active; a combined $117 billion (95% CI $76 
billion – $158 billion) or 11.1% of aggregated costs. These results indicate that an inactive 
individual incurs 26.6% (95% CI 16.1% - 371.1%) in excess health care expenditures 
compared to those meeting the minimum PA guidelines for health. The burden of CVDs, 
type 2 diabetes, and inactivity are too great to ignore, and greater efforts should be made 
in the realm of prevention. 
 
 
  21 
Physical Activity and Cardiovascular Disease 
Over six decades of research have documented the link between physical 
inactivity and chronic diseases such as CVD. In the late 1940’s the London transport 
study was one of the first to examine the link between work-related PA, coronary heart 
disease, and mortality by comparing these outcomes in bus drivers (inactive) and 
conductors (active) (J. N. Morris, Heady, Raffle, Roberts, & Parks, 1953). The findings 
concluded that the incidence of heart disease was 80% lower among active conductors 
(1.9 cases per 1000) compared to the sedentary drivers (2.7 cases per 1000) (J. N. Morris 
et al., 1953; J. Morris & Raffle, 1954). This seminal study ignited a burgeoning area of 
epidemiological research investigating the link between PA and health. In the 1970’s 
similar findings were reported among longshoremen but with a level of increased 
confidence; lower levels of work-related PA was a significant factor in coronary artery 
deaths even when smoking, weight, and blood pressure were taken in to account 
(Paffenbarger Jr & Hale, 1975; Paffenbarger Jr, Laughlin, Gima, & Black, 1970). A strong 
and independent relationship between PA and CVD mortality was also shown in the 
college alumni study, one of the most influential longitudinal cohort studies conducted. 
After decades of follow-up among the participants, it was concluded that low activity (< 
2000 kcals/week of energy expenditure) individuals had a 64% greater risk of heart 
attack compared to their high activity (>2000 kcals/week of energy expenditure) 
counterparts (Paffenbarger Jr, Wing, & Hyde, 1978). While many of the participants in 
these early studies were men, in 1976 the Nurses’ Health Study took on the task of 
investigating this relationship in women (Manson et al., 1999). After 10 years of follow-
up and controlling for a multitude of risk factors (i.e. smoking, BMI, familial history of 
CVD, age, hormone therapy, vitamin supplementation, and hypercholesterolemia) there 
was a 35% reduction in risk for CVD event among women who walked vigorously for at 
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least 150 min/week compared to those who walked infrequently. Although these studies 
were among the earliest conducted, many studies since have supported these early 
findings.  
A recent meta-analysis of prospective cohort studies examined the link between 
physical activity and risk of CVD among a variety of populations across the globe (Li & 
Siegrist, 2012). The analysis included 21 cohorts with a total population enrollment of 
more than 650,000 males and females, without CVD at the time of enrollment, and 
follow-up ranging from 5-32 years. Moderate occupational PA was significantly 
associated with a lower relative risk (RR) of CVD (0.89, 95% CI 0.82-0.97, p = 0.008) 
among men compared to the low PA referent group. There was no additional benefit 
resulting from high occupational PA among men (RR = 0.91, 95% CI 0.84-0.97, p = 
0.006). Among women, only a high level of occupational PA was significantly associated 
with lower CVD risk (0.84, 95% CI0.77-0.92, p < 0.001) compared to the low PA referent 
group. Moderate occupational PA was not significant (RR = 0.83, 95% CI 0.67-1.03, p = 
0.089) compared to the low PA referent group. When examining leisure-time PA (LTPA) 
there appeared to be a dose response in both men and women. In men, RR of CVD 
associated with moderate PA was 0.80 (95% CI 0.74-0.87, p < 0.001) and high PA was 
0.76 (95% CI 0.70-0.82, p < 0.001) compared to the low PA referent group. The results 
were similar among women; RR of CVD associated with moderate PA was 0.82 (95% CI 
0.67-0.88, p < 0.001) and high PA was 0.73 (95% CI 0.68-0.78, p < 0.001). These results 
suggest that there is a 10-20% reduction in CVD risk for those engaging in moderate 
levels of LTPA and a 20-30% reduction in CVD risk for those engaging in high levels of 
LTPA. Although this meta-analysis speaks to the association of PA and reduced CVD risk 
it does not touch upon the mediating potential of PA in the presence of other risk factors. 
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Given the multitude of risk factors that play a role in the development if CVDs this is an 
important aspect that cannot be ignored. 
Physical activity has also been shown to significantly reduce CVD mortality risk 
independent of other CVD risk factors. A cross-sectional study conducted using the Third 
National Health and Nutritional Examination Survey data investigated this aspect 
among healthy participants and those with metabolic risk factors (Reddigan et al., 2011). 
Survival analyses were conducted using hazard ratios for CVD mortality with and 
without metabolic risk factors (i.e. dyslipidemia, hypertension, obesity, insulin 
resistance, inflammation, and type 2 diabetes), by inactive, light, or moderate/vigorous 
PA intensity, and controlling for age, sex, income, ethnicity, smoking, alcohol, diet, and 
CVD history. Before including PA in the risk model, dyslipidemia (HR = 1.16, 95% CI 
1.03-1.32, p <0.05), type 2 diabetes (HR = 1.62, 95% CI 1.42-1.94, p < 0.05), 
hypertension (HR = 1.39, 95% CI 1.23-1.57, p < 0.05), inflammation (HR = 1.30, 95% CI 
1.15-1.47, p < 0.05), and insulin resistance (HR = 1.22, 95% CI 1.09-1.38, p < 0.05) were 
all significantly associated with increased CVD mortality risk compared to those without 
any risk factors. Interestingly, obesity alone was not a significant factor for increased 
CVD mortality risk (HR = 1.12, 95% CI 0.97-1.30). When PA was added to the risk model, 
engaging in light (HR = 0.72, 95% CI 0.62-0.84, p < 0.05) and moderate/vigorous (HR = 
0.72, 95% CI 0.61-0.84, p <0.05) levels of PA showed nearly identical reductions by 
nearly 30% for each risk factor, compared to the inactive referent group (HR =1.0). 
Furthermore, when all risk factors were present, the results remained consistent in 
reducing CVD risk among those engaging in light (HR = 0.72, 95% CI 0.62-0.84, p < 
0.05) and moderate/vigorous (HR = 0.72, 95% CI 0.61-0.84, p <0.05) PA.   
Interestingly, there were no significant differences between light and moderate/vigorous 
levels of PA in terms of risk reduction. These findings confirm that even a low level of PA 
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is not only protective in healthy populations but seems to attenuate risk regardless of the 
presence of other CVD risk factors, in isolate or in clusters.  
 
Physical Activity and Type 2 Diabetes  
 The evidence linking physical activity level to incidence of diabetes is less robust 
than that of CVDs. One of the earliest publications, Epidemiology of Diabetes and Its 
Vascular Lesions, was published in 1978 by Kelly West, whose research recognized that 
type 2 diabetes was preventable by maintaining a healthy body weight and engaging in 
regular PA (Meigs, 2010). The findings reported by Kelly spurred an increase in research 
to better understand this rising health concern. Cohort studies, including the Nurses’ 
Health Study and the Health Professionals Follow-up Study have shown an inverse 
association between type 2 diabetes and physical activity. The Nurses’ Health Study 
(n=71,102) showed that 30 minutes of brisk walking per day resulted a RR of 0.77 (95% 
CI .065-0.91, p = 0.002), a 23% reduction in diabetes risk among women, compared to 
the inactive referent across 8-years of follow-up after controlling for age, smoking, 
menopausal status, hormone therapy, family history of diabetes, alcohol consumption, 
hypertension, high cholesterol, and BMI (Hu et al., 1999). The Health Professionals 
Follow-up Study (n=37,918) showed similar results; RR of developing diabetes across 10 
years of follow-up was 0.72 (95% CI 0.60-0.86, p < .001) for men achieving 40 minutes 
of brisk walking per day compared to those who were inactive, controlling for age, 
smoking, family history of diabetes, alcohol consumption and BMI (Hu et al., 2001). 
 A recent meta-analysis investigating diabetes risk by examining 69 cohort studies 
(n=1,925,096) which were analyzed using different combinations of the studies based on 
subcategories reported, including total PA (LTPA + occupational PA + transport PA), , 
intensity of LTPA, time spent in LTPA, and fitness level (Aune, Norat, Leitzmann, 
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Tonstad, & Vatten, 2015). For total PA, 14 cohort studies were included in the analysis. A 
dose-response could not be determined because of differences in reporting but there was 
a significant reduction in diabetes risk for those engaging in high levels of PA compared 
to low (RR = 0.65, 95% CI 0.59-0.71). Although, it was not clear how these PA levels 
were defined. A total of 55 cohort studies were included to examine overall risk 
associated with LTPA, which showed a reduction in risk based on time and intensity of 
PA. Intensity was defined using metabolic equivalents (METs) an expression of energy 
expenditure where 1-MET is the equivalent of the cost of energy at rest. Similar 
reductions were observed for each level of intensity performed. The lowest reduction in 
risk was observed for those engaging in vigorous PA (> 6 METs) with a RR of 0.54 (95% 
CI 0.47-0.62) compared to low PA (1.5-3 METs). For the dose-response analysis when 
vigorous PA was performed for at least 5-hours per week, RR was 0.53 (95% CI0.48-
0.59). For moderate PA (3-5.9 METs) a similar reduction was observed for intensity (RR 
= 0.68, 95% CI 0.52-0.90) compared to low PA but the dose response could not be 
determined based on differences in reporting time spent in PA at this level. For low PA 
(1.5-3 METs) there was a dose response (RR = 0.71, 95% CI 0.52-0.97) for engaging in at 
least 5-hours at this intensity per week. Cardiorespiratory fitness was also evaluated and 
defined as milliliters of oxygen consumption (VO2) per kilogram of body weight per 
minute (ml/kg/min). The RR for high versus low fitness was 0.45 (95% CI 0.29-0.79), 
the most remarkable of the results. However, there was no clear indication of the VO2 
values assigned to high and low fitness levels. For the dose-response, the relative risk 
was 0.74 (95% CI 0.56-0.98) when VO2 was at least 20 ml/kg/min. This study is one of 
the most comprehensive meta analyses conducted on the isolated relationship between 
type 2 diabetes risk and PA. Overall, all levels of PA intensity resulted in a 25-40% 
reduction in risk reduction with higher levels associated with greater reductions in risk.  
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Obesity and Cardiometabolic Risk  
Factors such as obesity, stress, and chronic inflammation are associated with 
dysfunctional cardiometabolic profiles and are highly influential in the development of 
CVD and type 2 diabetes. The obesity rates in the U.S. are currently the highest ever 
documented. According to the most recent 2015-2016 National Health and Nutrition 
Survey (NHANES), 40% of adults (ages 20+) and 19% of children (ages 2-19) are 
considered obese (Warren et al., 2018). Furthermore, it appears that young adulthood is 
a particularly vulnerable period for weight gain. Obesity in young adults (ages 20-39 
years) is 30% compared to 17% in adolescents (ages 12-19 years); a 70% increase in 
prevalence rates between the two age groups (Dietz, 2017). Obesity is also associated 
with increases in systolic blood pressure, insulin resistance, and inflammation; trends 
that are becoming more prevalent in young adult populations. However, abdominal 
adiposity is one of the primary risk factors associated with the development of CVD and 
prolonged exposure, due development at younger ages, may lead to earlier disease onset 
(Murthy et al., 2016; Reis et al., 2013).  
Obesity and CVD risk. The Coronary Artery Risk Development in Young 
Adults (CARDIA) study is one of the first cohort studies to investigate the impact of 
longer durations of living with obesity on CVD risk. Participants (n=3275) were all aged 
18-30 at the time of enrollment and have been followed in 5-year increments, up to 25 
years (Reis et al., 2013). Obesity was determined as overall obesity determined by BMI 
(≥ 30 kg/m2) and abdominal adiposity based on waist circumference (> 88 cm for 
women, > 102 cm for men). During follow-up, 40.4% of participants developed obesity 
determined by BMI and 41% developed abdominal adiposity. The mean duration of 
obesity was 13.3 (SD ±6.5) years for overall obesity and 12.2 (SD ±6.2) years for 
abdominal obesity. Trend analyses for duration of overall and abdominal adiposity were 
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positively associated (p < 0.001) with higher blood pressure (BP), glucose, inflammation 
(i.e. C-reactive protein, diabetes, and anti-hypertensive and lipid lowering medication 
use, compared to baseline levels. In participants with an 11- to 15-year duration of overall 
obesity, there was a 34% increase in the presence of significant coronary artery 
calcification (CAC) (HR = 1.34, 95% CI 1.04-1.73) compared to non-obese. For 
participants with >20 years of overall obesity there was an 84% increase in the presence 
of CAC (HR = 1.84, 95% CI 1.25-2.70). The presence of CAC was even greater among 
those with abdominal adiposity. Among participants with 11- to 15- year duration there 
was a 56% increase of CAC (HR = 1.56, 95% CI 1.13-2.14); for those with 16- to 20-year 
duration there was a 76% increase (HR = 1.76, 95% CI 1.20 – 2.57); those with > 20-
years duration there was a 148% increase (HR = 2.48, 95% CI 1.53-4.01). CAC is one of 
the most influential risk factors for developing atherosclerosis and coronary heart 
disease and longer duration of exposure to excess adiposity may greatly influence future 
occurrences of these health issues. 
Obesity and metabolic risk. The CARDIA study also examined trajectories of 
cardiometabolic risk profiles in participants (n = 4420) based on factors associated with 
the metabolic syndrome; a cluster of risk factors including elevated triglycerides (≥ 150 
mg/dL), low HDL cholesterol ( <40 mg/dL in men; <50 mg/dL in women), abdominal 
adiposity, elevated systolic BP (≥135 mmHg) or self-report of hypertension, and elevated 
glucose (≥100 mg/dL) or self-report of diabetes (Murthy et al., 2016). The purpose of the 
study was to determine if the evolution of cardiometabolic risk was independent from 
BMI. A metabolic risk score was determined using a summative value of positive risk 
factors present in each participant at the time of measurement. Participants were 
classified as low-stable, low-worsening, intermediate-stable, intermediate-worsening, 
high-stable, and high-worsening, determined by baseline and follow-up scores. At 
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baseline, 34% of participants were overweight (BMI = 25-29.9 kg/m2) or obese (BMI ≥ 
30 kg/m2); at the 25-year follow-up, 74% were classified as such. Mean (± SD) BMI 
significantly increased from 24.4 kg/m2 (± 4.9) to 30.1 kg/m2 (± 17.1), (p < .0001) across 
25 years.  There was also a 21.4% increase in mean waist circumference from baseline to 
25 years (p < .0001). A waist circumference to BMI ratio (cm x m2/kg) was also 
calculated to examine if changes central adiposity were driving changes in stable or 
worsening metabolic trajectories. Those categorized as low-, intermediate-, or high-
stable had declining ratios over time (p < 0.0005), whereas low-, intermediate, and high-
worsening had stable ratios (p = 0.29); indicating excess weight gained was less likely to 
be accumulated viscerally.  
Metabolic risk factors were compared between the stratified groups, controlling 
for sex, age, race, education, smoking, PA, and obesity exposure (i.e. years of BMI 
defined obesity). Among the low-, intermediate, and, high-worsening groups, fasting 
glucose increased by 23.6%, 31%, and 35.5% respectively, compared to 14.2%, 13.3%, and 
17.8% among the low-, intermediate, and high-stable groups (p < 0.0001). The 
percentage of participants with diagnosed diabetes increased from 0.1% to 12.4% among 
low-worsening, 0.6% to 24.2% among intermediate-worsening, and 3.3% to 38.6% 
among high-worsening groups. Stable group participants with diagnosed diabetes 
increased from 0% to 3.5%, 0.7% to 7.5%, and 0.5% to 15.1% for low-, intermediate-, and 
high- groups. Triglycerides increased for all participants but were greatest among the 
low-, intermediate, and high-worsening with increases of 75.9%, 92.8%, and 78.7%. 
Among the low-, intermediate-, and high-stable groups the increases were 38.9%, 27.2%, 
and 43.7%. Although obesity profiles increased similarly across all groups, increases in 
these metabolic risk factors were greater among the worsening groups, independent of 
BMI, driving the increased risk observed at 25 years follow-up. This metabolic 
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deterioration occurring independently of BMI, is particularly problematic in terms of 
prevention, due to clinical guidelines emphasizing obesity (defined by BMI) as the 
primary risk factor for screening. Aside from obesity, if smoking, hypertension, personal 
or family risk of diabetes is not present, screening other risk factors, is not recommended 
until middle age. 
 
Physical Activity and Obesity 
Research suggests that much of the health risk associated with obesity can be 
attenuated by increasing PA and physical fitness even in the absence of weight loss. To 
investigate the effects of obesity (defined by BMI) and fitness on health outcomes and 
all-cause mortality, a meta-analysis was conducted to examine if one was more 
influential than the other (Barry et al., 2014). Participants (n = 92,986) from the 
Aerobics Center Longitudinal Study, Cooper Clinic Longitudinal Study, Mayo Clinic, and 
the Veteran Exercise Testing study were included in the analysis. Participants were 
classified by fitness (e.g. unfit and fit) and BMI (e.g. normal, overweight, obese) to create 
five comparison groups. The initial analysis conducted showed that normal weight and 
unfit individuals had an increased risk of death (HR = 2.39, 95% CI 1.62-3.52) compared 
to normal weight fit individuals. Follow-up analyses were conducted controlling for age, 
sex, chronic disease status, mean follow-up, confounder control, data origin, and article 
quality. Unsurprisingly, normal weight and unfit individuals with chronic disease had 
the largest risk of death (HR = 3.55, 95% CI 2.37-5.31) compared to those without 
chronic disease (HR = 2.10, 95% CI 1.70-2.61). Overweight, unfit individuals had double 
the mortality risk (HR = 2.14, 95% CI 1.77-2.58) whereas overweight and fit did not 
experience significant increased risk (HR = 1.14, 95% CI 1.00-1.27). Obese and unfit had 
a significantly elevated risk for mortality (HR = 2.99, 95% CI 2.56-3.49) but the risk was 
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not significant among obese and fit (HR = 1.28, 95% CI 0.78-2.10). The only group that 
had a greater risk of mortality than the normal and fit were the obese and fit when 
chronic disease was present (HR = 1.81, 95% CI 1.41-2.32). However, the risk of 
mortality in this group was nearly half that of the normal weight and unfit group. This 
analysis demonstrated that fitness has greater influence in mortality risk than BMI.  
 
Inflammation and Cardiometabolic Risk  
Chronic inflammation is another health risk factor that has been strongly 
implicated in the development of conditions such as visceral adiposity, CVD, and type 2 
diabetes due to maladaptive inflammatory responses (Lopez-Candales et al., 2017). 
Stress is seen as a common risk factor for 75-90% of CVDs (i.e. hypertension and 
atherosclerosis), metabolic diseases (i.e. type 2 diabetes and non-alcoholic fatty liver 
disease), psychiatric disorders (i.e. depression and anxiety), neurodegenerative diseases 
(i.e. Alzheimer’s disease, and Parkinson’s disease), and cancer due to the excessive 
inflammatory response involved in the pathophysiologies (Liu et al., 2017). 
Glucocorticoids released during the normal stress response will typically reduce pro-
inflammatory cytokines and enhance the production of anti-inflammatory cytokines. In 
essence, acute stress will enhance the immune system whereas prolonged stress will be 
immunosuppressive. Thus, chronic stress and the overstimulation and production of 
inflammatory chemicals have been implicated as a primary stress-related disease 
pathway.  
Fat cells have long been associated with metabolic dysfunction and are now 
known to activate similar responses initiated by immune cells. A recent cross-sectional 
study examining the relationship between inflammation and metabolic syndrome among 
participants of the National Cholesterol Education Program (n = 262) found that 
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systemic inflammation was significantly greater among overweight, obese, and very 
obese BMIs compared to normal BMI (Ebron et al., 2015).  Mean ± SD serum levels 
(mg/L) of C-reactive protein (CRP), an overall marker of systemic inflammation, was 
significantly greater among overweight (1.28 ± 3.0), obese (1.99 ± 3.11), and very obese 
(3.93 ± 5.12) compared to normal BMI (0.28 ± 0.29), p < 0.002. CRP is released 
following secretion of interleukin-6 (IL-6), a major inflammatory mediator. Mean ± SD 
serum levels (pg/L) of IL-6 were also significantly greater among overweight (3.0 ± 2.5), 
obese (3.3 ± 2.9), and very obese (4.3 ± 3.2) compared to normal BMI (1.3 ± 2.1), p < 
0.05. IL-6 can act as a pro-inflammatory or anti-inflammatory mediating cytokine. 
When IL-6 is released as a pro-inflammatory cytokine it is produced by adipocytes and is 
associated with insulin resistance. Adiponectin is also an inflammatory hormone also 
produced in adipose tissue that is involved in glucose regulation. Lower levels of 
adiponectin are associated with higher visceral fat accumulation and poorer glucose 
regulation. Mean ± SD serum adiponectin (mg/L) was found to be lower among 
overweight (17.6 ± 10.6), obese (13.8 ± 8.7), and very obese (10.9 ± 5.1) compared to 
normal BMI (23.1 ±11.6). These results indicate that these dysregulated inflammatory 
responses are driving insulin resistance and dysglycemia associated with BMI.  
Chronic psychosocial stress can also give rise to pro-inflammatory chemical 
mediators (i.e. neurotransmitters and hormones) that trigger the “fight or flight” 
response, a biological mechanism that is critical for human survival. Following acute 
stress the body is able to return to homeostasis but prolonged activation has been found 
to suppress immune function and promote inflammatory states that are linked to 
multiple acute and chronic disease pathophysiologies (Cohen et al., 2012). 
Glucocorticoid hormones are responsible for terminating the inflammatory response. It 
has been proposed that chronic stress may lead to glucocorticoid resistance (GCR) and 
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decrease the sensitivity of the immune cells which regulate the production of pro-
inflammatory cytokines. Cohen and colleagues (2012) examined this relationship by 
conducting partial correlations, controlling for age, sex, BMI, race, season, and 
education, to compare the relationship between stress and the immune response when 
injected with a cold virus. GCR was determined by examining circulating levels of 
cortisol in relation to levels of lymphocytes and neutrophils. If circulating levels of 
cortisol are not negatively correlated to lymphocytes and neutrophils, then GCR is more 
likely to be driving pro-inflammatory states. This is a result of the glucocorticoid 
receptors being resistant the signaling of cortisol. The findings showed no significant 
correlation between cortisol and lymphocytes (r = -0.01, SE .09, p > .05) and between 
cortisol and neutrophils (r = -0.02, SE .09, p > .05), among individuals with high levels 
of cortisol, indicating GCR was present. Examining the relationship between GCR and 
inflammation, there was a significant correlation between those with GCR and 
circulating levels of the pro-inflammatory marker IL-6 (r = 0.314, p <.001). This 
indicates prolonged exposure to stress is also the driving dysregulated inflammatory 
responses responsible for insulin resistance.  
 
Physical Activity and Inflammation 
Exercise has been recognized as an independent factor that mitigates 
dysregulated inflammatory responses. IL-6 in one of the inflammatory chemicals that 
can act as a pro-inflammatory cytokine when released by adipose cells or an anti-
inflammatory myokine when released by muscle cells. As a myokine, IL-6 is released 
during exercise, prompts the production and release of interleukin-10 (IL-10) which acts 
to reduce levels of TNF-alpha, and interleukin-1 receptor agonist (IL-1ra) which disrupts 
interleukin-1 beta (IL-1β) signaling (Pedersen, 2017). TNFα is a cytokine that is triggered 
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during acute inflammatory responses and is also involved in insulin resistance and 
atherosclerosis. IL-1β is a cytokine highly associated with coronary heart disease and 
disrupts insulin production in pancreatic beta cells. Chronic inflammation is also linked 
to visceral fat accumulation which is exacerbated by physical inactivity and enhances 
inflammatory responses; further increasing cardiometabolic dysfunction. Exercise has 
also been shown to increase interleukin-15 (IL-15), a protein highly expressed in skeletal 
muscle and decreases lipid deposition and white adipose tissue (Quinn et al., 2005). 
Furthermore, IL-15 stimulates the production of adiponectin, which improves glucose 
regulation.  
 A recent metanalysis of randomized controlled trials (n=824) was conducted to 
examine the effect exercise type using four arms (i.e. aerobic exercise, resistance 
exercise, combined aerobic and resistance exercise, and exercise advice only) on 
inflammatory responses in patients with diabetes (Hayashino et al., 2014). Inflammatory 
markers included were CRP, IL-6, and adiponectin. Overall, exercise was associated with 
reductions in CRP of -0.81 mg/L (95% CI -1.35 - -0.26) when controlled for BMI. 
Subgroup analyses were conducted and shown aerobic exercise reduced CRP by -1.12 
mg/L (95% CI -1.49 - -0.75). There was no significant change associated with the 
resistance, combined, or exercise advice groups. There was an overall reduction in IL-6 
of -0.88 pg/ml (95% CI -1.44 - -0.32) associated with exercise in general. Sub analyses 
revealed IL-6 was reduced by -0.91 pg/ml (95% CI -1.47 - -0.35) for aerobic exercise, but 
nonsignificant reductions for resistance, combined, or exercise advice groups. 
Adiponectin was increased among participants in all exercise groups and the increase 
was greater when BMI was controlled for, but all results were insignificant. However, 
adiponectin is typically released by adipocytes during weight loss and the upwards 
trends being greater after controlling for BMI, suggests something other than weight loss 
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may be driving the increased levels observed. More robust studies are needed to better 
understand the mechanisms at play.  
 There is a tremendous amount of evidence supporting the link between health 
and PA and it should not be overlooked in the realm of healthcare. While the evidence 
for addressing PA in clinical environments indicates the importance of the healthcare 
providers’ role, the emphasis has largely focused on changing patient behaviors and has 
been conducted in systems outside of the U.S. In addition, if effectiveness of adopting a 
process to address inactivity is primarily based on patient outcomes, reasons for 
outcomes not being achieved may be overlooked. There is great need to understand 
organizational practices and provider behaviors to move the science in this area forward, 
especially with regards to EIM. Furthermore, there has been over a decade of advocacy 
for adopting this process as a standard of care but only a few organizations have 
acknowledged doing so. Investigating the EIM Solution through the lens of a process 
evaluation has the potential to address the gaps in the research. 
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CHAPTER 3 
METHODS 
 
Setting & Participants 
Adults aged 18 years or older who were either healthcare providers or patients in 
a large Southwest university-based healthcare system were recruited for this study. 
Administrative and Institutional Review Board approval was obtained to examine 
deidentified patient data for select providers. Inclusion criteria for providers consisted of 
having a full- or part-time affiliation with one of four campus-based primary or acute 
care clinics. Exclusion criteria for providers included those who worked on an as needed 
(PRN) basis and those with specialties in sports medicine, orthopedics, and neurology. 
Selected providers were also recruited through email to complete a survey about their 
knowledge of PA guidelines, personal PA behaviors, and barriers to PA counseling, and 
familiarity with EIM. Providers were allocated to one of three groups: (1) EMR++ (n=11), 
(2) EMR+ (n=5), and (3) EMR (n=6). The EMR ++ group was allocated to receive an 
EMR systems change along with EIM resources and would attend a 30-minute EIM 
training session. The EMR+ group did not receive the training and the EMR group was 
only exposed to the systems change. The EMR group also served as the counterfactual 
comparison group.  
 Any patient aged 18 and older, who received care in the healthcare system during 
the study period, was eligible to participate in the study. Patient participants were 
recruited to complete an anonymous intercept survey. A messaging system, linked to a 
secure patient portal, was used to send invitations to eligible patients to participate, 
along with a link to the survey. These invitations were batched and sent through the 
patient portal the morning following their clinical encounter. The health services IT staff 
  36 
created the algorithm to generate the invitation to participate and were responsible for 
its implementation.  In addition, due to low engagement with the patient portal, patients 
were also recruited in the clinical environment using a recruitment flyer. The flyers 
contained a link to the online survey and were given to patients by a staff member at the 
end of their visit. The survey consisted of questions about the date of visit, location of 
service, provider seen, and academic status (i.e. freshman, sophomore, junior, senior, 
graduate student). Additional questions about provider engagement were related 
specifically to EIM outcomes. Patients were asked to indicate if they were asked about PA 
and if they received PA counseling, ExRx, PA resources, or a PA referral. If patients 
indicated they were given PA advice, a follow-up question was included asking them to 
briefly describe the advice given to them by the provider. Inclusion criteria for patients 
consisted of those who were evaluated by one of the selected providers in the primary or 
acute care settings and were affiliated students of the university. Patients were excluded 
if they were not affiliated students.  
 Deidentified patient data (n=2974) was obtained to examine provider level 
engagement with the patients about PA. Patient data was deidentified and coded by the 
health services senior research analyst prior to being shared, to ensure HIPAA 
compliance was maintained. Patients enrolled in the healthcare system are also made 
aware of the potential use of their data for research purposes in the notice of privacy 
practices. Descriptive measures were collected patient encounters included location of 
service, date, provider, diagnostic category, demographics (i.e. sex, age, race and 
ethnicity), and anthropometric data (i.e. height, weight, and body mass index). Data for 
the EIM-related outcomes were collected after the implementation of a documenting tool 
and included: (1) the PAVS (i.e. weekly minutes of moderate PA), (2) whether the PAVS 
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was reviewed or not reviewed, and (3) additional levels of provider engagement selected 
using the documenting tool. 
 
Design 
A quasi-experimental, multiple baseline time-series design, with nonequivalent 
comparison groups was used for this pragmatic trial. Pragmatic trials are useful for 
testing interventions in real-world clinical settings and informing policy. Due to the 
complexity of factors influencing outcomes in real-world settings, pragmatic trials help 
researchers account for the flexibility that is needed when delivering interventions when 
there are uncontrolled conditions (Ford & Norrie, 2016). Multiple baseline designs are 
useful for determining a baseline trend before an intervention is implemented and 
observing the trends during the implementation process. (Hawkins, Sanson-Fisher, 
Shakeshaft, D’Este, & Green, 2007). Additionally, an ITS design is commonly used to 
observe the effects of a known interruption (i.e. intervention) across a series of 
timepoints (Shadish, Cook, & Campbell, 2001) and is one of the most advantageous 
designs to use for evaluating healthcare programs in real-world settings (A. D. Harris et 
al., 2006; Lopez Bernal, Soumerai, & Gasparrini, 2018; Zhang, Wagner, Soumerai, & 
Ross-Degnan, 2009). The impact of the intervention can be determined by examining 
changing trends across the series of timepoints before and after each interruption.   
Furthermore, when a baseline trend cannot be established, including a 
deliberately chosen nonequivalent comparison group, with maximum pretest similarity, 
provides important data about the counterfactual inference (i.e. what would have 
occurred without the intervention) (Shadish et al., 2001).  All providers were employed 
within the same healthcare system and operations were similar across clinics, 
maximizing the counterfactual inference despite the nonequivalent sample size. The 
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impact of the intervention was determined by examining how the program was 
implemented and delivered, the representativeness of the populations delivering and 
receiving the intervention, changes in outcomes across the implementation period, and 
the clinical relevance associated with the outcomes (Ford & Norrie, 2016).  
 Prior to this study there was no formal process in place for providers to follow 
when addressing physical inactivity in this clinical environment. The extent to which this 
was occurring was unknown and no baseline trend could be established using EMR data. 
To establish this baseline, the anonymous patient intercept survey was collected for 4-
weeks prior to implementing the EIM Solution (Figure 2). An anonymous survey link 
was provided via the secure patient portal invitation and on the recruitment postcard. 
The survey was used to gain insights about any patient/provider interactions that were 
related to the patients’ PA behaviors (Appendix C).   
A standardized documentation tool (Figure 3) was developed during pre-
implementation which would be integrated into the vitals section of the EMR. 
Operationalizing this standardized EMR tool was done to provide consistency in data 
collection during implementation and to minimize disruptions to clinical workflow. The 
senior research analyst and tech support analysts for the health services department 
assisted in the development of these system modifications. The modifications aimed to 
capture which components of the EIM Solution were being utilized by the selected 
providers in the clinical environment.  
Modifications included a section to document the PAVS questions and the staff 
member asking and inputting the patient responses into the EMR. Entering the PAVS 
into the EMR was a forced action (Figure 4) to be completed before other vital statistics 
were obtained. The forced aspect was programmed to maximize the collection of the 
PAVS. The PAVS addition captured the number of minutes per week patients spent 
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participating in moderate-intensity aerobic PA. Non-provider support staff involved with 
the patient intake process at all participating locations received formal systems training 
during the pre-implementation phase. Training included how to ask patients and record 
the PAVS as well as how to navigate the EMR systems changes. The PAVS was collected 
at the same time as other vitals such as height, weight, and blood pressure. The PAVS-
related questions were asked as follows:  
1) “On average, how many days each week do you engage in at least 
moderate intensity physical activity, like brisk walking?”  
2) “On those days, on average, how many minutes do you engage physical 
activity at this level?” 
Numerical values corresponding to each question were entered in the EMR and the 
PAVS was calculated as a product of the two values obtained. Non-provider staff (e.g. 
medical assistants and registered nurses) were trained on how to ask and input the 
information during their routine patient intake process. The PAVS was self-reported by 
the patient and recorded as the total minutes of moderate intensity of PA per week 
(Figure 3). The PAVS-related questions were also translated into Mandarin and Arabic 
and posted in the rooms for support staff to use with patients when language barriers 
arose (Appendix D). 
Additional charting options were included for providers to select when documenting if 
the PAVS was reviewed, or not reviewed, by selecting a corresponding check box. If the 
PAVS reviewed was selected, additional levels of engagement were included in a 
dropdown menu to indicate if the provider identified the patients PA level, provided PA 
counseling, ExRx, resources or referrals, or did not address PA with the patient during 
that visit (Figure 4). 
 
  40 
Intervention 
Selected EMR++ and EMR+ providers received EIM resources published by the 
American College of Sports Medicine. The resources were disseminated by email to the 
EMR+ and EMR++ groups and physical copies were provided to the EMR++ group 
during the EIM training sessions. The resources provided included an EIM summary 
sheet (Appendix E), the EIM Providers’ Action Guide (Appendix F), a series of patent 
education materials (Appendices G-L) discussing PA recommendations for common 
health-related topics (e.g. prolonged sitting, PA for general health, anxiety and 
depression, type 2 diabetes, prediabetes and high blood pressure), and an ExRx 
(Appendix M). These resources aimed to give providers a basic understanding of how to 
address physical inactivity with their patient populations.  
The in-person training was conducted with the EMR++ providers, led by an 
ACSM Certified Exercise Physiologist and trained Exercise is Medicine Level II 
professional. The providers were trained to identify physically inactive patients by 
reviewing the PAVS in the EMR to determine if they are meeting the minimum PA 
guidelines for health (i.e. 150 minutes of weekly moderate intensity aerobic PA). 
Training also focused on disusing strategies appropriate for initiating PA advice or 
counseling such as identifying additional health-related risk factors (e.g. sedentary 
behavior, elevated vitals, anxiety, depression, etc.). Providers were also trained on how to 
provide eligible patients with an ExRx that follows the PA guidelines for health that 
focused on manageable and practical goals. Providers were also trained to give self-
directed PA resources (e.g. educational materials) and/or a referral to an internal 
partner (i.e. campus-based fitness facility) when deemed appropriate.  
EMR++ providers were also trained to document their level of engagement by 
using the standardized EMR charting options. To track reviewal of the PAVS, providers 
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will use a checkbox inserted next to the PAVS with options for “PAVS reviewed” or 
“PAVS not reviewed”. When “PAVS reviewed” was selected additional levels of 
engagement were documented by using a drop-down menu of charting options which   
included:  
1. Patient currently meets physical activity guidelines. 
2. Patient was encouraged to maintain current levels of physical activity. 
3. Patient does not meet minimum physical activity guidelines.  
4. Patient was encouraged to increase physical activity to at least 150 min/week.  
5. Patient was provided an exercise prescription. 
6. Patient a physical activity handout. 
7. Patient referred to the [internal fitness partner]. 
8. Physical activity was not appropriate to address during this visit 
The EMR+ providers also received instructions for interacting and documenting these 
steps but did not receive any training on counseling or interacting with patients around 
their PA behaviors. EMR++ and EMR+ providers were also encouraged to document any 
additional relevant notes. Because there is some level of discretion involved when 
addressing PA, providers were encouraged to provide additional documentation 
explaining why PA was not addressed. Since a true baseline did not exist for comparison, 
providers in the EMR group did not receive EIM resources or systems training and 
served to establish the counterfactual inference. The timeline for this study is illustrated 
in Table 1. 
 
Descriptive and Outcome Measures  
Descriptive data collected from the patient intercept survey included the 
following: number and proportion of patients reporting (1) being asked about PA, (2) 
  42 
receiving PA advice, (3) receiving an ExRx, (4) receiving PA resources, or (5) receiving a 
PA referral. Trends for these outcomes were also visually inspected using time-series 
graphs. Deidentified patient data collected from the EMR, included location and type of 
visit (e.g. new patient, established patient, acute care), provider seen, patient 
demographics (i.e. age, sex, race/ethnicity, height, weight, BMI), PAVS and related 
charting options, and diagnostic category (e.g. infection, injury, vaccination, chronic 
disease, etc.).  
The process evaluation was guided by the RE-AIM (i.e. reach, effectiveness, 
adoption, implementation, and maintenance) framework. RE-AIM was developed to 
evaluate the impact of multilevel health promotion programs, interventions, or policies 
that are implemented in “real-world” settings (Glasgow, Vogt, & Boles, 1999). Table 2 
provides a description of the RE-AIM dimensions that were evaluated. Reach was 
determined by the proportion and representativeness of patients receiving each 
component of the EIM Solution. Effectiveness was assessed by determining if there is a 
change in the proportion and representativeness of patients receiving the EIM Solution. 
Adoption was assessed by examining the proportion of providers who adopted each 
aspect of the EIM Solution. Implementation was evaluated by determining if the 
percentage and representativeness of providers who delivered the components of the 
EIM Solution changed over time. For this process evaluation, maintenance was not 
evaluated as it requires at least a 6-month post-implementation follow-up period.  
Outcomes related to reach were calculated as proportions. The proportion of 
patients screened using the physical activity vital sign was calculated in relation to the 
total number of patients encounters. The proportion of patients receiving PA counseling, 
ExRx, PA resources, or PA referrals was determined in relation to physical activity status. 
Effectiveness was calculated as change in percentage of patients who had the PAVS 
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reviewed and those who receive brief counseling, ExRx, self-directed PA resources, or a 
PA referral by examining trends across time. The percentages for each level of 
engagement were compared between providers receiving training and those who do not. 
The representativeness of patients was described for each outcome using patient 
demographics. Adoption was calculated as proportion of providers who review the PAVS 
and provided brief counseling, ExRx, self-directed PA resources, or a PA referral in 
relation to eligible patients. Outcomes related to implementation were calculated as the 
change in percentage of providers who reviewed the PAVS and provided brief counseling, 
ExRx, self-directed resources, or a PA referral for each group of providers. The 
percentages for implementation outcome were compared between providers across the 
8-week implementation period.  
To determine patient representativeness, patient data collected from the EMR 
was used. To determine provider representativeness, provider demographics (i.e. 
practice location, provider type, years in practice, age, sex), obtained from the provider 
survey will be used. For qualitative outcomes, provider perceptions, barriers, and 
facilitators to adopting the EIM Solution were assessed using an adapted version of the 
Physical Activity Promotion in Health Care survey (Appendix N) (Mark, Miners, 
Bauman, & Wallner, 1999; Shirley, van der Ploeg, & Bauman, 2010). The survey was 
electronically administered to providers in the EMR++ and EMR+ groups before the 
resources and training were provided.  
The provider survey was originally developed for Australian providers and minor 
adaptations were made to make the survey relevant for the current provider population. 
The questionnaire assesses the following domains: 1) knowledge of PA guidelines for 
health, 2) perceived role in PA promotion, 3) confidence in promoting PA, 4) barriers to 
promoting PA, and 5) feasibility of delivering PA promotion. The survey has been 
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validated and used in multiple healthcare settings and with various healthcare 
professionals (Mark et al., 1999; Shirley et al., 2010; Stubbs et al., 2007). In addition to 
the survey, providers was asked to participate in a post-study interview to assess 
perceptions and satisfaction of the EIM procedures and implementation process.   
 
Statistical Analyses 
Statistical analyses were conducted using SPSS Statistics Software Version 25 
(IBM Corp., Armonk, NY, USA). Descriptive statistics were used to determine the 
proportion of patients who were 1) assessed for physical inactivity, 2) counseled about 
PA by providers, 3) received exercise prescriptions, and 4) received self-directed PA 
resources or a PA referral across the 13-week study (Aim 1). Descriptive statistics were 
also used to determine the number, proportion, and representativeness of providers who 
1) conducted brief PA counseling, 2) delivered exercise prescriptions, and 3) provided 
self-directed PA resources or referral to inactive patients using the EIM solution with 
and without training. (Aim 2). Chi-square analysis was used to compare proportional 
differences for patients screened, counseled, prescribed exercise, and provided PA 
resources or referral between provider intervention groups (Aim 3).  Binary logistical 
regression was used to determine the effect of the intervention in the likelihood that 
patients would be counseled, prescribed PA, and provided PA resources or referrals 
during the implementation period (Aim 4). Descriptive statistics were used to describe 
providers’ (1) knowledge of PA guidelines for health, 2) perceived role in PA promotion, 
3) confidence in promoting PA, 4) barriers to promoting PA, and 5) feasibility of 
delivering PA promotion using the provider survey and interview data (Aim 5). Provider 
survey responses were presented as descriptive data using the proportions of 
respondents classified within each categorical variable. 
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CHAPTER 4 
MANUSCRIPT #1: EVALUATING THE IMPLEMENTATION OF EXERCISE IS 
MEDICINE WITH PATIENT OBSERVATIONAL DATA 
ABSTRACT 
 Background: The Exercise is Medicine™ (EIM) Solution is a health promotion 
strategy aimed at addressing physical inactivity in the healthcare environment. Recent 
calls to action have recommended making the EIM Solution a standard of care, yet little 
is known about how to do so. Furthermore, most EIM-related studies have focused 
effectiveness trials with a change in patient behaviors as the primary outcome. There has 
been little attention given to whether the EIM approach changes provider practices or 
promotes adoption of the EIM processes.  
 Purpose: The purpose of this study was to (1) establish baseline trends for 
utilization of EIM practices during a pre-implementation phase and (2) to implement 
and evaluate trained and untrained providers adoption of the EIM Solution processes.  
 Methods: A multiple baseline, interrupted time series design was used to 
establish trends and evaluate the adoption of EIM practices, among trained and 
untrained healthcare providers (HCPs), in a large Southwest university healthcare 
system. Patient intercept surveys (n=265) were collected for a 5-week pre-
implementation period (n=78) and during 8-weeks of EIM implementation (n=187). To 
determine the number and proportion of patients receiving EIM processes (e.g., asked 
about physical activity, counseled about physical activity), patients were asked to report 
which of the EIM processes they experienced during their healthcare appointment.  Time 
series data was used to examine trends across time for each outcome. Binary logistic 
regression modeling was used to test the effects of EIM training, EIM resources, and an 
electronic medical record (EMR) systems change on provider behaviors by study phase.  
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 Results: Adding the physical activity vital sign to the EMR significantly increased 
the number and proportions of patients who reported they were asked about physical 
activity (PA), χ2(4) = 95.47, p < .001. There was also a significant effect of HCP training 
and resource dissemination on patients receiving PA advice during implementation, 
χ2(4) = 36.25, p < .001. Time series analysis also showed increasing trends for all EIM 
outcomes among trained providers.  
 Conclusions: The findings of this study indicate that implementing the EIM 
Solution with HCP training and EIM-related resources increases provider engagement 
with patients about PA. Scaled-up trials with a longer duration are necessary to 
determine the best approaches for maximizing implementation of the EIM solution.  
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Introduction 
In 2007, Exercise is Medicine (EIM) was introduced, as a clinical health 
promotion strategy for primary care providers (PCPs) to promote physical activity (PA) 
in the healthcare environment (Haskell et al., 2007). The EIM Solution is a four-part 
process which includes the assessment of PA as a vital sign (PAVS), brief PA counseling 
delivered by the provider, utilizing exercise prescriptions (ExRX) to prescribe PA, and 
providing PA resources or referrals to inactive or insufficiently active patients. There 
have been calls to action for making EIM, endorsed by the American Medical Association 
and the American College of Sports Medicine, the standard of care when addressing 
physical inactivity among patient populations (Crump et al., 2019; Sallis, 2015). The EIM 
initiative was also endorsed by the American Academy of Family Physicians (AAFP) in 
2008 with the rationale that 84% of individuals consult a family physician and a 
provider driven PA encounter could lead to modest changes in patient PA; significantly 
impacting population health (Meriwether et al., 2008).  Following the endorsement of 
EIM, the AAFP recommendations for PA promotion in healthcare mirrored the EIM 
processes. However, little is known about provider and organizational practices that are 
necessary for successful implementation of the EIM Solution.  
Widespread adoption of EIM is lacking and with no clear guidance of what leads 
to or prevents successful implementation, organizations may be dissuaded from 
adopting EIM as a standard of care (Bauer et al., 2015). Much of the research that has 
been conducted with respect to EIM has investigated the validation of the PAVS 
(Coleman et al., 2012), effectiveness of adding the PAVS to the electronic medical record 
(EMR ) for identifying and documenting inactivity (Grant et al., 2014), acceptability and 
satisfaction with EIM protocols (Heath et al., 2015), and effectiveness of EIM provider 
training for increasing use of the processes (Fowles et al., 2018). There is a major gap in 
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research related to how the entire EIM Solution can be successfully implemented, from 
an organization standpoint, in real-world settings. In addition, many of these studies use 
patient outcomes (e.g. change in PA behavior, weight reduction, or improved 
biomarkers) as their measure of success. To truly determine if EIM can be successfully 
integrated into a healthcare system, studies evaluating implementation outcomes must 
occur before patient outcomes are assessed. 
Process evaluations are recognized as a way to understand program 
implementation, before assessing effectiveness outcomes (Saunders et al., 2005). 
Ignoring the evaluation process could be a detriment when investigating the success of 
an intervention, or lack thereof and may lead to findings that cannot be explained with 
confidence. However, it may be challenging to determine if implementation was 
successful when no true baseline of the processes being evaluated can be determined. 
Establishing baseline trends before program implementation is essential when 
examining if changes are due to the program being implemented.  A multiple baseline 
design is an appropriate evaluation method for establishing trends across a time series, 
when multiple groups deliberately receive an intervention, at different points in time 
(Hawkins et al., 2007). Furthermore, monitoring providers practices through the patient 
surveys during implementation is independent of what is being documented in the 
clinical records and may be insightful for investigating any differences or similarities in 
findings. To date, no study published in the literature has addressed patients’ 
perspectives of providers’ practices related to the EIM Solution.  
 The purpose of this study was to examine trends across time for EIM processes, 
reported by patients, and to determine if the proportions differed by the level of EIM 
resources and training providers received. The patient intercept surveys were also used 
to establish baseline trends for EIM outcomes and monitor trends throughout the EIM 
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implementation process. It was hypothesized that patients who reported being asked 
about PA would be significantly greater during implementation compared to pre-
implementation, but no differences would be observed between intervention groups 
during implementation. It was also hypothesized that patients who reported receiving PA 
counseling, PA resources, and a PA referral would be significantly greater among the 
trained providers (EMR++ group) during implementation compared to the untrained 
providers in the EMR+ (modified EMR and EIM resources) and EMR (modified EMR 
only) groups.   
 
Methods 
 
Setting and Participants 
Adults aged 18 years or older, who were patients in a large Southwestern 
university healthcare system, were recruited for this study. Patients (n=4506) were sent 
an invitation to participate in an anonymous survey, about their providers’ PA 
promotion behaviors, using a messaging system delivered through a secure patient 
portal. The recruitment messages were batched and sent through the patient portal the 
morning following their clinical encounter. Due to low engagement with the patient 
portal, patients were also recruited in the clinical environment using a recruitment flyer 
beginning in week three pre-implementation (i.e. phase one). The flyers provided the 
online survey link and were given to patients by a staff member at the end of their visit. A 
total of 265 patients (5.9%) completed the survey during pre-implementation (n=78) and 
implementation (n=187). To be included in the study, the participants had to be 
evaluated by one of the primary or acute care providers who were selected to participate 
in the study and an affiliated student of the university. Patients were excluded if they 
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were not affiliated students or were examined by a non-study related provider. Inclusion 
criteria for providers consisted of having a full- or part-time affiliation with one of four 
campus-based primary or acute care clinics. Exclusion criteria for providers included 
those who worked on an as needed (PRN) basis and those with specialties in sports 
medicine, orthopedics, and neurology.  
 
Design 
A multiple baseline time-series design was used to establish baseline trends and 
to determine if: (1) there were changes in the proportion of patients who reported being 
asked about their PA level or receiving EIM outcomes (i.e. PA counseling, ExRx, PA 
resources, or PA referrals) from providers over time; and (2) the changes were due to the 
level of the intervention received. Measurement for each of the EIM outcomes was 
conducted during pre-implementation and during two phases of implementation across 
the 13-week study using the anonymous patient intercept surveys (Figure 2). During the 
4-week pre-implementation period (phase one), routine clinical practices were evaluated 
to and ancillary staff were trained to obtain the PAVS during week four.  
The implementation phase was broken down into two phases, corresponding to a 
staggered HCP training and an EMR modification, which included a mechanism to 
document the PAVS and providers’ actions around PA. The mechanism (i.e. charting 
tool) was integrated and available to all providers beginning on day 27. The healthcare 
system is comprised of clinics on four campuses and the HCPs work across campuses, 
necessitating a staggered training approach. Providers who worked in the main primary 
care clinic and who were unlikely to travel to the other three clinic locations were trained 
on the EIM solution at the beginning of phase two (days 20 and 25).  Providers who were 
primarily located at another clinic and were likely to travel to other locations, on at least 
one day per week, were trained during phase two (day 46). Patient intercept surveys 
  51 
were collected using online survey software (Qualtrics XM, Provo, UT) and delivered via 
a secure patient portal to protect anonymity. Informed consent was obtained 
electronically before patients could continue responding to the remainder of the survey. 
Surveys were collected during phases one, two, and three to examine pre-
implementation and implementation trends.   
 
Descriptive and Outcome Measures 
The patient intercept survey consisted of questions about the date of visit, 
location of service, provider seen, academic status (i.e. freshman, sophomore, junior, 
senior, graduate student) and the patient’s PA behaviors. Patients were also asked about 
provider behaviors which were related specifically to EIM outcomes: (1) were they asked 
about PA, (2) did they receive PA advice, (3) did they receive an ExRx, (4) did they 
receive PA resources, or a PA referral. If patients indicated they were given PA advice, a 
follow-up question was included asking them to briefly describe the advice given to them 
by the provider.  
 
Intervention 
Twenty-two providers were purposively assigned to one of three intervention groups: (1) 
EMR++ (n=11), (2) EMR+ (n=5), and (3) EMR (n=6). Allocation to the groups was 
determined by the providers’ specialty and availability for training. Providers who 
specialize in primary care providers were assigned to the EMR++ group. Providers 
specializing in women’s health and primary care were assigned to the EMR+ group in 
addition to one PCP who was unable to attend training. Acute or urgent care providers 
were assigned to the EMR group. The EMR ++ group received EIM resources, a 30-
minute EIM training session, and the EMR update. The EMR update included the 
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addition of the charting tool to document the PAVS and additional actions the provider 
took during the patient encounter related to PA (Figure 5). The EMR+ group received 
the EIM resources and the EMR update but did not receive the provider training. The 
EMR group was only exposed to the EMR update and served as the counterfactual 
comparison group (i.e. what would happen in the absence of changes). 
The in-person training for the EMR++ providers, led by an ACSM Certified 
Exercise Physiologist and trained Exercise is Medicine Level II professional, followed the 
EIM Providers’ Action Guide (Appendix F). The training aimed to give providers a basic 
understanding of EIM and the outlined processes for addressing physical inactivity. 
Training focused on discussing strategies appropriate for initiating PA advice or 
counseling such as identifying inactivity or other health-related risk factors (e.g. 
sedentary behavior, elevated vitals, anxiety, depression, etc.). Providers were also trained 
on how to use the EIM branded ExRx form (Appendix M) to prescribe PA to inactive and 
insufficiently active patients, which follows the aerobic PA guidelines for health, as well 
as when to give self-directed PA resources (e.g. educational materials) and/or a PA 
referral. Training also included an overview of EMR system update and how to use the 
charting tool. 
The EIM resources were disseminated by email to the EMR++ and EMR+ groups 
at the end of the phase one (day 19). Physical copies were also provided to the EMR++ 
group during the EIM training sessions. The EIM resources included the EIM Providers’ 
Action Guide, additional EIM forms, and patient education materials (Appendices E-J). 
The EMR+ providers were asked to read and become familiar with the EIM processes 
and resources. The EMR++ providers who received the resources prior to their 
scheduled training were also asked to review the materials and told they would be 
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discussed during the training session. The EMR+ providers also received access to an 
EMR systems training video describing the EMR modifications (day 26). 
The EMR system was updated to include a standardized charting tool which was 
embedded in the vitals section of the EMR. All affiliated ancillary staff (i.e. medical 
assistants and nurses) were trained to ask the PAVS-related questions and enter the 
subsequent numerical values into the EMR. The PAVS was programmed to be a forced 
action in the EMR to ensure consistency in data collection and reduce disruption to the 
providers’ clinical flow. Additional documenting options were included in the charting 
tool to capture if a provider was reviewing the PAVS and which levels of the EIM 
processes were used during patient interactions. To track reviewal of the PAVS, a 
checkbox inserted next to the PAVS with options for “PAVS reviewed” or “PAVS not 
reviewed” was included. When “PAVS reviewed” was selected a drop-down menu with 
the additional documenting options became available to providers (Figure 5). 
The EMR modifications were integrated on day 27. Since a true baseline did not exist for 
comparison, providers in the EMR group did not receive any EIM resources or training 
to establish the counterfactual. 
 
Statistical Analyses 
Statistical analyses were conducted using SPSS Statistics Software Version 25 
(IBM Corp., Armonk, NY, USA). Descriptive statistics were used to describe the 
characteristics of the patients included in this study. Frequencies were recorded and 
proportions were calculated for each EIM outcome by provider intervention groups and 
across study phases. EIM outcomes were categorized dichotomously (i.e. either the 
patient reported experiencing the outcome or not). Daily proportions were determined 
by the number of respondents reporting they received the outcome relative to the 
  54 
number of survey respondents for each day by provider intervention group. The daily 
proportional data for each EIM outcome was plotted across a time series graph for visual 
analysis. Means and standard deviations were also calculated for each intervention group 
by phase of the study. The mean values were compared across phases to determine if a 
change in level was occurring within each group. A change in slope was determined by 
examining the if there was a change in variability explained (R2) for each for each group, 
by phase, across time. If there is a change in mean and slope, it can be assumed that the 
change is explained by time. If the slope is constant over time and does not change with 
the mean, the outcome is assumed to be more stable. Stability indicates the behavior has 
been replicated and is likely to continue across time. 
Logistic regression analysis, an extension of chi-square test, was performed to 
determine the impact of the provider intervention group and phase of the study, on the 
likelihood that participants were asked about PA, and received an ExRx, PA resources or 
PA referral. Logistic regression is similar to linear regression with the exception that the 
dependent variable (DV) must be a binary categorical variable and independent variables 
(IVs) can be continuous, ordinal, or categorical (Peng, Lee, & Ingersoll, 2002). Logistic 
regression examines the interaction between IVs included in the model and uses this to 
predict the probability that the change in the dependent variable (DV) is likely due to 
this interaction. In addition, this method calculates odds ratio and confidence intervals. 
The odds ratio, which is a measure of association between the IVs and DV, represents the 
odds that the DV will occur when exposed to the IV compared to the odds of the DV 
occurring when the IV is not present (Szumilas, 2010).  
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Results 
 
Descriptive Statistics and Time Series Analyses 
 Participant characteristics for patients completing the survey are summarized in 
Table 3. Provider characteristics are also provided in Table 4. Most of the patient 
respondents were female (58.7%) and were classified as graduate students (50.2%). 
Nearly 58% reported meeting the guidelines for aerobic PA (i.e. 150 min/week). The 
proportion of patients, for each provider group and phase, who reported they received 
any of the EIM outcomes is shown in Table 5.  
 Daily proportions of patients reporting they were asked about PA throughout the 
study is depicted a using times series graph shown in Figure 6. The baseline trends for 
being asked about PA was established during phase one (pre-implementation) using the 
time series data for the EMR++ (M = 25.39%, SD = 35.98%; R2 = 0.04), EMR+ (M = 
40.00%, SD = 45.95%; R2 = 0.01) and EMR (M = 16.67%, SD = 35.36%; R2 = 0.017) 
groups. During phase two, the beginning of the implementation period, there was an 
increase in level (i.e. mean proportions) and slope (i.e. R2) observed in the time series 
data for the EMR++ (M = 70.22%, SD = 35.13%; R2 = 0.25), EMR+ (M = 88.46%, SD = 
29.96%; R2 = 0.10 ), and EMR (M = 76.92%, SD = 38.81.13%; R2 = 0.48) groups, 
compared to phase one. There was also an increase in level and change in slope between 
phases two and three for the EMR++ (M = 97.06%, SD = 12.13%; R2 = 0.004), EMR+ (M 
= 96.15%, SD = 13.87%; R2 = 0.20) and EMR (M = 83.08%, SD = 31.19%; R2 = 0.23) 
groups.  
 Daily proportions of patients reporting they received PA advice is also depicted in 
Figure 7. The baseline trends were established for the EMR++ (M = 7.55%, SD = 17.28%; 
R2 = 0.07), EMR+ (M = 20.0%, SD = 42.16%; R2 = 0.10), and EMR (M = 5.56%, SD = 
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16.67%; R2 = 0.27) groups during phase one. During phase two, there was an increase in 
level and change in slope for the EMR++ (M = 32.33%, SD = 30.77%; R2 = 0.01) and 
EMR+ (M = 62.54%, SD = 42.16%; R2 = 0.24) groups, but relatively no change in level or 
slope for the EMR group (M = 7.69%, SD = 27.74%; R2 = 0.27). During phase three, no 
changes were observed in level or slope for the EMR++ group (M = 30.39%, SD = 
34.98%; R2 = 0.0002). Decreases in level and slope were observed for the EMR+ (M = 
29.49%, SD = 37.98%; R2 = 0.48) and EMR (M = 1.54%, SD = 5.55%; R2 = 0.01) groups, 
compared to phase two. The level was only greater than baseline for the EMR++ and 
EMR+ groups during phase three and stability was only observed within the EMR++ 
group.  
 The time series graph for the daily proportions of patients reporting they received 
an ExRx shows that the EMR++ group had the greatest proportion of patients reporting 
this outcome across implementation (Figure 8). Baseline levels were established for the 
EMR++ (M = 1.96%, SD = 8.08%, R2 = 0.09), EMR+ (M = 0.00%, SD = 0.00%; R2 = 
N/A), and EMR (M = 5.56%, SD = 16.67%; R2 = 0.27) groups. In phase two, there was an 
increase in level and change in slope for the EMR++ (M = 9.57%, SD = 24.58%; R2 = 
0.01) and the EMR+ (M = 8.97%, SD = 22.17%; R2 = 0.05) groups. However, there was a 
decrease observed in level and slope within the EMR group (M = 0.00%, SD = 0.00%; R2 
= N/A). During phase three, the level and slope for the EMR++ group (M = 10.78%, SD = 
26.97%; R2 = 0.0001) were relatively unchanged compared to phase two. Additionally, 
the level was higher in phases two and three for the EMR++ group, compared to 
baseline, and stability was observed. The level and slope returned to baseline for the 
EMR+ group (M = 0.00%, SD = 0.00%; R2 = N/A) during phase three and remained the 
same for the EMR group (M = 0.00%, SD = 0.00%; R2 = N/A) compared to phase two. 
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Trends for patients reporting they received PA resources is depicted in (Figure 9). 
Baseline level and slope was the same for all three groups (M = 0.00%, SD = 0.00%; R2 = 
N/A). The level and slope increased for the EMR++ group (M = 6.06%, SD = 22.15%; R2 
= 0.03) and the EMR+ group (M = 3.85%, SD = 13.87%; R2 = 0.07) during phase two but 
there was no change for the EMR group. During phase three there was a decrease in level 
observed for the EMR++ group (M = 3.13%, SD = 12.50%; R2 = 0.05) and an increase in 
level observed for the EMR+ (M = 8.33%, SD = 28.87%; R2 = 0.05) and EMR (M = 
1.54%, SD = 5.55%; R2 = 0.01) groups. Similar trends were observed for patients 
reporting they received a PA referral with baseline level for the EMR++ group (M = 
1.04%, SD = 4.17%; R2 = 0.11) being slightly greater than the EMR+ and EMR (M = 
0.00%, SD = 0.00%) groups (Figure 10). The level increased for the EMR++ group (M = 
5.61%, SD = 13.31%; R2 = 0.02) and the EMR+ group (M = 7.69%, SD = 27.74%; R2 = 
0.08) during phase two but no change was observed for the EMR group. The level only 
increased for the EMR++ group (M = 12.5%, SD = 22.36%; R2 = 0.08) during phase 
three. The EMR+ group had a decrease in level back to baseline and the EMR group 
continued to show no change.  
 
Logistical Regression Analysis 
The logistic regression model for being asked about PA was statistically 
significant, χ2(4) = 95.47, p < .001. The model explained 41.6% of the variance 
(Nagelkerke R2) and correctly classified 80.0% of cases. Sensitivity was 89.0%, 
specificity was 63.4%, positive predictive value was 81.8% and negative predictive value 
was 75.6%. Of the predictor variables entered into the model, only phase of study was 
significant. Likelihood of being asked about PA was significantly greater in phase two  
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(OR= 9.5, 95% CI = 4.8-19.2) and phase three (OR = 39.1, 95% CI = 14.3-106.8) 
compared to phase one. 
The model for receiving PA advice was statistically significant, χ2(4) = 36.25, p < 
.001. The model explained 19.1% of the variance (Nagelkerke R2) and correctly classified 
78.5% of cases. Sensitivity was 25.0%, specificity was 95.5%, positive predictive value 
was 64.0% and negative predictive power was 80.0%. Significant predictor variables 
were phase of study and provider intervention group. Likelihood of patients receiving PA 
advice was significantly greater in phase two (OR = 4.7, 95% CI = 2.0-11.0) and phase 
three (OR = 2.9, 95% CI = 1.2-7.4) compared to phase one. Likelihood of patients 
receiving PA advice was also significantly greater for the EMR++ group (OR = 6.0, 95% 
CI = 1.7-20.7) and the EMR+ group (OR = 11.6, 95% CI = 3.2-41.9) compared to the 
referent (EMR) group. The models for receiving an ExRx, PA resources, or a PA referral 
were not significant.  
 
Discussion 
 Findings from this study suggest that the EIM Solution, coupled with provider 
training for implementing it, may increase the number of patients who are asked about 
PA and receive PA counseling during their clinical visit. Training the ancillary support 
staff to obtain the PAVS and changing the EMR was also associated with an increased 
proportion of patients reporting they were asked about PA during their clinical visit. This 
did not differ statistically by provider group (EMR++, EMR+ or EMR group) nor was it 
expected that a between-groups difference would be observed due to the PAVS being 
programmed as a forced action.  However, there was a significant difference observed for 
the phase of study. Since all providers received the EMR system update as part of the 
intervention, at the same time, the increases were only observed during phases two and 
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three when the update went into effect. In addition, the greatest proportion of patients 
asked about PA was observed in phase three, for all groups. Based on the regression 
model, the odds of patients being asked about PA was 39.1 times greater during phase 
three compared to phase one. 
 The hypothesis that a greater proportion of patients who reported receiving PA 
advice, resources, or referrals, would be greater among the EMR++ patients during 
implementation was partially supported by the findings. Based on the logistic regression 
model, the odds of patients receiving PA advice from their provider was 4.7 times greater 
and 2.9 times greater during phases two and three respectively, compared to phase one. 
The odds of patients receiving PA advice from providers were 6.0 and 11.6 times higher 
for the EMR ++ and EMR+ groups respectively, compared to the EMR group. However, 
the time series indicates that stationarity was only observed in the EMR++ group. The 
overall total proportions were also greater for the EMR++ and EMR+ groups with 25.2% 
and 38.7% of patients reporting they received PA advice respectively, compared to the 
5.4% reported for patients in the EMR group.  
 While it seems the providers in the EMR+ group had the greatest increases for 
providing PA advice, contamination may have influenced the results. This study was a 
real-world, implementation trial and it was not possible to prevent communication 
between providers. During the evaluation process, it was discovered that one of the 
providers in the EMR+ group was given an overview of the training from a provider in 
the EMR++ group, and  another provider attended a non-provider staff training that 
may have caused some reactivity. The provider who received the overview was initially 
assigned to the EMR++ group but could not attend training and was subsequently 
reassigned. He reported receipt of the overview to the investigator. Interestingly, 11 of 
the 16 patients (69%) in the EMR+ group, who reported they received PA advice during 
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phase two, were evaluated by one of these two providers. Another aspect that makes 
contamination a credible explanation is that one of these providers was gone during 
phase three and the proportion of patients reporting PA advice for the EMR + group 
decreased from 63% to 29%. In addition, two-thirds of the patients reporting PA advice 
during phase three were evaluated by the other contaminated provider. Because this was 
not a strictly controlled study designed to avoid contamination, it is difficult to say with 
certainty that this is in fact the driving force; however, the numbers are compelling.  
 This study adds unique insights to the research on implementing the EIM 
Solution. To the investigator’s knowledge, there is no other study that has analyzed the 
effect of implementing additive models of the EIM Solution (i.e. EMR++ vs. EMR+ vs. 
EMR) within an organization at the same time; nor are there studies which examine how 
each level of the intervention received influences providers’ behaviors around the EIM 
processes. While The effect of adding a PAVS mechanism has shown to increase provider 
documentation around PA in organizational sites with the mechanism compared to sites 
without (Grant et al., 2014), there is little detail about the specific EIM processes that go 
beyond obtaining the PAVS. Furthermore, visual analysis of the EIM processes has not 
been performed to establish trends when statistical significance is lacking. Although the 
increasing trends observed for ExRx, PA resources, and PA referrals were low, providers 
who received training (EMR++) had the most consistent changes. The visual trend 
analysis shows there was greater consistency in provider provision of the other outcomes 
(i.e. ExRx, PA resources, PA referrals) within the EMR++ group, across the 
implementation phase, compared to the EMR+ and EMR groups. When consistency is 
observed it demonstrates that replication of the outcomes has occurred. Replication 
speaks to the generalizability the intervention’s effect on the outcomes and the likelihood 
that the behaviors will continue over time.  
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Conclusion 
 The findings of this study indicate that beyond asking about PA, providers in the 
EMR++ and EMR+ groups were more likely to implement other aspects of the EIM 
solution, including counseling patients about PA and providing PA resources. Only 
training ancillary staff and adapting the EMR system to include the PAVS increased the 
number of patients asked about their PA but may not have been enough to influence 
provider behaviors with respect to the other outcomes. Alternatively, the EMR group 
may have also been seeing patients for reasons that were more pressing than addressing 
PA through counseling, ExRx, resources or referrals. Because contamination seemed to 
highly influence the results for PA advice, there is no clear indication that using the 
resources without training would change provider behavior. However, it may be that 
training is not necessary for all providers if key personnel can effectively communicate 
the critical aspects of the program that are necessary for successful adoption. This is an 
important consideration from an administrative perspective, due to the competing 
demands and time constraints experienced by providers. Utilizing key personnel may be 
a more efficient use of the organization’s time and resources when adopting new 
processes.   
 The limitations of this study include having unequal sample sizes between groups 
and greater amounts of missing data for the EMR+ and EMR groups. Of the 64 days in 
the study, there were only six days in which surveys were not received from patients in 
the EMR++ group. In contrast, there were 27 days (42%) and 29 days (45%) missing 
from the EMR+ and EMR groups respectively. For this reason, results should be 
interpreted with caution. However, this study has uniquely examined the EIM Solution 
from the patient perspective with respect to observing changes in provider behaviors. 
Although the amount of missing data lends caution to the conclusions, the trends are 
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promising. Longer observation periods and improving patient recruitment methods 
could yield more robust data and should be examined in scaled-up trials.  
 A strength of this study was the methodology used (i.e. a multiple baseline 
design) to establish pre-implementation trends. From the process evaluation lens this is 
an extremely important consideration when examining how the introduction of a new 
program influences behaviors. When pre-implementation data is unavailable for 
comparison it is more difficult to demonstrate the changes were due to the 
implementation of the program. Another strength of the study was the use of the visual 
analysis using the time series data. While there was no statistical significance for some of 
the EIM-related outcomes, the trends are compelling and should be examined in scaled-
up trials, with longer observational periods.  
 This study demonstrated that the design was appropriate for this process 
evaluation, which could be easily translated and used in other healthcare settings. 
Although the current study was conducted in a university-based setting, the primary 
difference is the age of the population served. The benefits of adopting the EIM Solution 
in any healthcare setting could have far-reaching implications in the realm of preventive 
health. The implications of early intervention, when used in a university-based 
healthcare system, should also be considered. Although more most of the population was 
meeting the PA guidelines for health, 42% of patients were either inactive or 
insufficiently active. Early intervention in this young population could lead to 
considerable and beneficial long-term impacts on health and disease outcomes. In 
conclusion, the results from this pilot study show that adopting the EIM Solution may be 
effective for increasing provider engagement with PA promotion in the healthcare 
environment.  
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CHAPTER 5 
MANUSCRIPT #2: EXERCISE IS MEDICINE: A PROCESS EVALUATION 
CONDUCTED IN A UNIVERSITY-BASED HEALTHCARE SYSTEM 
ABSTRACT 
 Background: Calls to action have existed for more than a decade to make the 
Exercise is Medicine (EIM) Solution a standard of care for addressing physical activity 
(PA) in the clinical environment. However, little research exists on the best practices for 
implementing this process in the context of organizational adoption and provider 
behaviors. A process evaluation is an approach that may help address this issue by 
contextualizing the influential characteristics of the program.  
 Methods: Twenty-two healthcare providers affiliated with a university-based 
healthcare system were selected to be evaluated for this quasi-experimental study. 
Providers were assigned to one of three groups. Group one (EMR++, n=11) was exposed 
to change in the electronic medical record (EMR) system, received EIM training 
resources, and attended and an EIM training session. Group two (EMR+, n=6) received 
resources and the EMR systems change but did not receive training and group 3 (EMR 
n=5) was exposed to the systems change only. The systems change included the addition 
of a documenting tool used to track EIM-related outcomes. Outcomes included EMR 
recorded data regarding whether patients were asked about patient PA as a vital sign 
(PAVS), provided PA advice, exercise prescriptions (ExRx), PA resources or PA referrals. 
Time series data was used to examine trends across time for each outcome. Chi-square 
analysis was used to test the effects of each EIM training, EIM resources, and systems 
change on provider behaviors.  
 Results: Overall, EMR data indicate 97% of patients were asked about PA and 
providers reviewed the PAVS for 23% of patients. Among patients whose PAVS was 
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reviewed, 18% received PA advice. There was no recorded data for ExRx and the 
proportion of documented encounters for receiving PA resources or referrals was less 
than 1%. The greatest proportions of EMR records indicating the PAVS was reviewed 
(47%), PA level was identified (32%), or PA advice was provided (9%) occurred within 
the EMR++ group. Additionally, 97% of encounters documenting PA advice given to 
patients occurred among providers in the EMR++ group and 85% of the patients who 
received it were classified as either inactive or insufficiently active. 
 Conclusion: Training the staff to collect and document the PAVS within the EMR 
was highly effective for ensuring the PAVS was collected. Providing providers with 
training on how to use the PAVS in the EMR and interact with patients appeared to have 
an impact on the providers’ assessment of the PAVS and actions taken as indicated by 
EMR data. Providers who received EIM training were more likely to identify inactive 
patients based on PAVS documentation and document provision of PA counseling, 
consistent with the EIM Solution approach.   
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Introduction 
 The idea that exercise is a necessary component of health and should be viewed 
as medicine as has been a basic tenet of Western medicine since its birth. The fathers of 
Western medicine, Hippocrates and Galen, were the first physicians on record to 
prescribe physical activity for a variety of ailments (Tipton, 2014). Through the 
centuries, exercise has been recognized for health preservation and became a standard 
for physician training in the 19th century (Berryman, 2010). However, as public health 
priorities shifted to managing infectious diseases, physical education moved out of the 
realm of medicine and into sport-related curriculum. This changed when a new era of 
exercise science emerged following the seminal findings of Morris and Paffenbarger (J. 
Morris & Raffle, 1954; Paffenbarger Jr et al., 1970).  
 The American College of Sports Medicine (ACSM) was founded in 1954 as a 
collaborative effort between epidemiologists, physiologists, and cardiologists to pursue 
evidence-based research related to physical activity (PA) and health. Over half a century 
later, the Exercise is Medicine (EIM) initiative was jointly introduced by ACSM and the 
American Medical Association as a clinical solution for addressing physical inactivity 
(Haskell et al., 2007). EIM was also endorsed by the American Academy of Family 
Physicians (AAFP) in 2008 with the rationale that 84% of individuals consult a family 
physician and providing brief counseling leading to modest changes in PA could 
significantly influence population health (Meriwether et al., 2008). The EIM Solution 
suggests healthcare providers use the following processes: 1) assess PA as a vital sign 
(PAVS), 2) provide brief PA counseling, 3) provide exercise prescriptions (ExRX) to 
inactive or insufficiently active patients, and 4) give patients self-directed resources or 
refer them to a PA program or facility. However, there has been very little research on 
how to implement these processes.  
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  Calls to action for adopting EIM processes (Crump et al., 2019; Pearce, 2008; 
Sallis, 2015) and commentary on strategies for using the EIM approach (Cowan, 2016; 
Sallis et al., 2015) have been driving the notion that this is a relevant solution to PA 
promotion in the healthcare environment. However, there is a dearth of research 
regarding implementation. Studies have been conducted to validate the use of the PAVS 
(Coleman et al., 2012) effectiveness of adding the PAVS to an electronic medical record 
(EMR) for increasing PA documentation (Grant et al., 2014), acceptability of protocols 
(Heath et al., 2015) and effectiveness of training workshops for increasing provider 
adoption of prescribing PA (Fowles et al., 2018). While these are certainly important 
aspects to address, many of the studies rely on changes in patient PA or other health-
related outcomes (i.e. change in weight, BMI, biometrics) as measures of effectiveness. 
Furthermore, there is little to no research investigating the implementation of the EIM 
Solution in its entirety. If the EIM approach is to be established as a standard of care, 
this must be better understood.  
 The health benefits of exercise and physical activity are undeniable, and the role 
of healthcare providers in this realm of health promotion cannot be overlooked. Despite 
decades of position statements, policies, and guidelines calling for greater efforts to 
promote PA in the healthcare environment, there is no clear indication this is occurring 
on a routine basis. Current estimates show that only 34% of U.S. adults have reported 
being counseled by a healthcare provider about PA behaviors; despite perceived 
importance being high among clinicians (Shuval et al., 2017). This may be due to no 
existing standard of care or a lack of understanding of what is necessary to change 
provider practices and organizational cultures that support PA promotion in healthcare. 
To better understand this problem, there is a need to investigate these factors to 
determine why adoption remains low (Huijg et al., 2015). Programs or interventions 
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delivered in healthcare are often complex and target multiple factors that may respond 
unpredictably, and these complexities must be understood.  
A process evaluation is useful for investigating real-world complexities and 
should be conducted before examining effectiveness on patient outcomes (Saunders et 
al., 2005). A process evaluation plan should aim to (a) understand the program and how 
it is intended to work, (b) define the purpose for the evaluation, and (c) contextualize the 
influential characteristics of the program (Saunders et al., 2005). Examining fidelity (i.e. 
was the program delivered as intended), dose (i.e. how much of the program was 
implemented), adaptation (i.e. tailoring to the local environment), and reach (i.e. who 
received the intervention) allows inferences to be made about influential mechanisms 
(G. F. Moore et al., 2015). Evaluating these complexities can provide greater insight into 
the effectiveness of implementation, allowing for a better understanding of the program, 
and can inform future investigations. (G. F. Moore et al., 2015).  
Thoughtful planning and consideration of these complexities is important when 
developing the study design. Pragmatic trials allow a degree of flexibility that is needed 
when uncontrolled conditions exist (Ford & Norrie, 2016). In addition, multiple 
baselines designs are useful for observing the effects of a an intervention across a series 
of timepoints when a program or intervention is introduced (Hawkins et al., 2007). 
Using a multiple baseline time series design is a valuable strategy for evaluating 
healthcare programs in real-world settings (A. D. Harris et al., 2006; Lopez Bernal et al., 
2018; Zhang et al., 2009). Examining the changing trends, or lack thereof, across time 
can assist with determining the impact of the intervention and the influence of planned 
interventions. 
The purpose of this study was to conduct a process evaluation of the 
implementation of the EIM Solution in a university healthcare system. The rationale for 
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this study is that there is a need to understand how the EIM processes influence provider 
behaviors. While the university healthcare environment is uniquely different due to the 
age and perceived health of the patient population, targeting this population may be far 
reaching in the realm of preventive health. Overlooking the role of these providers may 
be a missed opportunity for understanding the impact of early intervention. 
Furthermore, regardless of the population served, this investigation aims to provide 
insights that can be translated across different organizations. 
 
Methods 
 
Setting & Participants 
This study was conducted in a large Southwestern university healthcare system 
which served 19,714 patients with 57,382 patient encounters during the 2018/2019 
academic year. Of these encounters, 31% were conducted in the primary care setting. 
Providers were physicians (MDs, n=7) and nurse practitioners (NPs, n=15) who were 
selected with administrative and Institutional Review Board approval to be evaluated for 
this study. Inclusion criteria consisted of having a full- or part-time affiliation with one 
of four campus-based primary or acute care clinics. Providers who worked on an as 
needed (PRN) basis and those with specialties in sports medicine, orthopedics, and 
neurology were excluded from the evaluation. EMR data was reviewed for documented 
patient encounters (n=2974) during the implementation process from March-June 2019. 
In addition, providers selected for the study (n=22) were also recruited to complete a 
survey about PA promotion in the healthcare environment before implementation and at 
the end of the study. The same providers were also recruited to complete an exit 
interview at the end of the study to examine provider perceptions of the EIM processes.   
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Design 
A multiple baseline time-series design was used for this pragmatic 13-week trial. 
Since no formal process was in place for providers to use when addressing physical 
inactivity, the extent to which it was happening was unknown. Due to this issue, baseline 
(i.e. pre-implementation) trends could not be established using electronic medical record 
(EMR) data. To address this issue, an anonymous patient survey was collected daily 
during a 4- week pre-implementation period and the entire 9-week implementation 
period to assess patient reports of whether they were asked about PA during their 
healthcare visit provider PA counseling, delivery of ExRx or referral to PA facilities. 
These results are reported elsewhere (Birchfield et al., in progress). Measurement for 
each of the EIM outcomes was also collected from the providers using EMR data, during 
implementation. There were two phases of implementation, corresponding to the 
occurrence of two provider training sessions, which were staggered. Primary care 
providers (PCPs) who were assigned to the main primary care clinic and were unlikely to 
be scheduled in other locations attended training at the beginning of phase two (days 20 
and 25) and prior to an update to the EMR system going live (day 27). PCPs who were 
primarily assigned to another clinic or were scheduled in another clinic on at least one 
day per week, received training at the beginning of phase three (day 46). Providers who 
did not receive training were used as the counterfactual comparison group.  
 
Pre-Implementation 
Prior to implementing the EIM processes, a documentation tool (Figure 3) was 
developed for integration into the vitals section of the EMR. Operationalizing this 
documentation tool was done to provide consistent documenting procedures and to 
facilitate precise data collection for the EIM-related outcomes. Affiliated health services 
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research and tech support analysts assisted with developing the tool and modifying the 
EMR system. The documentation tool included a section to record the PAVS and the 
name of the non-provider support staff member (e.g. medical assistants and registered 
nurses) who recorded the information. The PAVS captured the patient’s self-reported 
weekly minutes of moderate-intensity aerobic PA as a vital statistic using procedures 
outlined in the EIM Solution. Entering the PAVS into the patient chart was implemented 
as a forced action to maximize documentation. The forced action made it such that the 
PAVS had to be completed before entering other vitals, such as height, weight, and blood 
pressure and a message prompt was included if bypassing this entry was attempted 
(Figure 4).   
Obtaining the PAVS as part of the patient intake process was also a design aspect 
which aimed to minimize disruptions to provider workflow. Support staff involved with 
the patient rooming process received formal systems training during the last week of the 
pre-implementation phase. Support staff were trained to navigate the EMR systems 
change, ask the PAVS-related questions, and document the patient responses in the 
designated section of the patient chart. Once the systems change was complete, the PAVS 
was obtained by asking the following questions as outlined in the EIM protocols:  
1) “On average, how many days each week do you engage in at least 
moderate intensity physical activity, like brisk walking?”  
2) “On those days, on average, how many minutes do you engage physical 
activity at this level?” 
Corresponding values for each question were entered in the EMR which was 
programmed to calculate the PAVS as a product of the two. The PAVS-related questions 
were also printed on laminated cards and posted next to computer stations used in the 
exam rooms (Appendix D). This was done to assist support staff with the adoption of this 
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change in the patient intake process. Based on feedback from administrative personnel, 
the cards also included translations in Mandarin and Arabic, as these were identified as 
the most common language barriers present within the patient population  
 Additional charting options were included for providers to select when 
documenting if the PAVS was reviewed, or not reviewed, by selecting a corresponding 
check box. If the PAVS reviewed box was selected, providers were able to select and chart 
from a dropdown menu which one of the EIM processes they used with their patients 
(Figure 5). The reviewing and charting options were included to track provider 
utilization of the EIM processes but were not programmed to be forced actions. This 
design consideration was made to minimize provider burden and as a safeguard so that 
providers in the counterfactual comparison group would not be forced to use it.  
 
Implementation 
Providers were allocated for this non-randomized study to one of three groups: 
(1) EMR++ (n=11), (2) EMR+ (n=5), and (3) EMR (n=6). Allocation was determined by 
the providers’ specialty and availability for training. Because the EIM Solution was 
designed for use in primary care, PCPs were targeted to receive the bulk of the 
intervention and were assigned to the EMR++ group. Providers with dual roles in 
women’s health and primary care were assigned to the EMR+ group and included one 
PCP who was could not attend training. Providers who were affiliated with the acute care 
clinic were assigned to the EMR group. The EMR++ group received the EMR systems 
change, EIM branded resources, and attended a 30-minute EIM training session. The 
EMR+ group received the EMR systems change and EIM resources but did not receive 
the training. The EMR group was only exposed to the EMR systems change and served as 
the counterfactual comparison group. The resources were disseminated by email to the 
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EMR++ and EMR+ groups on the last day of the pre-implementation, (phase one, day 
19) and physical copies were provided to the EMR++ group during the EIM training 
sessions.  
Training sessions were conducted by an ACSM Certified Exercise Physiologist 
and Exercise is Medicine Level II professional. Training occurred for the first group of 
EMR++ providers (n=6) at the beginning phase two (days 20 and 25) and to the second 
group of EMR++ providers (n=5) at the beginning of phase three (day 46). The providers 
in the first training group were affiliated with the main primary care clinic and were 
unlikely to work in other locations although one provider was scheduled to work in 
another clinic on one day per week. The second group of trained providers (n=5) worked 
in one of three other primary care clinics, and three were scheduled to work at least one 
day in the main clinic. The trainings were planned in this fashion to determine (1) if 
providers were communicating the information to their colleagues and (2) if this was 
occurring was it effective enough to change the untrained providers behaviors.   
The disseminated EIM resources included an EIM summary sheet (Appendix E), 
the EIM Providers’ Action Guide (Appendix F), a series of EIM-branded patent 
education materials (Appendices G-L) discussing PA recommendations for common 
health-related topics (e.g. prolonged sitting, PA for general health, anxiety and 
depression, type 2 diabetes, prediabetes and high blood pressure), and the EIM-branded 
ExRx form (Appendix M). These resources aimed to give providers a basic understanding 
of how to address physical inactivity with their patient populations using the EIM 
process. Providers in the EMR+ group also received access to an EMR system training 
video which included the same presentation presented to the non-provider support staff. 
Three of the EMR++ providers who were trained last, also served as clinic managers and 
attended the non-provider staff training. They also received the training video to share 
  73 
with the support staff and were also asked to share the information about the systems 
change with the two remaining providers. The EMR group did not receive any training 
materials or EIM-related resources.  
 
Descriptive and Outcome Measures 
A provider survey (Appendix N) was used to assess their perceptions of PA 
promotion in healthcare. The survey was electronically administered to providers in the 
EMR++ and EMR+ groups before the resources and training were provided. The survey 
was an adapted version of the Physical Activity Promotion in Health Care survey (Mark 
et al., 1999; Shirley et al., 2010). The original survey was created for physical therapists 
and adaptations to the survey were made to make the survey captured the demographics 
of this provider population and to include questions specifically related to EIM.  The 
questionnaire assessed (1) provider knowledge of PA guidelines, (2) perceived role of 
healthcare providers in PA promotion, (3) confidence in promoting PA in the healthcare 
environment, (4) barriers to PA promotion in the healthcare environment, and (5) 
feasibility of promoting PA. The survey has been validated and used in multiple 
healthcare settings (Mark et al., 1999; Shirley et al., 2010; Stubbs et al., 2007). In 
addition, providers were asked to participate in a post-study interview to assess 
perceptions of EIM and satisfaction with the use of EIM procedures and protocols. 
Outcomes for the EIM processes were measured using patient data from the 
EMR system and were recorded using the previously described documentation tool. 
Patient data was deidentified and coded by the senior research analyst for the health 
services department, prior to being shared, to ensure HIPAA compliance was 
maintained. Patients are made aware of the potential use of their deidentified data for 
research purposed in the notice of privacy practices. The EIM-related outcomes 
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included: (1) the PAVS, including the number of days and minutes of PA reported, (2) 
PAVS reviewed or not reviewed status, and (3) levels of provider engagement selected 
when the documenting too was used. In addition, descriptive measures were collected for 
each patient encounter about the location, date of encounter, type of visit, provider, 
patient demographics (i.e. sex, age, race and ethnicity), anthropometric data (i.e. height, 
weight, and body mass index), and primary diagnostic category. 
 
Statistical Analyses 
SPSS Statistics Software Version 25 (IBM Corp., Armonk, NY, USA) was used for 
the statistical analyses. Descriptive statistics were used to describe the frequency and 
proportion of patient characteristics obtained from the EMR system. Patient categories 
were created for continuous variables due to skewness and an inability to normalize the 
distribution using transformation techniques. Frequencies for EIM-related outcomes 
were also used to calculate proportions for the overall study and for the provider groups 
by phase of implementation. EIM-related outcomes were also categorized dichotomously 
(i.e. the outcome was either documented by the provider or not).  
The daily proportions for each EIM-related outcome was plotted, by group and 
study phase, to create time series graphs using patient surveys and EMR data. Daily 
proportions were determined for each EIM-related outcome using the total occurrences 
documented relative to the total number of visits for that day. Proportional means and 
standard deviations were also calculated for each phase of the study, by intervention 
group, to observe changes in level across phases. A change in slope was also determined 
by examining the R2 value of the trend for each phase. If there was a change in mean and 
slope, it is likely the change was explained by time. If the mean was constant over time or 
if the slope did not change with the mean, the outcome was considered stationary.  
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Chi-square tests of independence were conducted for each EIM outcome to 
determine if there were differences occurring between provider groups. This analysis 
technique is used for large sample sizes when there are two nominal variables being 
compared to determine if any differences are present (Kim, 2017). The significance 
threshold for was set at p < .05. The Bonferroni correction was applied to adjust for 
multiple comparisons when appropriate. If the omnibus test was significant, cellwise 
analysis using the standardized adjusted residuals was conducted post-hoc. This method 
uses contingency tables, to determine where differences were occurring for each 
categorical variable tested (Garcia-Perez & Nunez-Anton, 2003). The adjusted residuals 
scores (i.e. z-scores) were used to calculate individual chi-square for each outcome by 
group and p-values to determine significance.  
 
Results 
 
Descriptive and Statistical Analyses 
 Patient demographic characteristics (Table 6) and PA categories (Table 7) are 
summarized by provider group and for the overall study. Provider characteristics are also 
summarized for each intervention group (Table 4). Overall, 48% of patients were male 
and 52% of patients were female, 65% were between the ages of 18 and 24 years of age, 
49% were white, 55% were in the normal weight range (BMI = 18.5-24.9 kg/m2). Most 
patients (56%) were meeting the aerobic PA guidelines for health (≥ 150 min/week), 
based on the self-reported PAVS.  Figure 11 shows the total distribution of patients for 
each demographic category, by provider group. Figures 12 and 13 show the distribution 
of patient physical activity levels by provider group and patient sex respectively. The 
providers were primarily NPs (68%) and female (77%) with an average age of 49 years. 
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On average, providers had 18 years of experience; 55% were PCPs, 18% were women’s 
health providers, and 27% were acute care providers. 
 The chi-square analysis showed significant differences in the distribution of 
patient for sex, χ2(2) = 24.90, p <. 001, age, χ2(4) = 61.85, p <. 001, and PA level, χ2(8) = 
28.28, p <. 001 by provider group. The post-hoc cellwise comparison results (Table 8) 
revealed there were more males (54%) and fewer females (46%) in the EMR group than 
in the EMR++ (males = 45%; females 55%) and EMR+ groups (males = 44%; females = 
56%).  A greater proportion of patients aged 18-24 years were seen by the EMR providers 
(74%) compared to the EMR++ (58%) and EMR providers (66%). Fewer patients aged 
25-39 were seen by the EMR providers (24%) compared to the EMR ++ group (38%) and 
EMR+ group (31%). Although the omnibus test revealed there were significant 
differences in the proportion of patients in the PA categories across groups, the post-hoc 
analysis did not reveal any significant differences between groups.  
  The total proportions of provider engagement for EIM-related outcomes are 
summarized, by patient demographic and PA levels, in Table 9. Overall, 97% of patients 
had the PAVS recorded and providers reviewed the PAVS for 23% of patients. In 
encounters where the PAVS was reviewed, PA level was identified in the EMR for 69% of 
the encounters and providers documented giving PA advice to 18% of patients. There 
was no recorded data for ExRx and the proportion of encounters in which the providers 
documented providing PA resources or referrals was less than 1%. The EMR++ group 
(Table 10) reported the highest proportions for PAVS reviewed (47%), PA identified 
(32%), and PA advice (9%).  
 Chi-square analysis was also conducted for the provider engagement categories 
and included effect sizes (Cramer’s V). Results showed significant differences between 
provider groups in the proportion of documented encounters with PAVS asked (χ2(2) = 
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29.27, p <. 001, Cramer’s V = 0.10, p < .001), PAVS reviewed (χ2(2) = 791.81, p <. 001 
Cramer’s V = 0.52, p < .001), PA level identified (χ2(2) = 501.09, p <. 001, Cramer’s V = 
0.41, p < .001), and PA advice provided (χ2(2) = 141.31, p <. 001, Cramer’s V = 0.22, p < 
.001). Post-hoc analyses are summarized in Table 11 and show where the differences 
between groups occurred. The EMR group was the least likely to obtain the PAVS (χ2(2) 
= 28.94, p < .001) compared to the EMR++ and EMR+ groups. While there were 
significant differences between all groups for the remaining outcomes, the EMR++ 
group was the most likely to review the PAVS (χ2(2) = 779.53, p < .001), identify PA 
(χ2(2) = 493.28, p < .001), and provide PA advice (χ2(2) = 140.90, p < .001) compared to 
the EMR+ and EMR groups.  
 Provider engagement was also examined by each patient PA category and is 
summarized in Table 12. The greatest proportions of provider engagement were 
occurring within the EMR++ providers for all categories of PA. Among the EMR++ 
providers, PA level was identified for 32% of patients in all PA categories combined, 
compared to 5% in the EMR+ group and 0.4% for the EMR group. For PA advice, 8.9% 
of patients within the EMR++ group received PA counseling compared to 0.5% and 0% 
in the EMR+ and EMR groups respectively. There were no observable outcomes to 
report for the ExRx, PA Resources, or PA referral. 
 
Time Series Analyses 
 Daily proportions of documented patient encounters with the PAVS recorded is 
depicted using a times series graph shown in Figure 14. The level for being asked about 
PA during phase two of implementation was similar across the EMR++ (M = 98.42%, SD 
= 3.00%), EMR+ (M = 98.97%, SD = 1.83%) and EMR (M = 96.30%, SD = 4.53%) 
groups. During phase three, three was relatively no change in level observed for the 
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EMR++ (M = 96.42%, SD = 6.12%) or EMR+ (M = 96.7%, SD = 5.05%) groups. Time 
series for the PAVS reviewed is also shown in Figure 15. There were differences observed 
in level for phase 2 between the EMR++ (M = 48.50%, SD = 11.28%), EMR+ (M = 
14.86%, SD = 19.17%), and EMR (M = 0.65%, SD = 1.39%) groups. The level did not 
change between phases for the EMR++ group (M = 43.88%, SD = 17.08%) but decreased 
for the EMR+ group (M = 0.00%, SD = 0.00%) and stayed  relatively the same for the 
EMR group (M = 0.00%, SD = 0.00%). Figure 16 show the time series trends for PA 
advice. The trends were primarily observed within the EMR++ group for both phases, 
with no change in level from phase two (M = 8.65%, SD = 5.53%) to phase three (M = 
9.00%, SD = 7.19%). There trends observed for the EMR+ and EMR groups were 
unsubstantial during phase two and no change was observed for phase three. Trends 
were not graphed for ExRx, PA resources, or PA referrals since little or no activity was 
occurring within any group.  
 
Qualitative Results 
 The PA promotion in healthcare survey was completed by 82% (n=18) of 
providers selected for this study in the pre-implementation phase. Among those, 100% 
agreed that it was part of the healthcare providers role to discuss PA, provide PA advice, 
and to role-model PA behaviors. Most providers (94%) were confident they could 
identify inactive patients, provide PA advice, and prescribe exercise. The majority (89%) 
also indicated they were confident they could disseminate PA resources and provide PA 
referrals. In addition, 33% indicated they had provided PA counseling often (6-9 
patients) and 50% indicated very often (10+ patients) in the previous 30 days. Moreover, 
67% were able to correctly identify the physical activity guidelines for moderate aerobic 
PA (i.e. 150 min/week) and 94% agreed that several 10-minute bouts of walking each day 
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was enough to improve or maintain health. The most common barriers to PA promotion 
were lack of time, identified by 78%, and feeling it would not change patient behaviors, 
identified by 44%. Lack of skill and lack of remuneration were identified by 17% and 11% 
reported they had no interest and felt it would not be beneficial to the patient.  
 At the end of the study, 23% of providers (n=5) completed the survey but there 
were no changes observed in their responses from pre- to post-implementation. These 
same providers also completed an exit interview about their perceptions of EIM and with 
the implementation processes. A thematic approach was used to identify patterns in 
responses and three themes emerged: (1) usefulness of the resources, (2) engagement 
with the patient population, and (3) engagement with the EMR system. For theme one, 
all providers found the EIM provider training materials to be useful and 80% thought 
the “Being Active for a Better Life” and “Sit Less Move More” were the most useful 
patient resources. Three of the five (60%) found the exercise prescription forms useful. 
One provider stated that the EIM materials and process was not useful because inactivity 
was not an issue for the population served. For theme two, 60% indicated the EIM 
approach made it easier for them to engage with patients about PA and that the ExRx 
form made it easier to quantify and prescribe PA. One provider indicated that it did not 
change the way in which they engaged with patients, but it did reinforce the way they 
have always thought of exercise AS medicine. One provider commented they were 
impressed with the quality of the messaging presented in the patient education materials 
and that they were a good way to reinforce their conversations about PA. All providers 
expressed that they would like to have electronic versions of the patient education 
materials integrated into the EMR system if they were going to continue to be used. For 
theme three, 60% indicated they liked the idea of obtaining the PAVS and would 
recommend continuing this practice. However, there was agreement that the charting 
  80 
options were important to have but needed to more user friendly. Two of the five thought 
the systems change was burdensome and created unnecessary work for the non-provider 
staff. 
 
Discussion 
 The findings of this study suggest training ancillary staff on how to obtain the 
PAVS and programming the PAVS to be a forced action in the EMR resulted in all but a 
small percentage of patients (~3%) having their PAVS documented. Consistent with our 
hypothesis, recording of the PAVS remained stable throughout the implementation 
period and did not differ between provider groups. This suggests that the PAVS can be 
obtained during the patient intake process and only requires minimal training for 
ancillary staff.  Although 3% of patients did not have a PAVS recorded, the reason for 
why it was missing is not clear. It is likely there were competing demands when the 
PAVS was not asked (e.g. injury) and times when interaction with the vitals section of the 
EMR system was not occurring (e.g. vaccination). If no vitals were entered, then the 
forced aspect of the design would not prevent utilizing other sections of the patient chart. 
Adherence to this aspect of the process was consistent during implementation indicating 
that there is a greater chance of the behavior continuing in the future.  
 In regards, to providers reviewing the PAVS, the greatest proportion was 
observed in the EMR++ group and did not change across phases. There was some 
activity occurring for the EMR+ group during phase two but there was a reduction to no 
activity during phase three. For the EMR group there was relatively nothing happening 
in phase two and this trend continued during phase three. The effect size (Cramer’s V = 
0.52) is considered large and shows the provider groups were strongly influenced by the 
level of the intervention they received. There was also a large effect (Cramer’s V = 0.41) 
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for identifying PA level. This may in part explain the greater consistency observed in the 
EMR++ providers for adopting these processes demonstrated in the times series graph. 
There have been no studies that have looked at implementing different levels of the EIM 
Solution (EMR++ vs. EMR+ vs. EMR) nor have there been studies that have addressed 
how each level influences providers’ behaviors. Furthermore, studies focused on provider 
training have not addressed if training protocols increases providers’ actions for 
reviewing and identifying patient PA levels. This is an important implication to consider 
since it is known that increasing PA is a cost-effective approach for improving health 
outcomes (Abu-Omar et al., 2017).  
 While providers only documented providing PA advice in 4% of all patient 
encounters, the findings from this study are promising. First, the trends observed for PA 
advice occurred primarily within the EMR++ group and were stationary during both 
phases of implementation; meaning the proportion of patients counseled by EMR++ 
providers was relatively stable. Second, 97% of PA advice was documented by EMR++ 
providers who indicated they reviewed the PAVS.  Additionally, 85% of the patients 
receiving PA advice from an EMR++ provider were classified as either inactive or 
insufficiently active.  Collectively, these findings suggest the addition of a brief provider 
training focusing on how to use the PAVS to identify inactive or insufficiently active 
patients and provide brief counseling may be necessary to optimize implementation of 
the EIM solution. The training program utilized in the present study focused on 
counseling individuals based on current PA level as opposed to disease status or BMI and 
our results suggest the providers were able to identify and provide counseling to these 
individuals. Previous EIM-related studies have not addressed provider training as a 
mechanism that increases providers’ behaviors around identifying and counseling 
patients who are not meeting PA guidelines. This is an important to examine in the 
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context of EIM since studies related to PA counseling in general have shown that 
counseling by a PCP significantly improves patient PA behaviors (Orrow et al., 2012; 
Pavey et al., 2011). Furthermore, the implications of training providers to focus their 
efforts on identifying the inactive and insufficiently active patient populations will 
maximize reach to those who are most in need.  
 
Conclusion 
 The findings of this study show that training the ancillary staff and including the 
PAVS in the EMR system is an effective approach for increasing the collection of the 
PAVS and providing a brief training program to providers may enhance the 
identification of patients not meeting PA guidelines and the provision of PA counseling 
to patients. Although the EMR data show documenting PA advice was low and was 
negligible for ExRx, PA resources, and PA referrals, further investigation is warranted. 
The seemingly insignificant findings in this study may be due to the limitations of the 
EMR system itself. During the design process, it was discovered that the documenting 
tool had constraints that could not be overcome: (1) the options that were available were 
discrete choices and providers could only select one; and (2) character limits within the 
drop-down menu would not allow for the inclusion of statements that indicated multiple 
processes were used. A better approach may be to include the charting options in a 
template that the providers could use to document multiple actions in the S.O.A.P. notes 
section. Having a consistent process for providers to follow that can be integrated into 
the EMR system seems to be the best approach for measuring and analyzing the 
outcomes of interest. Tracking and measuring the outcomes through documentation 
seems to be the most efficient way to capture which processes providers are adopting.  
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However, the best approach for achieving this is a design aspect that will largely be 
determined by the capacity of EMR system.   
 Another limitation of this study is that the provider training seemed to primarily 
influence engagement with the documenting tool for the EMR++ providers. Future 
studies should also consider having a separate training that demonstrates how to 
navigate the system for providers in the comparison groups. This would allow for closer 
examination of differences between those who receive systems training with resources 
and those who receive the combined EIM and systems training. Finally, one reason for 
staggering the provider trainings was to monitor if trained providers were sharing 
information with untrained providers and advocating for the adoption of the processes 
but it is not clear if this was occurring. Another reason for staggering the trainings was to 
see if the results shifted as more providers were trained. This was also not clearly 
observed although three of the five providers in the second training group had early 
insight into documenting due to their roles as clinic managers. It may be worth 
evaluating whether training should occur at the same time for all providers or if 
identifying providers who are willing to be advocates may be just as effective in 
communicating the training concepts. This is an important consideration from an 
administrative perspective for examining the most efficient use of time and resources.    
 Strengths of this study include the methodology used (i.e. a multiple baseline 
design) to establish trends during implementation and the use of acute care providers as 
the counterfactual comparison group. Since acute care providers are more likely to be 
seeing patients with more urgent needs, it was expected that addressing PA would not be 
prioritized. Another strength of the study was the use of the visual analysis using the 
time series data. When significant findings are lacking, examining the trends through 
visual analysis provides unique insights. If trends are emerging it helps in making a 
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stronger case for examining the outcomes in scaled-up trials despite the lack of 
statistically significant findings. 
 The methods used for this process evaluation could be easily translated to other 
healthcare settings since the main difference is the age of the population served. While 
adopting the EIM Solution could have far-reaching implications in the realm of 
preventive health, more robust data is needed to confirm the effectiveness for changing 
provider behaviors. In addition, while most of the population (56%) was meeting the 
minimum recommendations for aerobic PA, 44% were not. The implications of early 
intervention in inactive or insufficiently active populations should not be overlooked. 
There may be considerable and beneficial long-term impacts on health if strategies 
aimed at disease prevention are adopted. In conclusion, the EIM Solution may be 
effective for increasing PA promotion in the healthcare environment and further 
investigation is needed.   
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CHAPTER 6 
LIMITATIONS AND FUTURE DIRECTIONS 
 The overall findings of the two studies show that implementing an EMR systems 
change with minimal staff training is sufficient for obtaining the PAVS, which was 
confirmed by the comparison of patient reported and EMR documented data during 
phase three. This shows that there was congruence between what was being documented 
in the EMR system and what was reported by patients. PA advice documented in the 
EMR was also compared to the patient survey data. There were clear increases for both 
EMR+ and EMR++ providers for this outcome, between pre-implementation and 
implementation in patient reported trends. However, the EMR data showed that PA 
advice was the greatest among EMR++ providers and that interactions were more likely 
to occur with the target patient population (i.e. inactive and insufficiently active). 
the outcome was only stable for the EMR++ group, which was observed in both data sets. 
This demonstrates that training providers is a good predictor that the providers’ 
behaviors around PA counseling is more likely to continue.  
 Despite the significant increase in trends observed in this study it is not clear if 
the differences observed were due to the additive levels of intervention received by 
providers. Future investigations should aim to compare training with and without EIM 
resources to determine if it was the training alone or there is an additive effect of training 
with EIM resources. Although the patient surveys served to establish a baseline pattern, 
it may not have accurately represented the providers’ behaviors, especially among the 
EMR+ providers. The patient observation data obtained during pre-implementation 
showed that this group had a greater proportion of patients reporting they were asked 
about PA and received PA advice at baseline compared to the group that received 
training. In addition, EMR+ providers had a greater proportion of patients reporting PA 
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advice during phase two. However, there was strong evidence of contamination observed 
in the patient reported data between phases two and three, with the results returning to 
near baseline levels. Although, this could not be confirmed with the EMR data due to 
lack of documentation within the EMR+ group.  
 Results must be cautiously interpreted. It is important to consider the low 
response rate and amount of missing days in the patient survey data and a lack of 
documentation in the EMR. These issues make it difficult to determine which of the data 
sets was more characteristic of the providers behaviors. Furthermore, engagement with 
the EMR system was low within the EMR+ group and the trends could not be accurately 
compared with the patient survey data.  Future studies should aim to improve patient 
recruitment strategies so more robust data can be obtained but there is a need to 
overcome the challenges of HIPAA compliance laws to facilitate this process. Another 
limitation of this study is the duration of the observation period. Although the 
observation period seemed to be enough to establish trends for this pilot study, the time 
frames between phases was relatively narrow. Since maintenance was not observed it is 
difficult to say if the behaviors will continue among providers.  
 While the findings observed in the EMR++ group are compelling, it is not clear if 
they would continue to remain stable. Future studies should focus on longer 
observational periods to ensure stability is achieved. There are also limitations with 
regards to the effectiveness of training. Since engagement with the EMR system was low 
for the EMR+ providers, at minimum a systems training should be provided to this 
comparison group to gain better insights. Future studies should also aim to examine a 
systems change outside of an acute care setting. While it was expected that provider 
behaviors in this group would not change due to competing priorities, it may have had  
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greater influence on behaviors in a more comparable group of providers; with the caveat 
that adequate systems training is received.  
 The limitations of the EMR system itself should also be considered when 
developing strategies for documenting and measuring these outcomes. The documenting 
tool used in this study was created so that charting options could be consistently tracked 
and measured. However, the challenges with the tools capacity to capture multiple 
outcomes was a major limitation. Providers may have been using multiple strategies but 
were forced to choose only one. Providing templates that could be imported into the 
EMR system for documenting purposes may be a more effective strategy for tracking 
documented outcomes. Lastly, it is important to address whether the PAVS needs to be a 
forced action. It was an effective strategy for this study and is in line with the EIM 
position that every patient is asked about PA during every encounter. However, it is not 
clear if this practice would be prioritized, especially in populations that are perceived to 
be highly active. Comparing the two approaches should be addressed but may be difficult 
to do within the same organization using the same EMR system. However, this could be 
achieved by including a comparable organization such as another university-based 
setting. Implementing the same approach but without the forced aspect could address 
this gap. Ultimately, this study has provided a unique examination of the EIM solution 
that future studies could use and build upon.  
  88 
REFERENCES 
Abu-Omar, K., Rütten, A., Burlacu, I., Schätzlein, V., Messing, S., & Suhrcke, M. (2017). 
The cost-effectiveness of physical activity interventions: A systematic review of 
reviews. Preventive Medicine Reports, 8, 72–78. 
https://doi.org/10.1016/j.pmedr.2017.08.006 
 
Ainsworth, B. E., & Youmans, C. P. (2002). Tools for physical activity counseling in 
medical practice. Obesity, 10(s11), 69S. 
 
American Diabetes Association. (2018). Economic Costs of Diabetes in the U.S. in 2017. 
Diabetes Care, 41(5), 917–928. https://doi.org/10.2337/dci18-0007 
 
American Heart Association. (2017). Cardiovascular disease: A costly burden for America 
projections through 2035. Washington DC: American Heart Association. 
 
Archer, E., & Blair, S. N. (2011). Physical Activity and the Prevention of Cardiovascular 
Disease: From Evolution to Epidemiology. Progress in Cardiovascular Diseases, 
53(6), 387–396. https://doi.org/10.1016/j.pcad.2011.02.006 
 
Aune, D., Norat, T., Leitzmann, M., Tonstad, S., & Vatten, L. J. (2015). Physical activity 
and the risk of type 2 diabetes: A systematic review and dose–response meta-
analysis. European Journal of Epidemiology, 30(7), 529–542. 
https://doi.org/10.1007/s10654-015-0056-z 
 
Ball, T. J., Joy, E. A., Gren, L. H., & Shaw, J. M. (2016). Concurrent Validity of a Self-
Reported Physical Activity “Vital Sign” Questionnaire With Adult Primary Care 
Patients. Preventing Chronic Disease, 13. https://doi.org/10.5888/pcd13.150228 
 
Barry, V. W., Baruth, M., Beets, M. W., Durstine, J. L., Liu, J., & Blair, S. N. (2014). 
Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis. Progress in 
Cardiovascular Diseases, 56(4), 382–390. 
https://doi.org/10.1016/j.pcad.2013.09.002 
 
Bauer, M. S., Damschroder, L., Hagedorn, H., Smith, J., & Kilbourne, A. M. (2015). An 
introduction to implementation science for the non-specialist. BMC Psychology, 
3(1). https://doi.org/10.1186/s40359-015-0089-9 
 
Berryman, J. W. (2010). Exercise is medicine: A historical perspective. Current Sports 
Medicine Reports, 9(4), 195–201. 
 
Burr, J. F., Rowan, C. P., Jamnik, V. K., & Riddell, M. C. (2010). The Role of Physical 
Activity in Type 2 Diabetes Prevention: Physiological and Practical Perspectives. 
The Physician and Sportsmedicine, 38(1), 72–82. 
https://doi.org/10.3810/psm.2010.04.1764 
 
Carlson, S. A., Fulton, J. E., Pratt, M., Yang, Z., & Adams, E. K. (2015). Inadequate 
Physical Activity and Health Care Expenditures in the United States. Progress in 
Cardiovascular Diseases, 57(4), 315–323. 
https://doi.org/10.1016/j.pcad.2014.08.002 
  89 
Centers for Disease Control and Prevention. (2017). National diabetes statistics report, 
2017. Atlanta, GA: Centers for Disease Control and Prevention. 
 
Clarke, T., Ward, B., Norris, T., & Schiller, J. (2017). Early release of selected estimates 
based on data from the National Health Interview Survey, January–September 
2016: Lack of health insurance coverage and type of coverage. Center for Disease 
Control and Prevention. 
 
Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & 
Turner, R. B. (2012). Chronic stress, glucocorticoid receptor resistance, 
inflammation, and disease risk. Proceedings of the National Academy of 
Sciences, 109(16), 5995–5999. https://doi.org/10.1073/pnas.1118355109 
 
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., 
… Braun, B. (2010). Exercise and Type 2 Diabetes: The American College of 
Sports Medicine and the American Diabetes Association: joint position 
statement. Diabetes Care, 33(12), e147–e167. https://doi.org/10.2337/dc10-
9990 
 
Coleman, K. J., Ngor, E., Reynolds, K., Quinn, V. P., Koebnick, C., Young, D. R., … Sallis, 
R. E. (2012). Initial validation of an exercise “vital sign” in electronic medical 
records. Med Sci Sports Exerc, 44(11), 2071–2076. 
 
Corder, K., Winpenny, E., Love, R., Brown, H. E., White, M., & Sluijs, E. van. (2017). 
Change in physical activity from adolescence to early adulthood: A systematic 
review and meta-analysis of longitudinal cohort studies. British Journal of 
Sports Medicine, bjsports-2016-097330. https://doi.org/10.1136/bjsports-2016-
097330 
 
Cowan, R. E. (2016). Exercise Is Medicine Initiative: Physical Activity as a Vital Sign and 
Prescription in Adult Rehabilitation Practice. Archives of Physical Medicine and 
Rehabilitation, 97(9), S232–S237. https://doi.org/10.1016/j.apmr.2016.01.040 
 
Crump, C., Sundquist, K., Sundquist, J., & Winkleby, M. A. (2019). Exercise Is Medicine: 
Primary Care Counseling on Aerobic Fitness and Muscle Strengthening. The 
Journal of the American Board of Family Medicine, 32(1), 103–107. 
https://doi.org/10.3122/jabfm.2019.01.180209 
 
Dalen, J. E., Alpert, J. S., Goldberg, R. J., & Weinstein, R. S. (2014). The Epidemic of the 
20th Century: Coronary Heart Disease. The American Journal of Medicine, 
127(9), 807–812. https://doi.org/10.1016/j.amjmed.2014.04.015 
 
Dietz, W. H. (2017). Obesity and Excessive Weight Gain in Young Adults: New Targets 
for Prevention. JAMA, 318(3), 241. https://doi.org/10.1001/jama.2017.6119 
 
Ebron, K., Andersen, C. J., Aguilar, D., Blesso, C. N., Barona, J., Dugan, C. E., … 
Fernandez, M. L. (2015). A Larger Body Mass Index is Associated with Increased 
Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in 
Individuals with Metabolic Syndrome. Metabolic Syndrome and Related 
Disorders, 13(10), 458–464. https://doi.org/10.1089/met.2015.0053 
  90 
Ford, I., & Norrie, J. (2016). Pragmatic Trials. New England Journal of Medicine, 
375(5), 454–463. https://doi.org/10.1056/NEJMra1510059 
 
Fowles, J. R., O’Brien, M. W., Solmundson, K., Oh, P. I., & Shields, C. A. (2018). Exercise 
is Medicine Canada physical activity counselling and exercise prescription 
training improves counselling, prescription, and referral practices among 
physicians across Canada. Applied Physiology, Nutrition, and Metabolism, 
43(5), 535–539. https://doi.org/10.1139/apnm-2017-0763 
 
Garcia-Perez, M. A., & Nunez-Anton, V. (2003). Cellwise residual analysis in two-way 
contingency tables. Educational and Psychological Measurement, 63(5), 825–
839. 
 
Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999). Evaluating the public health impact of 
health promotion interventions: The RE-AIM framework. American Journal of 
Public Health, 89(9), 1322–1327. 
 
Grant, R. W., Schmittdiel, J. A., Neugebauer, R. S., Uratsu, C. S., & Sternfeld, B. (2014). 
Exercise as a Vital Sign: A Quasi-Experimental Analysis of a Health System 
Intervention to Collect Patient-Reported Exercise Levels. Journal of General 
Internal Medicine, 29(2), 341–348. https://doi.org/10.1007/s11606-013-2693-9 
 
Harris, A. D., McGregor, J. C., Perencevich, E. N., Furuno, J. P., Zhu, J., Peterson, D. E., 
& Finkelstein, J. (2006). The Use and Interpretation of Quasi-Experimental 
Studies in Medical Informatics. Journal of the American Medical Informatics 
Association, 13(1), 16–23. https://doi.org/10.1197/jamia.M1749 
 
Harris, S. S. (1989). Physical Activity Counseling for Healthy Adults as a Primary 
Preventive Intervention in the Clinical Setting: Report for the US Preventive 
Services Task Force. JAMA, 261(24), 3588. 
https://doi.org/10.1001/jama.1989.03420240102035 
 
Haskell, W. L., Lee, I.-M., Pate, R. R., Powell, K. E., Blair, S. N., Franklin, B. A., … 
Bauman, A. (2007). Physical Activity and Public Health: Updated 
Recommendation for Adults from the American College of Sports Medicine and 
the American Heart Association. Medicine & Science in Sports & Exercise, 39(8), 
1423–1434. https://doi.org/10.1249/mss.0b013e3180616b27 
 
Hawkins, N. G., Sanson-Fisher, R. W., Shakeshaft, A., D’Este, C., & Green, L. W. (2007). 
The Multiple Baseline Design for Evaluating Population-Based Research. 
American Journal of Preventive Medicine, 33(2), 162–168. 
https://doi.org/10.1016/j.amepre.2007.03.020 
 
Hayashino, Y., Jackson, J. L., Hirata, T., Fukumori, N., Nakamura, F., Fukuhara, S., … 
Ishii, H. (2014). Effects of exercise on C-reactive protein, inflammatory cytokine 
and adipokine in patients with type 2 diabetes: A meta-analysis of randomized 
controlled trials. Metabolism, 63(3), 431–440. 
https://doi.org/10.1016/j.metabol.2013.08.018 
  91 
Heath, G. W., Kolade, V. O., & Haynes, J. W. (2015). Exercise is MedicineTM: A pilot 
study linking primary care with community physical activity support. Preventive 
Medicine Reports, 2, 492–497. 
 
Hu, F. B., Leitzmann, M. F., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Rimm, E. B. 
(2001). Physical Activity and Television Watching in Relation to Risk for Type 2 
Diabetes Mellitus in Men. Archives of Internal Medicine, 161(12), 1542. 
https://doi.org/10.1001/archinte.161.12.1542 
 
Hu, F. B., Sigal, R. J., Rich-Edwards, J. W., Colditz, G. A., Solomon, C. G., Willett, W. C., 
… Manson, J. E. (1999). Walking Compared With Vigorous Physical Activity and 
Risk of Type 2 Diabetes in Women: A Prospective Study. JAMA, 282(15), 1433. 
https://doi.org/10.1001/jama.282.15.1433 
 
Huijg, J. M., Gebhardt, W. A., Verheijden, M. W., van der Zouwe, N., de Vries, J. D., 
Middelkoop, B. J. C., & Crone, M. R. (2015). Factors Influencing Primary Health 
Care Professionals’ Physical Activity Promotion Behaviors: A Systematic Review. 
International Journal of Behavioral Medicine, 22(1), 32–50. 
https://doi.org/10.1007/s12529-014-9398-2 
 
Jaacks, L. M., Siegel, K. R., Gujral, U. P., & Narayan, K. M. V. (2016). Type 2 diabetes: A 
21st century epidemic. Best Practice & Research Clinical Endocrinology & 
Metabolism, 30(3), 331–343. https://doi.org/10.1016/j.beem.2016.05.003 
 
Katzmarzyk, P. T., Lee, I.-M., Martin, C. K., & Blair, S. N. (2017). Epidemiology of 
Physical Activity and Exercise Training in the United States. Progress in 
Cardiovascular Diseases, 60(1), 3–10. 
https://doi.org/10.1016/j.pcad.2017.01.004 
 
Khan, T., Tsipas, S., & Wozniak, G. (2017). Medical Care Expenditures for Individuals 
with Prediabetes: The Potential Cost Savings in Reducing the Risk of Developing 
Diabetes. Population Health Management, 20(5), 389–396. 
https://doi.org/10.1089/pop.2016.0134 
 
Kim, H.-Y. (2017). Statistical notes for clinical researchers: Chi-squared test and Fisher’s 
exact test. Restorative Dentistry & Endodontics, 42(2), 152. 
https://doi.org/10.5395/rde.2017.42.2.152 
 
Lee, I.-M., Shiroma, E. J., Lobelo, F., Puska, P., Blair, S. N., & Katzmarzyk, P. T. (2012). 
Effect of physical inactivity on major non-communicable diseases worldwide: An 
analysis of burden of disease and life expectancy. The Lancet, 380(9838), 219–
229. https://doi.org/10.1016/S0140-6736(12)61031-9 
 
Li, J., & Siegrist, J. (2012). Physical Activity and Risk of Cardiovascular Disease—A 
Meta-Analysis of Prospective Cohort Studies. International Journal of 
Environmental Research and Public Health, 9(2), 391–407. 
https://doi.org/10.3390/ijerph9020391 
 
  92 
Liu, Y.-Z., Wang, Y.-X., & Jiang, C.-L. (2017). Inflammation: The Common Pathway of 
Stress-Related Diseases. Frontiers in Human Neuroscience, 11. 
https://doi.org/10.3389/fnhum.2017.00316 
 
Lopez Bernal, J., Soumerai, S., & Gasparrini, A. (2018). A methodological framework for 
model selection in interrupted time series studies. Journal of Clinical 
Epidemiology, 103, 82–91. https://doi.org/10.1016/j.jclinepi.2018.05.026 
 
Lopez-Candales, A., Hernández Burgos, P. M., Hernandez-Suarez, D. F., & Harris, D. 
(2017). Linking Chronic Inflammation with Cardiovascular Disease: From 
Normal Aging to the Metabolic Syndrome. Journal of Nature and Science, 3(4). 
 
Manson, J. E., Hu, F. B., Rich-Edwards, J. W., Colditz, G. A., Stampfer, M. J., Willett, W. 
C., … Hennekens, C. H. (1999). A Prospective Study of Walking as Compared with 
Vigorous Exercise in the Prevention of Coronary Heart Disease in Women. New 
England Journal of Medicine, 341(9), 650–658. 
https://doi.org/10.1056/NEJM199908263410904 
 
Mark, A., Miners, A., Bauman, W. F., & Wallner, F. (1999). Illawarra physical activity 
project. Wollongong: University of Wollongong. 
 
Meigs, J. B. (2010). Epidemiology of type 2 diabetes and cardiovascular disease: 
Translation from population to prevention: The Kelly West award lecture 2009. 
Diabetes Care, 33(8), 1865–1871. 
 
Meriwether, R. A., Lee, J. A., Lafleur, A. S., & Wiseman, P. (2008). Physical activity 
counseling. American Family Physician, 77(8). 
 
Möhler, R., Bartoszek, G., Köpke, S., & Meyer, G. (2012). Proposed criteria for reporting 
the development and evaluation of complex interventions in healthcare 
(CReDECI): Guideline development. International Journal of Nursing Studies, 
49(1), 40–46. https://doi.org/10.1016/j.ijnurstu.2011.08.003 
 
Moore, G., Audrey, S., Barker, M., Bond, L., Bonell, C., Cooper, C., … Baird, J. (2014). 
Process evaluation in complex public health intervention studies: The need for 
guidance. Journal of Epidemiology and Community Health, 68(2), 101–102. 
https://doi.org/10.1136/jech-2013-202869 
 
Moore, G. F., Audrey, S., Barker, M., Bond, L., Bonell, C., Hardeman, W., … Baird, J. 
(2015). Process evaluation of complex interventions: Medical Research Council 
guidance. BMJ, 350(mar19 6), h1258–h1258. https://doi.org/10.1136/bmj.h1258 
 
Morgan, F., Battersby, A., Weightman, A. L., Searchfield, L., Turley, R., Morgan, H., … 
Ellis, S. (2016). Adherence to exercise referral schemes by participants – what do 
providers and commissioners need to know? A systematic review of barriers and 
facilitators. BMC Public Health, 16(1), 227. https://doi.org/10.1186/s12889-016-
2882-7 
 
Morris, J. N., Heady, J., Raffle, P., Roberts, C., & Parks, J. (1953). Coronary heart-
disease and physical activity of work. The Lancet, 262(6796), 1111–1120. 
  93 
Morris, J., & Raffle, P. (1954). Coronary heart disease in transport workers. A progress 
report. British Journal of Industrial Medicine, 11(4), 260. 
 
Murthy, V. L., Abbasi, S. A., Siddique, J., Colangelo, L. A., Reis, J., Venkatesh, B. A., … 
Shah, R. V. (2016). Transitions in Metabolic Risk and Long‐Term Cardiovascular 
Health: Coronary Artery Risk Development in Young Adults (CARDIA) Study. 
Journal of the American Heart Association, 5(10). 
https://doi.org/10.1161/JAHA.116.003934 
 
National Center for Education Statistics. (2018). Fast Facts: Back to School Statistics. 
Retrieved from Institute of Education Sciences website: 
https://nces.ed.gov/fastfacts/display.asp?id=372 
 
Orrow, G., Kinmonth, A.-L., Sanderson, S., & Sutton, S. (2012). Effectiveness of physical 
activity promotion based in primary care: Systematic review and meta-analysis of 
randomised controlled trials. Bmj, 344, e1389. 
 
Paffenbarger Jr, R. S., & Hale, W. E. (1975). Work activity and coronary heart mortality. 
New England Journal of Medicine, 292(11), 545–550. 
 
Paffenbarger Jr, R. S., Laughlin, M. E., Gima, A. S., & Black, R. A. (1970). Work activity 
of longshoremen as related to death from coronary heart disease and stroke. New 
England Journal of Medicine, 282(20), 1109–1114. 
 
Paffenbarger Jr, R. S., Wing, A. L., & Hyde, R. T. (1978). Physical activity as an index of 
heart attack risk in college alumni. American Journal of Epidemiology, 108(3), 
161–175. 
 
Pavey, T. G., Taylor, A. H., Fox, K. R., Hillsdon, M., Anokye, N., Campbell, J. L., … 
Taylor, R. S. (2011). Effect of exercise referral schemes in primary care on 
physical activity and improving health outcomes: Systematic review and meta-
analysis. BMJ, 343(nov04 2), d6462–d6462. https://doi.org/10.1136/bmj.d6462 
 
Pearce, P. Z. (2008). Exercise is MedicineTM: Current Sports Medicine Reports, 7(3), 
171–175. https://doi.org/10.1097/01.CSMR.0000319712.63793.5f 
 
Pedersen, B. K. (2017). Anti-inflammatory effects of exercise: Role in diabetes and 
cardiovascular disease. European Journal of Clinical Investigation, 47(8), 600–
611. https://doi.org/10.1111/eci.12781 
 
Peng, C.-Y. J., Lee, K. L., & Ingersoll, G. M. (2002). An Introduction to Logistic 
Regression Analysis and Reporting. The Journal of Educational Research, 96(1), 
3–14. https://doi.org/10.1080/00220670209598786 
 
Physical Activity Guidelines Advisory Committee. (2018). Physical activity guidelines 
advisory committee scientific report. Washington, DC: US Department of Health 
and Human Services. 
 
 
  94 
Quinn, L., Straitbodey, L., Anderson, B., Argiles, J., & Havel, P. (2005). Interleukin-15 
stimulates adiponectin secretion by 3T3-L1 adipocytes: Evidence for a skeletal 
muscle-to-fat signaling pathway. Cell Biology International, 29(6), 449–457. 
https://doi.org/10.1016/j.cellbi.2005.02.005 
 
Reddigan, J. I., Ardern, C. I., Riddell, M. C., & Kuk, J. L. (2011). Relation of Physical 
Activity to Cardiovascular Disease Mortality and the Influence of 
Cardiometabolic Risk Factors. The American Journal of Cardiology, 108(10), 
1426–1431. https://doi.org/10.1016/j.amjcard.2011.07.005 
 
Reis, J. P., Loria, C. M., Lewis, C. E., Powell-Wiley, T. M., Wei, G. S., Carr, J. J., … Liu, K. 
(2013). Association Between Duration of Overall and Abdominal Obesity 
Beginning in Young Adulthood and Coronary Artery Calcification in Middle Age. 
JAMA, 310(3), 280. https://doi.org/10.1001/jama.2013.7833 
 
Rowley, W. R., Bezold, C., Arikan, Y., Byrne, E., & Krohe, S. (2017). Diabetes 2030: 
Insights from Yesterday, Today, and Future Trends. Population Health 
Management, 20(1), 6–12. https://doi.org/10.1089/pop.2015.0181 
 
Sallis, R. (2015). Exercise is medicine: A call to action for physicians to assess and 
prescribe exercise. The Physician and Sportsmedicine, 43(1), 22–26. 
https://doi.org/10.1080/00913847.2015.1001938 
 
Sallis, R., Franklin, B., Joy, L., Ross, R., Sabgir, D., & Stone, J. (2015). Strategies for 
Promoting Physical Activity in Clinical Practice. Progress in Cardiovascular 
Diseases, 57(4), 375–386. https://doi.org/10.1016/j.pcad.2014.10.003 
 
Samdal, G. B., Meland, E., Eide, G. E., Berntsen, S., Abildsnes, E., Stea, T. H., & 
Mildestvedt, T. (2019). The Norwegian Healthy Life Centre Study: A pragmatic 
RCT of physical activity in primary care. Scandinavian Journal of Public Health, 
47(1), 18–27. https://doi.org/10.1177/1403494818785260 
 
Saunders, R. P., Evans, M. H., & Joshi, P. (2005). Developing a Process-Evaluation Plan 
for Assessing Health Promotion Program Implementation: A How-To Guide. 
Health Promotion Practice, 6(2), 134–147. 
https://doi.org/10.1177/1524839904273387 
 
Schiller, J. S., Clarke, T. C., & Norris, T. (2018). Early Release of Selected Estimates  
Based on Data From the January–September 2017 National Health Interview 
Survey (pp. 1–123) [Early Release Program]. Retrieved from Center for Disease 
Control and Prevention website: 
https://www.cdc.gov/nchs/nhis/releases/released201803.htm 
 
Shadish, W. R., Cook, T. D., & Campbell, D. T. (2001). Experimental and quasi-
experimental designs for generalized causal inference. Boston: Houghton 
Mifflin. 
 
Shirley, D., van der Ploeg, H. P., & Bauman, A. E. (2010). Physical Activity Promotion in 
the Physical Therapy Setting: Perspectives From Practitioners and Students. 
Physical Therapy, 90(9), 1311–1322. https://doi.org/10.2522/ptj.20090383 
  95 
Shuval, K., Leonard, T., Drope, J., Katz, D. L., Patel, A. V., Maitin‐Shepard, M., … 
Grinstein, A. (2017). Physical activity counseling in primary care: Insights from 
public health and behavioral economics. CA: A Cancer Journal for Clinicians, 
67(3), 233–244. 
 
Slavich, G. M. (2015). Understanding inflammation, its regulation, and relevance for 
health: A top scientific and public priority. Brain, Behavior, and Immunity, 45, 
13–14. https://doi.org/10.1016/j.bbi.2014.10.012 
 
Stubbs, T., Vita, P., van der Ploeg, H., Bauman, A., Holford, R., & Smith, B. (2007). 
Physical activity promotion: Are GPs getting the message? Australian Family 
Physician, 36(10), 871. 
 
Szumilas, M. (2010). Explaining odds ratios. Journal of the Canadian Academy of Child 
and Adolescent Psychiatry = Journal De l’Academie Canadienne De Psychiatrie 
De L’enfant Et De L’adolescent, 19(3), 227–229. 
 
The DECODE Study Group, & on behalf of the European Diabetes Epidemiology Group. 
(2004). Prediction of the risk of cardiovascular mortality using a score that 
includes glucose as a risk factor. The DECODE Study. Diabetologia, 47(12), 
2118–2128. https://doi.org/10.1007/s00125-004-1574-5 
 
The Emerging Risk Factors Collaboration. (2010). Diabetes mellitus, fasting blood 
glucose concentration, and risk of vascular disease: A collaborative meta-analysis 
of 102 prospective studies. The Lancet, 375(9733), 2215–2222. 
https://doi.org/10.1016/S0140-6736(10)60484-9 
 
Tipton, C. M. (2014). The history of “Exercise Is Medicine” in ancient civilizations. 
Advances in Physiology Education, 38(2), 109–117. 
https://doi.org/10.1152/advan.00136.2013 
 
Tulloch, H., Fortier, M., & Hogg, W. (2006). Physical activity counseling in primary care: 
Who has and who should be counseling? Patient Education and Counseling, 
64(1–3), 6–20. https://doi.org/10.1016/j.pec.2005.10.010 
 
US Department of Health and Human Services. (1996). Physical activity and health: A 
report of the Surgeon General. DIANE Publishing. 
 
US Department of Health and Human Services. (2008). 2008 physical activity 
guidelines for Americans. Http://Www. Health. Gov/Paguidelines/. 
 
U.S. National Physical Activity Plan. (2016). National Physical Activity Plan Alliance. 
Retrieved from 
http://physicalactivityplan.org/docs/2016NPAP_Finalforwebsite.pdf 
 
 
 
 
 
  96 
US Preventive Services Task Force, Grossman, D. C., Bibbins-Domingo, K., Curry, S. J., 
Barry, M. J., Davidson, K. W., … Tseng, C.-W. (2017). Behavioral Counseling to 
Promote a Healthful Diet and Physical Activity for Cardiovascular Disease 
Prevention in Adults Without Cardiovascular Risk Factors: US Preventive 
Services Task Force Recommendation Statement. JAMA, 318(2), 167. 
https://doi.org/10.1001/jama.2017.7171 
 
VanWormer, J. J., Pronk, N. P., & Kroeninger, G. J. (2009). Clinical Counseling for 
Physical Activity: Translation of a Systematic Review Into Care 
Recommendations. Diabetes Spectrum, 22(1), 48–55. 
https://doi.org/10.2337/diaspect.22.1.48 
 
Varma, V. R., Dey, D., Leroux, A., Di, J., Urbanek, J., Xiao, L., & Zipunnikov, V. (2017). 
Re-evaluating the effect of age on physical activity over the lifespan. Preventive 
Medicine, 101, 102–108. https://doi.org/10.1016/j.ypmed.2017.05.030 
 
Vuori, I. M., Lavie, C. J., & Blair, S. N. (2013). Physical activity promotion in the health 
care system. 88, 1446–1461. Elsevier. 
 
Warren, M., Beck, S. E., & Rayburn, J. (2018). The State of Obesity: Better Polocies for a 
Healthier America 2017 (pp. 1–68). Retrieved from Robert Wood Johnson 
Foundation website: tfah.org/stateofobesity2018 
 
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016). Targeting inflammation in metabolic 
syndrome. Translational Research, 167(1), 257–280. 
https://doi.org/10.1016/j.trsl.2015.06.017 
 
Zhang, F., Wagner, A. K., Soumerai, S. B., & Ross-Degnan, D. (2009). Methods for 
estimating confidence intervals in interrupted time series analyses of health 
interventions. Journal of Clinical Epidemiology, 62(2), 143–148. 
https://doi.org/10.1016/j.jclinepi.2008.08.007 
 
  97 
APPENDIX A 
TABLES  
  98 
 
 
  
Table 1: Study timeline 
 
   
 Pre-Implementation Implementation 
Objective WK 1 WK 2 WK 3 WK 4 WK 5 WK 6 WK 7 WK 8 WK 9 WK 10 
WK 
11 
WK 
12 
WK 
13 
Patient Intercept 
Survey 
X X X X X X X X X X X X X 
Non-provider Staff 
Training 
   X       
   
Provider Training  
Session   
(EMR++) 
    X     X 
   
EMR Systems 
Update 
     X     
   
Specific Aim 1 X X X X X X X X X X X X X 
Specific Aim 2 X X X X X X X X X X X X X 
Specific Aim 3 X X X X X X X X X X X X X 
Specific Aim 4 X X X X X X X X X X X X X 
Specific Aim 5   X X X         
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Table 2: Components of the RE-AIM framework used to guide the process evaluation of implementing the 
EIM Solution. 
 
Dimension Definition Study Outcome Level 
Reach  
 
Specific Aim 1 
The total 
proportion of 
the target 
population 
receiving each 
of the EIM 
processes. 
Proportion of patients screened for physical inactivity relative to 
total patient encounters.  
Patient  
Proportion of patients receiving brief counseling relative to patients 
not meeting aerobic PA guidelines. 
Proportion of patients receiving exercise prescription (ExRx) 
relative to patients not meeting aerobic PA guidelines. 
Proportion of patients receiving self-directed PA resources relative 
to patients not meeting PA guidelines. 
Proportion of patients receiving a PA referral to an internal fitness 
partner relative to patients not meeting PA guidelines. 
Effectiveness  
 
 
Specific Aim 3 
The effect of 
implementing 
the EIM 
Solution 
determined by 
the change in 
proportions of 
patients 
receiving the 
EIM processes, 
during pre-
implementation 
compared to 
implementation. 
Change in proportion of patients screened for physical inactivity 
during pre-implementation compared to implementation. 
Provider 
Change in proportion inactive or insufficiently active patients who 
receive brief counseling during pre-implementation compared to 
implementation. 
Change in proportion of inactive or insufficiently active patients who 
receive an ExRx during pre-implementation compared to 
implementation. 
Change in proportion of inactive or insufficiently active patients who 
receive self-directed PA resources during pre-implementation 
compared to implementation. 
Change in proportion of inactive or insufficiently active patients who 
receive PA referrals during pre-implementation compared to 
implementation. 
Adoption 
 
Specific Aim 2 
Proportions of 
the targeted 
population 
receiving each 
EIM process 
during 
implementation, 
by provider 
group. 
Proportion of patients who are screened for physical inactivity, by 
provider group.  
Provider 
Proportion of inactive or insufficiently active patients who receive 
brief counseling, by provider group. 
Proportion of inactive or insufficiently active patients who receive 
ExRx, by provider group. 
Proportion of inactive or insufficiently active patients who receive 
PA resources, by provider group. 
Proportion inactive or insufficiently active patients who receive self-
directed PA referrals, by provider group. 
Implementation 
 
Specific Aim 4 
The consistency 
of delivering the 
EIM Solution 
during the 
implementation 
phase, 
determined by 
changes in the 
proportions of 
the patients 
receiving each 
EIM process, for 
each provider 
group. 
Change in the proportion of patients screened for physical inactivity, 
by provider group. 
Provider 
Change in the proportion of inactive or insufficiently active patients 
who receive brief counseling, by provider group.   
Change in the proportion of inactive or insufficiently active patients 
who receive ExRx to inactive patients, by provider group. 
Change in the proportion of inactive or insufficiently active patients 
who receive self-directed PA resources, by provider group.  
Change in the proportion of inactive or insufficiently active patients 
who receive PA referrals, by provider groups. 
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Table 3. Demographic characteristics and self-reported physical activity for patients who completed the intercept 
survey.  
  
Phase 1 Phase 2 Phase 3 Total 
  (n=78) (n = 111) (n = 76) (n = 265) 
Variable n % n % n % n % 
Sexa   
          
 Male 27 34.6% 56 50.5% 26 34.2% 109 41.1% 
 Female 51 65.4% 55 49.5% 49 64.5% 155 58.7% 
Academic Status b   
          
 Freshman 23 29.5% 7 6.3% 1 1.3% 31 11.7% 
 Sophomore 11 14.1% 10 9.0% 4 5.3% 25 9.4% 
 Junior 9 11.5% 11 9.9% 10 13.2% 30 11.3% 
 Senior 12 15.4% 14 12.6% 18 23.7% 44 16.6% 
 Graduate 23 29.5% 68 61.3% 42 55.3% 133 50.2% 
Physical Activity   
          
 Inactive/Insufficiently Active (0-149 min/wk) 36 46.2% 45 40.5% 31 40.8% 112 42.3% 
 Moderately Active (150-299 min/wk) 27 34.6% 37 33.3% 29 38.2% 93 35.1% 
 Highly Active (300-599 min/wk) 12 15.4% 23 20.7% 9 11.8% 44 16.6% 
 Very Highly Active (≥600 min/wk) 3 3.8% 6 5.4% 7 9.2% 16 6.0% 
Meets PA Guidelines 42 53.8% 66 59.5% 45 59.2% 153 57.7% 
a. One respondent did not report biological sex 
     
  
b. Two respondents did not report academic status 
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Table 4. Characteristics of providers for each intervention group. a 
Variable EMR++ - Group 1 EMR + - Group 2 EMR - Group 3 
Sex       
  Male n = 3 n = 1 n = 3 
  Female n = 8 n = 4 n = 3 
Occupation       
  Physician n = 3 n = 1 n = 3 
  Nurse Practitioner n = 8 n = 4 n = 3 
Specialty       
  Primary Care n = 1 n = 2 n = 0 
  Women's Care n = 0 n = 3 n = 0 
  Acute Care n = 0 n = 0 n = 6 
a. The EMR++ providers were exposed to an EMR systems change, received EIM-related 
resources, and attended a 30-minute EIM training session. The EMR+ did not receive 
training and the EMR providers were exposed to the EMR systems change only. 
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Table 5. Numbers and proportions of patients who reported receiving EIM outcomes in the intercept survey. 
Intervention 
Group a Phase b 
# of Survey 
Responses 
Asked 
about PA 
Received 
PA Advice 
Received 
ExRx 
Received 
PA 
Resources 
Received 
PA 
Referral 
n % n % n % n % n % 
EMR++ - Group 1 1 n = 46 12 26.1% 5 10.9% 1 2.2% 0 0.0% 1 2.2% 
(n=11) 2 n = 67 23 67.2% 21 31.3% 4 6.0% 2 3.0% 4 6.0% 
 3 n = 34 33 97.1% 11 32.4% 3 8.8% 2 5.9% 4 11.8% 
 Total n = 147 68 46.0% 37 25.2% 8 5.4% 4 2.7% 9 6.1% 
                  
EMR+ - Group 2 1 n = 16 5 31.3% 2 12.5% 0 0.0% 0 0.0% 0 0.0% 
(n=5) 2 n = 25 23 92.0% 16 64.0% 3 12.0% 1 4.0% 2 8.0% 
 3 n = 21 20 95.2% 6 28.6% 0 0.0% 1 4.8% 0 0.0% 
 Total n = 62 48 77.4% 24 38.7% 3 4.8% 2 3.2% 2 3.2% 
                  
EMR - Group 3 1 n = 16 2 12.5% 1 6.3% 1 6.3% 0 0.0% 0 0.0% 
(n=5) 2 n = 19 15 78.9% 1 5.3% 0 0.0% 0 0.0% 0 0.0% 
 3 n = 21 17 81.0% 1 4.8% 0 0.0% 1 4.8% 0 0.0% 
 Total n = 56 34 60.7% 3 5.4% 1 1.8% 1 1.8% 0 0.0% 
a. The EMR++ providers were exposed to an EMR systems change, received EIM-related resources, and attended a 30-
minute EIM training session. The EMR providers +did not receive training and the EMR providers were exposed to the 
EMR systems change only. 
b. Phases are defined as the following: phase 1 = pre-implementation; phase 2 = provider training 1 (day 20); phase 3 = 
provider training 2 (day 46).  
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Table 6. Demographic categories for patient encounters documented in the electronic medical record 
for each provider group. a 
  EMR++ - Group 1 EMR+ - Group 2 EMR - Group 3 Total 
    (n = 1294) (n=700) (n = 980) (N = 2974) 
Variable n % b n % n % n % 
Sex         
 Male 578 44.7% 307 43.9% 530 54.1% 1415 47.6% 
 Female 716 55.3% 393 56.1% 450 45.9% 1559 52.4% 
Age Category         
 18 - 24 yrs 751 58.0% 460 65.7% 724 73.9% 1935 65.1% 
 25 - 39 yrs 490 37.9% 218 31.1% 230 23.5% 938 31.5% 
 ≥ 40 yrs 53 4.1% 22 3.1% 26 2.7% 101 3.4% 
Race/Ethnicity         
 Asian 177 13.7% 108 15.4% 198 20.2% 483 16.2% 
 Black/African 
American 
61 4.7% 29 4.1% 50 5.1% 140 4.7% 
 Hispanic/ Latino 187 14.5% 102 14.6% 112 11.4% 401 13.5% 
 White 661 51.1% 360 51.4% 434 44.3% 1455 48.9% 
 Other c 55 4.3% 29 4.1% 41 4.2% 125 4.2% 
 Not Reported 153 11.8% 72 10.3% 145 14.8% 370 12.4% 
BMI Category d, e         
 
Underweight 66 5.10% 40 5.7% 58 5.9% 164 5.5% 
 
Normal Weight  703 54.3% 365 52.1% 554 56.5% 1622 54.5% 
 
Overweight  306 23.6% 176 25.1% 233 23.8% 715 24.0% 
  Obesity  180 13.9% 96 13.7% 95 9.7% 371 12.5% 
a. EIM++ providers were exposed to an EMR systems change, received EIM-related resources, and 
attended a 30-minute EIM training session; EMR+ providers did not receive training and EMR 
providers were exposed to the systems change only. 
b. Subcategory proportions were calculated as the number of patients within the category relative to 
the total number of patient encounters for each provider group.  
c. "Other" includes American Indian/Alaskan Native, Native Hawaiian/Pacific Islander, and 
Multiracial. 
d. BMI categories were defined as underweight = >18.5 kg/m2, normal weight = 18.5-24.9 kg/m2, 
overweight = 25.0-24.9 kg/m2, and obese = ≥ 30.0 kg/m2. 
e. BMI data is missing for 3.4% of the total sample. 
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Variable n % 
b
n % n % n %
Physical Activity Level
c
Inactive 174 9.9% 127 18.1% 152 15.5% 453 15.2%
    Male 81 14.0% 68 22.1% 66 12.5% 215 15.2%
    Female 93 13.0% 59 15.0% 86 19.1% 238 15.3%
Insufficiently Active 315 27.9% 145 20.7% 268 27.3% 728 24.5%
    Male 121 20.9% 48 15.6% 133 25.1% 302 21.3%
    Female 224 31.3% 97 24.7% 135 30.0% 456 29.2%
Moderately Active 343 30.4% 250 35.7% 268 27.3% 861 29.0%
    Male 169 29.2% 97 31.6% 156 29.4% 422 29.8%
    Female 218 30.4% 153 38.9% 112 24.9% 483 31.0%
Highly Active 268 23.7% 139 19.9% 195 19.9% 602 20.2%
    Male 165 28.5% 74 24.1% 123 12.6% 362 25.6%
    Female 139 19.4% 65 16.5% 72 16.0% 276 17.7%
Very Highly Active 53 4.7% 29 4.1% 46 4.7% 128 4.3%
    Male 32 5.5% 16 5.2% 28 2.9% 76 5.4%
    Female 28 3.9% 13 3.3% 18 4.0% 59 3.8%
Not Reported (missing data) 24 1.9% 11 1.3% 51 5.2% 86 2.9%
    Male 10 1.7% 4 1.3% 24 2.4% 38 2.7%
    Female 14 2.0% 6 1.5% 27 6.0% 47 3.0%
Meets Physical Activity Guidelines
751 58.0% 417 59.6% 510 52.0% 1678 56.4%
     Male 366 63.3% 186 60.6% 307 57.9% 859 60.7%
     Female 366 54.4% 231 58.8% 203 45.1% 800 51.3%
a. EIM++ providers were exposed to an EMR systems change, received EIM-related resources, and attended a 30-minute EIM 
training session; EMR+ providers did not receive training and EMR providers were exposed to the systems change only.
b. Overall proportions for each PA category were determined bythe number of observations relative to total encounters within 
each provider group. Proportions for each sex were determined by the number of observations realtive to the number of patients 
within each sex category for each provider group. 
c. PA categories are defined as inactive = 0 min/wk, insufficiently active = 0-149 min/wk, moderately active = 150-299 min/wk, 
highly active = 300-599 min/wk, and very highly active = ≥ 600 min/wk. 
Table 7. Numbers and proportions of patient-reported physical activity levels, by patient sex, documented in the electronic 
medical record for each provider group. 
a
Total
(N = 2974)
≥ 150 min/week Moderate PA
EMR++ - Group 1 EMR+ - Group 2 EMR - Group 3
(n = 1294) (n=700) (n = 980)
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Table 8. Chi-square contingency table showing results for cellwise post-hoc analysis for patient demographic categories 
by provider group. 
 EMR ++  EMR+ EMR 
Patient 
Characteristic 
Adjusted 
Residual χ2 
p-
value 
Adjusted 
Residual χ2 
p-
value 
Adjusted 
Residual χ2 
p-
value 
Sex a          
Male -2.79 37.21 .02 -2.25 1.87 .08 4.98 24.78 <. 001 
Female 2.79 37.21 .02 2.25 1.87 .08 -4.98 24.78 <. 001 
Age b          
18-24 years -7.05 49.98 <. 001 0.41 0.06 1.00 7.07 49.96 <. 001 
25-39 years 6.52 36.78 <. 001 -0.26 0.15 1.00 -6.64 44.09 <. 001 
≥ 40 years 1.85 9.3 0.49 -0.42 2.68 1.00 -1.57 2.46 0.65 
Physical Activity c          
Inactive -2.59 23.01 0.57 2.26 19.38 0.75 0.69 0.48 1.00 
Insufficiently Active 1.00 4.56 1.00 -3.57 20.48 0.12 2.20 4.82 0.77 
Moderately Active -0.88 0.10 1.00 3.18 5.55 0.26 -1.98 3.91 0.86 
Highly Active 2.13 4.71 0.81 -1.41 1.73 0.98 -0.98 0.95 1.00 
Very Highly Active 0.12 5.29 1.00 -0.67 0.56 1.00 0.49 0.24 1.00 
a. Bonferroni correction applied; significant if p < 0.025 
b. Bonferroni correction applied; significant if p < 0.0125 
c. Bonferroni correction applied; significant if p < 0.006 
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Table 9. Total proportions of provider engagement documented in the electronic medical record for patient demographic and physical activity 
categories. 
Variable 
Total 
Patient 
Encounters  
 
Provider Engagement - Charting Options Selected e 
PAVS 
Reviewed d 
Activity Level 
Identified 
PA Advice / 
Counseling ExRx 
PA 
Resources PA Referral 
n % n % n % n % n % n % 
Sex                           
 Male n = 1415 298 21.1% 208 69.8% 49 16.4% 0 0.0% 2 0.7% 0 0.0% 
 Female n = 1559 371 23.8% 250 67.4% 69 18.6% 0 0.0% 2 0.5% 1 0.3% 
Age                      
 18 - 24 yrs n = 1935 355 18.3% 248 69.9% 53 14.9% 0 0.0% 3 0.8% 0 0.0% 
 25 - 39 yrs  n = 938 279 29.7% 185 66.3% 59 21.1% 0 0.0% 1 0.4% 1 0.4% 
 ≥ 40 yrs n = 101 35 34.7% 25 71.4% 6 17.1% 0 0.0% 0 0.0% 0 0.0% 
Race/Ethnicity                      
 Asian n = 483 97 20.1% 64 66.0% 18 18.6% 0 0.0% 0 0.0% 0 0.0% 
 Black/African American n = 140 24 17.1% 15 62.5% 6 25.0% 0 0.0% 0 0.0% 0 0.0% 
 Hispanic/ Latino n = 401 85 21.2% 55 64.7% 16 17.6% 0 0.0% 1 1.2% 0 0.0% 
 White n = 1455 341 23.4% 244 71.6% 57 16.7% 0 0.0% 2 0.6% 1 0.3% 
 Other a n = 125 32 25.6% 21 65.6% 5 15.6% 0 0.0% 0 0.0% 0 0.0% 
 Not Reported n = 370 90 24.3% 59 65.6% 16 17.8% 0 0.0% 1 1.1% 0 0.0% 
BMI b                      
 Underweight  n = 164 38 23.2% 23 60.5% 8 21.1% 0 0.0% 0 0.0% 0 0.0% 
 Normal Weight  n = 1622 355 21.9% 258 72.7% 54 15.2% 0 0.0% 2 0.6% 0 0.0% 
 Overweight n = 715 168 23.5% 111 66.1% 28 16.7% 0 0.0% 2 1.2% 0 0.0% 
 Obesity n = 371 95 25.6% 58 61.1% 24 25.3% 0 0.0% 0 0.0% 1 1.1% 
 Not Reported (missing) n = 102 13 12.7% 8 61.5% 4 23.1% 0 0.0% 0 0.0% 0 0.0% 
Physical Activity c                      
 Inactive n = 453 65 14.3% 14 21.5% 24 36.9% 0 0.0% 2 3.1% 0 0.0% 
 Insufficiently Active n = 758 181 23.9% 57 31.5% 78 43.1% 0 0.0% 2 1.10% 1 1.10% 
 Moderately Active n = 905 227 25.1% 211 97.4% 10 4.4% 0 0.0% 0 0.0% 0 0.0% 
 Highly Active n = 638 161 25.2% 147 91.3% 5 3.1% 0 0.0% 0 0.0% 0 0.0% 
 Very Highly Active n = 135 30 22.2% 27 90.0% 1 3.3% 0 0.0% 0 0.0% 0 0.0% 
      
                 
Total n = 2974 669 22.5% 458 68.5% 118 17.6% 0 0.0% 4 0.6% 1 0.1% 
a. "Other" includes American Indian/Alaskan Native, Native Hawaiian/Pacific Islander, and Multiracial. 
b. BMI categories were determined as the following: underweight = >18.5 kg/m2; normal weight = 18.5-24.9 kg/m2; overweight = 25.0-24.9 
kg/m2; obese = ≥ 30.0 kg/m2. 
c. PA categories were determined as the following: insufficiently active = 0-149 min/wk; moderately active = 150-299 min/wk; highly active = 
300-599 min/wk; very highly active = ≥ 600 min/wk 
d. Proportions for PAVS reviewed were calculated using the number of patient encounters with PAVS reviewed relative to the total number of 
encounters within each subcategory.  
e. Proportions for provider engagement categories were calculated using the number of patient encounters with reported outcome relative to 
the number of patient encounters with PAVS reviewed. 
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Table 10. Total proportion a of documented provider engagement for EIM outcomes by intervention group. 
    
PAVS 
Reviewed 
Provider Engagement - Charting Options Selected 
  
Patient 
Encounters 
Activity Level 
Identified 
PA Advice / 
Counseling 
PA 
Resources 
PA 
Referral 
Any 
Documented 
Engagement  
Group b  n % n % n % n % n % n % 
EMR++ n = 1294 608 47.0% 416 32.1% 114 8.8% 4 0.3% 1 0.1% 535 41.3% 
                            
EMR+ n = 700 55 7.9% 38 5.4% 4 0.6% 0 0.0% 0 0.0% 42 6.0% 
                            
EMR n = 980 6 0.6% 4 0.4% 0 0.0% 0 0.0% 0 0.0% 4 0.4% 
a. Proportions were calculated using the number of patient encounters with reported outcomes relative to the total 
number of encounters by provider group. 
b. The EMR++ providers were exposed to an EMR systems change, received EIM-related resources, and attended a 30-
minute EIM training session. The EMR providers did not receive training and the EMR provider were exposed to the 
systems change only.  
c. Providers who selected at least one charting option. 
  108 
  
Table 11. Chi-square contingency table showing results for cellwise post-hoc analysis for provider engagement 
documented in the electronic medical system, by provider group. 
 EMR ++  EMR+ EMR 
Level of 
Engagement a 
Adjusted 
Residual χ2 
p-
value 
Adjusted 
Residual χ2 
p-
value 
Adjusted 
Residual χ2 
p-
value 
PA Asked 
PA Reviewed 
PA Identified 
PA Advice 
2.88 
27.92 
22.21 
11.87 
8.29 
779.53 
493.28 
140.90 
.016 
<.001 
<.001 
<.001 
2.60 
10.64 
8.36 
-5.26 
6.76 
113.21 
69.89 
27.67 
.03 
<.001 
<.001 
<.001 
-5.38 
-19.91 
-15.88 
-7.71 
28.94 
396.41 
252.17 
59.44 
< .001 
<.001 
<.001 
<.001 
a. Bonferroni correction applied; significant if p < 0.025 
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Variable n % n % n % N %
Lev el of Moderate PA Reported
Inactiv e (0 m in/wk) 1 7 4 1 3.4% 1 27 1 8.1 % 1 52 1 5.5% 453 1 5.2%
PA Docum entation
None 1 35 1 0.4% 1 27 1 8.1 % 1 51 1 5.4% 41 3 91 .2%
Activ ity  Lev el Identified 1 3 1 .0% 0 0.0% 1 0.1 % 1 4 0.5%
PA Adv ice/Counseling 24 1 .9% 0 0.0% 0 0.0% 24 0.8%
ExRx 0 0.0% 0 0.0% 0 0.0% 0 0.0%
PA Resources 2 0.2% 0 0.0% 0 0.0% 2 0.1 %
PA Referral 0 0.0% 0 0.0% 0 0.0% 0 0.0%
Insufficiently  Activ e (1 -1 49 m in/wk) 345 26.7 % 1 45 20.7 % 268 27 .3% 7 58 25.5%
PA Docum entation
None 21 5 1 6.6% 1 37 1 9.6% 268 27 .3% 620 20.8%
Activ ity  Lev el Identified 50 3.9% 7 1 .0% 0 0.0% 57 1 .9%
PA Adv ice/Counseling 7 7 6.0% 1 0.1 % 0 0.0% 7 8 2.6%
ExRx 0 0.0% 0 0.0% 0 0.0% 0 0.0%
PA Resources 2 0.2% 1 0.1 % 0 0.0% 2 0.1 %
PA Referral 1 0.1 % 0 0.0% 0 0.0% 1 0.0%
Moderately  Activ e (1 50-299 m in/wk) 387 29.9% 249 35.6% 268 27 .3 905 30.4%
PA Docum entation
None 1 88 1 4.5% 229 32.7 % 268 27 .3% 685 23.0%
Activ ity  Lev el Identified 1 92 1 4.8% 1 7 2.4% 2 0.2% 21 1 7 .1 %
PA Adv ice/Counseling 7 0.5% 3 0.4% 0 0.0% 1 0 0.3%
ExRx 0 0.0% 0 0.0% 0 0.0% 0 0.0%
PA Resources 0 0.0% 0 0.0% 0 0.0% 0 0.0%
PA Referral 0 0.0% 0 0.0% 0 0.0% 0 0.0%
Highly  Activ e (300-599 m in/wk) 304 23.5% 1 38 1 9.7 % 1 95 1 9.9% 638 21 .5%
PA Docum entation
None 1 64 1 2.7 % 1 27 1 8.1 % 1 94 1 9.8% 485 1 6.2%
Activ ity  Lev el Identified 1 35 1 0.4% 1 1 1 .6% 1 0.1 % 1 47 4.9%
PA Adv ice/Counseling 5 0.4% 0 0.0% 0 0.0% 5 0.8%
ExRx 0 0.0% 0 0.0% 0 0.0% 0 0.0%
PA Resources 0 0.0% 0 0.0% 0 0.0% 0 0.0%
PA Referral 0 0.0% 0 0.0% 0 0.0% 0 0.0%
Very  Highly  Activ e (≥ 600 m in/wk) 60 4.6% 29 4.1 % 46 4.7 % 1 35 4.5%
PA Docum entation
None 34 2.6% 27 3.9% 46 4.7 % 1 07 4%
Activ ity  Lev el Identified 25 1 .9% 2 0.3% 0 0.0% 27 0.9%
PA Adv ice/Counseling 1 0.1 % 0 0.0% 0 0.0% 1 0.03%
ExRx 0 0.0% 0 0.0% 0 0.0% 0 0.0%
PA Resources 0 0.0% 0 0.0% 0 0.0% 0 0.0%
PA Referral 0 0.0% 0 0.0% 0 0.0% 0 0.0%
a. The EMR++ prov iders were exposed to an EMR sy stem s change, receiv ed EIM-related resources, and 
attended a 30-m inute EIM training session. The EMR+ prov iders did not receiv e training and the EMR 
prov iders were exposed to the sy stem s change only . 
b. Proportions were determ ined for each group using the num ber of encounters with the docum ented outcom e, 
relativ e to the group totals. Total proportions were calculated using the total num ber of encounters for each 
category  relativ e to the ov erall total. 
Table 1 2. Proportions of docum ented engagem ent, by  patient PA lev el and prov ider group. 
a, b
EMR++ - Group 1 EMR+ - Group 2 EMR - Group 3
(n=1 294) (n=7 00) (n=980)
Total
(N=297 4)
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APPENDIX B 
FIGURES  
  111 
Figure 1: Key components of a process evaluation and relations among them. Reprinted from “Process 
evaluation of complex interventions: Medical Research Council guidance,” by G.F. Moore, et al., 2015, BMJ, 
350, p. 2. Copyright by the British Medical Journal Publishing Group. 
  
  112 
Figure 2: Implementation processes which occurred during phases 1-3 of the study. 
 
  
Phase 1: Pre-
Implementation
•Study Days 1-19 
•Days 1-15: PA charting 
tool developed and 
tested
•Days 17-18: Charting 
tool training sessions 
conducted with non-
provider staff
•Day 19: EIM resources 
emailed to EMR+ and 
EMR++ Providers 
(n=16)
Phase 2: 
Implementation
•Study Days: 20-46
•Days 20 and 25
EIM provider training 
conducted at clinc 1 
with EMR++ providers 
(n=6)
•Day 26: EMR+ group 
received systems 
training video
•Day 27: Charting tool 
integrated into EMR 
system
Phase 3: 
Implementation
•Study Days: 46-64
•Day 46: EIM provider 
training conducted at 
clincs 2-4 with EMR ++ 
providers (n=5)
Days 1-46:  Patient survey data collected 
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Figure 3. Screenshot of the vital signs section of the EMR with the PAVS modifications. 
  114 
Figure 4. Screenshot of the message prompt to complete the PAVS before proceeding to other vitals. 
 
  
  
  115 
Figure 5. Screenshot of the provider documentation options available in the EMR when the PAVS is marked 
as reviewed. 
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Figure 11. Distribution of patient demographic categories, documented in the electronic medical record, for each provider 
group. a 
   
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Obese (n = 371)
Overweight (n = 715)
Normal Weight (n = 1622)
Underweight (n = 164)
Not Reported (n = 370)
Other (n = 125)
White (n = 1455)
Hispanic/ Latino (n = 401)
Black/African American (n = 140)
Asian (n = 483)
≥ 40 yrs (n = 101)
25 - 39 yrs (n = 938)
18 - 24 yrs (n = 1935)
Female (n = 1519)
Male (n = 1415)
EMR++ (n = 1294) EMR+ (n = 700) EMR (n = 980)
a. EIM++ providers were exposed to an EMR systems change, received EIM-related resources, and attended a 30-
minute EIM training session; EMR+ providers did not receive training and EMR providers were exposed to the 
systems change only. 
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Figure 12. Distribution of physical activity levels, by intervention group a, based on self-reported physical activity 
documented in the electronic medical record.  
  
 
  
a. EIM++ = providers were exposed to an EMR systems change, received EIM-related resources, and attended a 30-
minute EIM training session. The EMR+ providers did not receive training and EMR providers were exposed to the 
systems change only. 
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Very Highly Active (≥ 600 min/wk) 
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Figure 13. Distribution of physical activity levels, by group a and sex, based on self-reported PAVS documented in the 
electronic medical record.  
  
 
 
  
a. EIM++ = providers were exposed to an EMR systems change, received EIM-related resources, and attended a 
30-minute EIM training session. The EMR+ providers did not receive training and EMR providers were exposed to 
the systems change only. 
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APPENDIX C 
PATIENT SURVEY  
  128 
EIM Patient Intercept Survey 
 
Start of Block: Default Question Block 
 
Q1 Study: Implementing the Exercise is Medicine™ Solution: A Process Evaluation Conducted in a 
University-Based Healthcare System 
   
Hello, I am a doctoral student under the direction of Dr. Cheryl Der Ananian in the College of Health Solutions at Arizona 
State University. I am conducting a research study to evaluate physical activity promotion in the ASU healthcare 
environment and am inviting you to participate in a brief 9-question survey.       
 
I am inviting you to participate in a one-time survey regarding your recent visit to one of the ASU health clinics. You must 
be 18 or older to complete the survey and your participation is voluntary.  If you chose to participate, you have the right 
not to answer any question and can stop taking the survey at any time.  If you choose not to participate in the study, there 
is no penalty.         
 
Your responses to the survey will be used to inform the research team about the ASU providers’ physical activity 
promotion efforts. We will not be collecting any personally identifiable information and your responses to 
the survey will be confidential and anonymous. As a participant, there is no direct benefit to you and there are no 
foreseeable risks or discomforts to your participation. The results of this survey may be used in reports, presentations, or 
publications and will only be shared in the aggregate form. 
 
If you have any questions concerning the research study, please contact the research team at: 
Natasha.Birchfield@asu.edu or Cheryl.DerAnanian@asu.edu. If you have any questions about your rights as a 
participant in this research, or if you feel you have been placed at risk, you can contact the Chair of the Human Subjects 
Institutional Review Board, through the ASU Office of Research Integrity and Assurance, at (480) 965-6788.  
  
By selecting the option below and continuing with this survey I am agreeing to be a part of this study. 
o I am at least 18 years old and consent to take this survey.   
 
Skip To: Q2 If Q1 = I am at least 18 years old and consent to take this survey. 
 
Q2 Please provide the date (mm/dd/yyyy) of your most recent visit to ASU Health Services.  
 
Q3 What is your biological sex? 
o Male    
o Female   
o Prefer not to answer    
 
Q4 Which of the following best describes your academic status? 
o Freshman   
o Sophomore    
o Junior    
o Senior   
o Graduate Student   
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Q5 Which ASU healthcare clinic did you visit? 
o Downtown Primary Care Clinic    
o Polytechnic Primary Care Clinic  
o Tempe Acute Care Clinic   
o Tempe Primary Care Clinic  
o West Campus Primary Care Clinic  
Display This Question: 
If Q5 = Downtown Primary Care Clinic 
Q6 Which provider did you see during your visit? 
o Thomas Eccles, MD   
o Diane Labban, FNP   
o Stacy Maahs, FNP   
o Tammy Ostroski, FNP    
o Rita Wermers, NP   
o Other (Please enter the provider's name in the space provided below):   
Display This Question: 
If Q5 = Polytechnic Primary Care Clinic 
Q7 Which provider did you see during your visit? 
o Lisa Eckerson, FNP   
o Deborah Garland, MD   
o Tammy Ostroski, FNP   
o Denise Sarsam, FNP    
o Other (Please enter the provider's name in the space provided below):   
Display This Question: 
If Q5 = Tempe Acute Care Clinic 
Q8 Which provider did you see during your visit? 
o David Eisenbise, FNP   
o Jennifer Gresham, FNP   
o Heather Healy, FNP   
o Carmen Henry, FNP   
o Mario Islas, MD    
o Stefanie Schroeder, MD   
o Other (Please enter the provider's name in the space provided below): 
Display This Question: 
If Q5 = Tempe Primary Care Clinic 
Q9 Which provider did you see during your visit? 
o Gloria Baca, NP   
o Denise Beighe, MD  
o Joan Cobb, FNP    
o Thomas Eccles, MD   
o Lisa Eckerson, FNP   
o Stanford Ho, MD   
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o John Hopkins, MD  
o Diane Labban, FNP   
o Larisa Lopatko, FNP   
o Stacy Maahs, FNP   
o Eva Wang, FNP   
o Joy Wolfe, MD   
o Other (Please enter the provider's name in the space provided below):  
Display This Question: 
If Q5 = West Campus Primary Care Clinic 
Q10 Which provider did you see during your visit? 
o John Hopkins, MD   
o Larisa Lopatko, FNP   
o Michelle Flanagan, FNP   
o Other (Please enter the provider's name in the space provided below):  
 
 
Q11 Which of the following applies to your visit today? Please select all that apply. 
▢ I was asked about my physical activity or exercise behaviors.   
▢ My provider gave me advice about my physical activity or exercise behaviors.   
▢ My provider gave me a prescription for physical activity or exercise.   
▢ My provider suggested I visit the Sun Devil Fitness Complex.   
▢ I was given a brochure about physical activity and my health.   
▢ None of the above   
 
Display This Question: 
If Q11 = My provider gave me advice about my physical activity or exercise behaviors. 
 
Q12 Briefly describe the advice given to you by your provider. 
 
Q13 On average, how many days per week are you physically active at least at a moderate intensity, such as brisk walking? 
o 0   
o 1    
o 2    
o 3    
o 4    
o 5    
o 6    
o 7    
 
Skip To: End of Survey If Q13 = 0 
 
Q14 On average, how many minutes per day are you active at this level? Please answer using a numeric value. 
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APPENDIX D 
PAVS RESOURCE CARD: QUESTIONS INCLUDING TRANSLATIONS 
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ASU Health Services: Physical Activity Vital Sign 
Obtaining the PAVS: At the beginning of the patient intake process, ask the following 
two questions and enter in the corresponding cells in the “vitals” section of the patient 
chart.  
1. On average, how many days per week do you engage in at least moderate 
intensity physical activity, like brisk walking?  
2. On average, how many minutes per day do you engage in physical activity at 
this level? 
Arabic Translation:  
1.  ؟ع    يسرلا   
 شملا لثم هدش   ثكا  وا هدشلا  لدتعم   
 ضاير  طاشن سرامت  عوبسلاا   
 
ف موي مك 
2.  ؟هدش   ثكا وا  هدشلا  هلدتعم هضاير سرامت مويلا   
 
ف هقيقد مك 
Mandarin Translation - Traditional Chinese Characters:  
1. 平均來說，請問您每週有幾天會運動（中等強度或以上，例如: 快走）？ 
2. 平均來說，請問您ㄧ天會運動幾分鐘 （中等強度或以上）？ 
Mandarin Translation - Simplified Chinese Characters Translation:  
1. 平均来说，请问您每周有几天会运动（中等强度或以上，例如: 快走）？ 
2. 平均来说，请问您ㄧ天会运动几分钟 （中等强度或以上）？ 
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APPENDIX E 
THE MIRACLE DRUG: EXERCISE IS MEDICINE OVERVIEW 
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EXERCISE IS MEDICINE: PROVIDERS’ ACTION GUIDE  
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APPENDIX G  
EXERCISE IS MEDICINE: SIT LESS MOVE MORE 
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APPENDIX H 
BEING ACTIVE FOR A BETTER LIFE  
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APPENDIX I 
EXERCISE IS MEDICINE: BEING ACTIVE WITH DEPRESSION/ANXIETY 
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APPENDIX J 
EXERCISE IS MEDICINE: BEING ACTIVE WHEN YOU HAVE TYPE 2 DIABETES  
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APPENDIX K 
EXERCISE IS MEDICINE: BEING ACTIVE WHEN YOU HAVE PREDIABETES  
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APPENDIX L 
EXERCISE IS MEDICINE: BEING ACTIVE WITH HAVE HIGH BLOOD PRESSURE  
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APPENDIX M 
EXERCISE IS MEDICINE: EXERCISE PRESCRIPTION FORM 
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APPENDIX N 
PHYSICAL ACTIVITY PROMOTION IN THE HEALTHCARE ENVIRONMENT 
PROVIDER SURVEY 
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Physical Activity Promotion in the Healthcare Environment 
 
Q1 Study: Implementing the Exercise is Medicine™ Solution: A Process 
Evaluation Conducted in a University-Based Healthcare System 
   
Hello ASU Providers! I am a doctoral student under the direction of Dr. Cheryl Der 
Ananian in the College of Health Solutions at Arizona State University. For my 
dissertation, I am conducting a research study to evaluate physical activity promotion in 
the ASU healthcare environment and am inviting you to participate in a survey.  
I am inviting you to participate in this survey regarding your perceptions of physical 
activity promotion in the health care environment.  Your participation is voluntary.  If 
you chose to participate, you have the right not to answer any question and can stop 
taking the survey at any time.  If you choose not to participate in the study, there is no 
penalty.         
Your responses to the survey will be used to inform the research team about your 
experiences with physical activity promotion in the ASU healthcare system. As a 
participant, there is no direct benefit to you and there are no foreseeable risks or 
discomforts to your participation. The results of this survey may be used in reports, 
presentations, or publications and will only be shared in the aggregate form. Your name 
and/or other personally identifiable information will not be shared at any time. 
If you have any questions concerning the research study, please contact the research 
team at: Natasha.Birchfield@asu.edu or Cheryl.DerAnanian@asu.edu. If you 
have any questions about your rights as a participant in this research, or if you feel you 
have been placed at risk, you can contact the Chair of the Human Subjects Institutional 
Review Board, through the ASU Office of Research Integrity and Assurance, at (480) 
965-6788.  
  
By selecting the option below and continuing with this survey I am agreeing to be a part 
of this study. 
o I consent to participate and would like to continue to the survey.   
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Q2 Please select your provider type: 
o Physician   
o Nurse Practitioner   
 
Q3 What is your biological sex? 
o Male  
o Female  
 
Q4 What is your age? Please answer using a whole numerical value. 
 
Q5 How many years have you been in practice as a healthcare provider? Please answer 
using the number of years and months (e.g. 2 years 7 months) in practice. 
 
Q6 How long have you worked as a healthcare provider at ASU? Please answer using 
number of years and months (e.g. 2 years 7 months). 
 
Q7 How many days per week do you typically work in an ASU healthcare clinic? Please 
only include number of days worked from Monday through Friday.   
 
Q8 Which of the following best describes your work schedule: Please select all that apply 
▢ Full time  
▢ Part-time   
▢ PRN  
 
Q9 Which ASU Health Services clinic are you primarily affiliated with? 
o Downtown Campus Primary Care    
o Polytechnic Campus Primary Care   
o Tempe Campus Acute Care   
o Tempe Campus Primary Care   
o West Campus Primary Care   
 
Q10 What is the average number of patients you personally see at ASU each week? 
Please estimate to the best of your ability using a whole numerical value. Please avoid 
providing a range of values.  
 
Q11 Please provide the usual number of hours you work each week in ASU Health 
Services clinics. Please answer using a whole numerical value. 
 
Q12 On average, how many days per week do you engage in at least moderate intensity 
physical activity such as brisk walking? Please answer using a whole numerical value. 
Q13 On average, how many minutes per day do you engage in at least moderate intensity 
physical activity? Please answer using a whole numerical value. 
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Q14 How physically active do you think you are compared to other Americans? 
o Less Active  
o About the Same  
o More Active  
 
Q15 Generally, activities such as taking the stairs each day is enough physical activity to 
improve health. 
o Agree   
o Disagree  
 
Q16 Half an hour of walking on most days is enough physical activity to improve health. 
o Agree    
o Disagree  
 
Q17 Exercise that is good for health must be a high intensity level, such as running.  
o Agree   
o Disagree  
 
Q18 Several short walks of 10-minutes each on most days is better than one round of golf 
per week for good health. 
o Agree    
o Disagree   
 
Q19 Discussing the benefits of a physically active lifestyle with patients is part of the 
healthcare providers role. 
o Agree    
o Disagree  
 
Q20 Suggesting ways for patients to increase daily physical activity is part of the 
healthcare providers role. 
o Agree   
o Disagree    
 
Q21 I feel confident in giving general advice to patients about physical activity. 
o Agree    
o Disagree  
 
Q22 I feel confident in suggesting specific physical activity programs for my patients. 
o Agree   
o Disagree   
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Q23 Healthcare providers should be physically active to act as a role model for their 
patients. 
o Agree    
o Disagree  
 
Q24 How often have you encouraged your patients to be more physically active in the 
past month? 
o Never    
o Rarely (1-2 patients)    
o Sometimes (3-5 patients  
o Often (6-9 patients)    
o Very Often (10 or more patients)  
 
 
Page Break  
Q25 How often does one of the following prevent you from promoting a physically active 
lifestyle to your patients? Please select only one response for each statement. 
 Never  Sometimes Often 
Lack of time  o  o  o  
Lack of counseling 
skills  o  o  o  
Lack of 
remuneration for 
promoting physical 
activity  
o  o  o  
Lack of interest in 
promoting physical 
activity to patients  
o  o  o  
Feeling it would not 
change the patients' 
behavior   
o  o  o  
Feeling it would not 
be beneficial for the 
patient  
o  o  o  
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Q26 What kinds of physical activity would be feasible for you to deliver to your patients. 
Please select only one response for each statement. 
 Feasible Not Feasible 
Brief counseling integrated 
into your regular 
consultations 
o  o  
Separate one-on-one 
consultations o  o  
Group sessions o  o  
Distribution of resources 
(e.g. brochures)  o  o  
 
Q27 Please select if you agree or disagree with the following statements: 
 Agree Disagree 
I am confident I can 
identify physically inactive 
patients.  
o  o  
I am confident I can 
provide brief counseling to 
physically inactive patients.  
o  o  
I am confident I can 
prescribe physical activity 
to inactive patients.  
o  o  
I am confident I can refer 
physically inactive patients 
to an ASU facility or 
program.  
o  o  
I am confident I can 
provide resources (e.g. 
brochures) to patients 
about being physically 
active.  
o  o  
 
Q28 Are you aware of the Physical Activity Guidelines for Americans? 
o Yes   
o No    
Skip To: Q30 If Q28 = No 
Q29 Please describe the Physical Activity Guidelines for Americans. 
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Q30 Have you viewed any Exercise is Medicine branded resources? 
o Yes, I viewed the handouts that were provided   
o No  
Skip To: Q33 If Q30 = No 
Q31 Please select which of the following items you have reviewed: Select all that apply 
▢ Exercise is Medicine Summary Sheet   
▢ Healthcare Providers' Resource Guide   
▢ Prescription for Health Series: Sit Less Move More 
▢ Prescription for Health Series: Being Active with Anxiety and Depression   
▢ Prescription for Health Series: Being Active for a Better Life   
▢ Prescription for Health Series: Being Active with Type 2 Diabetes   
▢ Prescription for Health Series: Being Active with Prediabetes 
▢ Prescription for Health Series: Exercising with High Blood Pressure   
 
Q32 Please state if you agree or disagree with the following statements: 
 Agree  Disagree  
The Exercise is Medicine 
Summary Sheet was a 
useful resource.  
o  o  
The Healthcare Providers' 
Action Guide was a useful 
resource.  
o  o  
The Prescription for Health 
Series topic guides 
provided useful 
information.  
o  o  
 
Q33 Did you participate in the Exercise is Medicine providers' training workshop? 
o Yes   
o No   
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APPROVAL: EXPEDITED REVIEW 
Cheryl Der Ananian 
Exercise Science and Health Promotion 
602/827-2290 
Cheryl.Derananian@asu.edu 
Dear Cheryl Der Ananian: 
On 3/3/2019 the ASU IRB reviewed the following protocol: 
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Type of 
Review: 
Initial Study  
Title: Implementing the Exercise is Medicine™ Solution: A Process 
Evaluation Conducted in a University-Based Healthcare 
System 
Investigator: Cheryl Der Ananian 
IRB ID: STUDY00009762 
Category of 
review: 
(5) Data, documents, records, or specimens, (7)(a) Behavioral 
research 
Funding: None 
Grant Title: None 
Grant ID: None 
Documents 
Reviewed: 
• EIM problems with sitting brochure, Category: Resource 
list; 
• Provider interview consent, Category: Consent Form; 
• Provider survey consent, Category: Consent Form; 
• Exercise for anxiety and depression, Category: Resource 
list; 
• Patient Survey Consent , Category: Consent Form; 
• ASUHS Letter of Support, Category: Other (to reflect 
anything not captured above); 
• Provider survey - PA promotion, Category: Measures 
(Survey questions/Interview questions /interview 
guides/focus group questions); 
• Patient intercept survey, Category: Measures (Survey 
questions/Interview questions /interview guides/focus group 
questions); 
• Patient survey recruitment message, Category: Recruitment 
Materials; 
• Provider training evaluation form, Category: Measures 
(Survey questions/Interview questions /interview 
guides/focus group questions); 
• Exercise and type 2 diabetes, Category: Resource list; 
• Provider interview questions, Category: Measures (Survey 
questions/Interview questions /interview guides/focus group 
questions); 
• Sit less move more, Category: Resource list; 
• EIM Providers' Action Guide, Category: Participant 
materials (specific directions for them); 
• Provider survey recruitment message, Category: 
Recruitment Materials; 
• Exercise for prediabetes, Category: Resource list; 
• Exercise for better life, Category: Resource list; 
• Exercise and high blood pressure, Category: Resource list; 
• 
EIM_Process_Eval_IRB_Application_2.27.19_nb_edits.doc
x, Category: IRB Protocol; 
• EIM Summary, Category: Participant materials (specific 
directions for them); 
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The IRB approved the protocol from 3/3/2019 to 3/2/2020 inclusive. Three weeks 
before 3/2/2020 you are to submit a completed Continuing Review application and 
required attachments to request continuing approval or closure.  
If continuing review approval is not granted before the expiration date of 3/2/2020 
approval of this protocol expires on that date. When consent is appropriate, you must use 
final, watermarked versions available under the “Documents” tab in ERA-IRB. 
In conducting this protocol you are required to follow the requirements listed in the 
INVESTIGATOR MANUAL (HRP-103). 
Sincerely, 
IRB Administrator 
cc: Natasha Birchfield 
Aaron Krasnow 
Pamela Swan 
Marc Adams 
Cheryl Der Ananian 
Natasha Birchfield 
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Date: February 13, 2019 
 
Re: Letter of Support from Arizona State University Health Services 
 
Dear Ms. Birchfield,  
 
This letter confirms that that I, as an authorized representative of ASU Health Services, allow you access to 
the ASU health clinics and data, as requested. You can conduct your dissertation study-related activities at 
the listed sites, under the supervision of your advisor, Cheryl Der Ananian, PhD. Study-related activities may 
commence upon IRB approval for the proposed project. 
 
• Research Site(s): ASU Health Services, 451 E. University Dr., Tempe, AZ 85287 
ASU Health Services, 7332 E. Sun Devil Mall, Mesa, AZ 85212 
ASU Health Services, 500 N. 3rd St, Suite 155, Phoenix, AZ 85004 
ASU Health Services, 4701 W. Thunderbird Rd., Glendale, AZ 85306 
 
• Study Purpose:  The purpose of this study is to conduct a process evaluation of the 
implementation of the Exercise is Medicine™ (EIM) Solution in a university-based 
healthcare system to address physical inactivity with patients in primary care.  
 
• Study Activities: Patients will be invited to participate in an anonymous intercept survey 
via a link provided in an email sent through the ASU patient portal. The survey will be 
administered using the Qualtrics survey platform. All tracking options will be disabled, 
and no personally identifiable information will be collected, to ensure participant 
anonymity. This will help us establish a baseline trend and compare reported patient 
trends to documented data trends in the electronic medical record (EMR). Patient 
intercept data will be collected (Mon-Fri) at each location.  
 
The EMR will be modified to collect a physical activity vital sign and will include charting 
options to document patient/provider interactions related to physical activity counseling, 
prescriptions, educational materials, and referrals. Providers will also receive training 
resources when the EMR changes occur. Two-to-four weeks following the EMR system 
update, three phases of in-person EIM training, will be conducted with 17 primary care 
providers 2-4 weeks apart. A satisfaction with training questionnaire will be administered 
in paper form at the end of each training session.  
 
The Physical Activity Promotion in the Healthcare Environment survey will be 
administered using Qualtrics to assess provider behaviors, perceptions, and barriers 
towards addressing physical activity. Providers will be invited via email to complete the 
survey before the EMR system modification and release of the EIM training resources. 
The survey will also be administered upon completion of the study.  
 
 
Providers and non-provider staff will also be interviewed at the end of the study to assess 
their satisfaction with the EMR modification, EIM processes and resources, and the EIM 
training if applicable.       
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• Subject Enrollment: Patients evaluated in the primary care clinics will be eligible to 
participate in the anonymous intercept survey and completion of the survey will be at the 
patient’s discretion.  
 
Seventeen primary care providers will be selected to participate in the study. 
 
• Site(s) Support: ASU Health Services agrees to modify the EMR to add the charting options 
for collecting the physical activity vital sign (PAVS) and for providers to document levels 
of engagement. Deidentified data will be provided for daily encounters occurring within 
the participating clinics.  
 
• Data Management: Deidentified data, including date of visit, clinic location, provider, 
provider type, visit type, reason for visit, patient sex, patient age, patient race, patient’s 
academic major, patient height, patient weight, BMI, physical activity vital sign, PHQ-2 
score, primary diagnostic category, and charting options recorded by providers will be 
provided using the EMR database. All data will be stored in a university sponsored 
Dropbox business account which will be password protected and only accessible by 
members of the research team. Any computer accessing the Dropbox files will be 
encrypted in accordance with ASU’s electronic security plan.  
  
• Anticipated End Date: The anticipated end date for the study is March 31, 2020.  
 
ASU Health Service’s participation will only take place during the study’s active IRB approval 
period. All study related activities must cease if IRB approval expires or is suspended. 
Furthermore, any activities involving Personal Private Information or Protected Health 
Information require compliance with HIPAA Laws and ASU’s Policy. 
 
Our organization agrees to the terms and conditions stated above. If we have any concerns related to this 
project, we will contact the PI. For concerns regarding IRB policy or human subject welfare, we may also 
contact ASU’s IRB. 
 
Regards, 
 
 
 
 
February 13, 2019 
Signature 
 
Aaron Krasnow, PhD 
Date Signed 
 
Associate Vice President of ASU Health 
Services 
Full Name Job Title 
 
 
 
